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Abstract 
Aicardi-Goutières syndrome (AGS) is an autosomal recessive encephalopathy with low 
incidence. The disease is caused by mutations in the genes encoding for TREX1, 
SAMHD1, ADAR, IFIH1 and the three genes encoding for the heterotrimeric RNase H2 
enzyme. Biallelic mutations in any of the genes cause elevated type I interferon levels in 
the cerebrospinal fluid (CSF), the hallmark of AGS. In AGS patients, increased type I 
interferon levels cause massive inflammation in the brain that leads to mental and 
physical retardation that likely cause death in early childhood. AGS shows significant 
overlap with the prototypic autoimmune disease systemic lupus erythematosus (SLE). 
Like AGS patients, SLE patients are also characterized by increased type I interferon 
levels, anti-nuclear autoantibodies (ANAs) and arthritis. Moreover, heterozygous 
mutations in TREX1, SAMHD1 and RNase H2 are also found in a small fraction of SLE 
patients. Due to the genetic, molecular and clinical overlap, AGS is regarded as a 
monogenic variant of SLE. This overlap allows for the investigation of SLE 
pathomechanisms using genetically engineered mouse models with AGS-related 
mutations. 
In order to generate a mouse model that allows for the identification of pathomechanisms 
in AGS patients with mutations in the genes encoding for the RNase H2 enzyme, we 
generated mice with deficiency for the RNase H2 enzyme. Mice with complete deficiency 
for the RNase H2 enzyme (Rnaseh2c-/- or Rnaseh2bKOF/KOF) died perinatally or were 
stillborn. Mouse embryonic fibroblasts (MEFs) from E14.5 Rnaseh2bKOF/KOF embryos 
displayed impaired proliferation that was caused by the accumulation of MEF cells in 
G2/M of the cell cycle which increased with cultivation time or if MEF cells were isolated 
from E18.5 Rnaseh2bKOF/KOF embryos. Gene expression analysis of E14.5 fetal liver cells 
revealed a robust p53-mediated DNA damage response with the cell cycle inhibitor cyclin-
dependent kinase inhibitor 1a (Cdkn1a, p21) being the most up-regulated gene. We found 
increased numbers of phosphorylated histone H2AX (γH2AX) in fetal liver and thymus 
cells from E18.5 Rnaseh2bKOF/KOF embryos, indicative of DNA double-strand breaks. 
Finally, we could show increased ribonucleotide loads in genomic DNA from embryos that 
were completely deficient for the RNase H2 enzyme. Collectively, we have demonstrated 
that complete RNase H2 deficiency causes persistent genomic ribonucleotide loads that 
render the DNA instable and prone to DNA strand breaks. DNA damage leads to the 
activation of p53 that in turn activates the cell cycle inhibitor p21 that inhibits cell cycle 
progression and likely causes accumulation of RNase H2-deficient cells in G2/M.  
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To bypass early lethality we also generated bone marrow chimera and cell type-specific 
knockouts of the Rnaseh2b gene. While fetal liver cells of E14.5 Rnaseh2bKOF/KOF 
embryos could maintain hematopoiesis of irradiated recipient mice for almost one year, 
bone marrow cells from these primary recipients failed to reconstitute lethally irradiated 
mice in a secondary transfer. In line with this observation, VavCre-mediated deletion of 
the Rnaseh2b gene caused a more than hundred fold reduction of peripheral blood B 
cells, while B cell numbers remained unaltered upon CD19Cre-mediated deletion that 
occurs much later in B cell development. These data suggested that RNase H2 deficiency 
leads to the accumulation of genomic ribonucleotides that might cause the accumulation 
of a so far uncharacterized DNA damage species with increasing cell cycle passages. The 
data further supported our hypothesis that the impact of RNase H2 deficiency is 
determined by the number of cell proliferation.  
Finally, an epidermis-specific knockout of the Rnaseh2b gene displayed the most 
dramatic phenotype. Knockout mice were characterized by hyperpigmentation, hair loss 
and spontaneous ulcerations of the skin. Microscopically, these mice displayed moderate 
thickening of the epidermis and dermal fibrosis as indicated by increased collagen 
deposition. Macroscopic skin phenotypes were completely dependent on p53 expression, 
since concomitant deletion of the p53 gene rescued mice from hyperpigmentation, hair 
loss and ulcerations. This data demonstrated that Rnaseh2b deficiency in the epidermis 
may also lead to DNA damage and subsequent p53 activation as shown for fetal liver from 
E14.5 RNase H2-deficient embryos. Preliminary data also indicate an increased incidence 
of cancer formation in RNase H2/p53 double knockouts, identifying the RNase H2 enzyme 
as an important tumor suppressor. 
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Zusammenfassung 
Das Aicardi Goutières Syndrom (AGS) beschreibt eine sehr seltene autosomal rezessive 
Enzelopathie, die durch Mutationen in den Genen Trex1, Samhd1, Adar, Ifih1 sowie in 
allen drei Genen, die für das heterotrimere RNase H2 Enzym kodieren, hervorgerufen 
wird. Biallelische Mutationen in diesen Genen führen zu einer unkontrollierten Typ I 
Interferon Antwort und erhöhte Zytokinspiegel in der zerebrospinalen Flüssigkeit, das 
Hauptcharakteristikum dieser Erkrankung. Die unkontrollierte Typ I Interferon Antwort geht 
einher mit einer massiven Entzündung des Gehirns, die geistige und körperliche 
Schädigungen, als auch den frühen Kindstod zur Folge haben kann. Von besonderem 
Interesse ist das Aicardi Goutières Syndrom auf Grund seiner Gemeinsamkeiten mit der 
prototypischen Autoimmunerkrankung Systemischer Lupus Erythematodes (SLE). SLE ist 
wie AGS durch eine unkontrollierte Typ I Interferon Antwort, antinukleäre Autoantikörper 
und Arthritis charakterisiert. Außerdem werden in einem Teil der SLE Patienten 
heterozygote Mutationen in den Genen Trex1, Samhd1 sowie in allen drei Genen des 
heterotrimeren RNase H2 Enzyms gefunden. Aufgrund der klinischen, molekularen und 
genetischen Gemeinsamkeiten zwischen SLE und AGS, wird das Aicardi Goutières 
Syndrom als eine monogenetische Variante des SLE betrachtet und stellt somit ein 
wertvolles Werkzeug für die Entschlüsselung SLE-relevanter Pathomechanismen dar.  
Für die Identifizierung von Pathomechanismen des SLE generierten wir verschiedene 
RNase H2-defiziente Mausmodelle. Vollständig RNase H2-defiziente Mäuse und Mäuse 
mit einer hypomorphen Expression des RNase H2 Enzyms verstarben allerdings in der 
frühen embryonalen Entwicklung (E10.5) (Rnaseh2c-/-) beziehungsweise wurden tot 
geboren (Rnaseh2bKOF/KOF). Mausembryonale Fibroblasten aus E14.5 Rnaseh2bKOF/KOF 
Embryonen wiesen eine reduzierte Wachstumsrate auf, welche durch die Akkumulation 
der Zellen in der G2/M Phase des Zellzyklus hervorgerufen wurde. Beide Phänomene 
zeigten eine stärkere Ausprägung mit Fortlauf der Kultur oder wenn Mausembryonale 
Fibroblasten aus E18.5 Rnaseh2bKOF/KOF Embryonen gewonnen wurden. Eine Microarray-
basierte Genexpressionsanalyse fötaler Leberzellen von E14.5 Rnaseh2bKOF/KOF 
Embryonen offenbarte die verstärkte Expression p53-induzierter Gene, während das Gen 
Cdkn1a (cell cycle-dependent kinase inhibitor 1a), auch bekannt als p21, die stärkste 
Aufregulation zeigte. Das vermehrte Auftreten von phosphoryliertem Histon H2AX 
(γH2AX) in fötalen Leber- und Thymuszellen von E18.5 Rnaseh2bKOF/KOF Embryonen legte 
die Existenz einer DNA Schadensantwort nahe. Nachfolgende Untersuchungen konnten 
zeigen, dass die Abwesenheit des RNase H2 Enzyms zu einer vermehrten Akkumulierung 
von Ribonukleotiden in der genomischen DNA führt. Zusammenfassend weisen unsere 
Daten darauf hin, dass der vermehrte Einbau von Ribonukleotiden die genomische DNA 
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anfällig für DNA Schaden macht und dass dieser Schaden eine p53-mediierte DNA 
Reparaturantwort auslöst. 
Um trotz der frühen Letalität RNase H2-defizienter Mäuse mögliche Pathomechnismen 
des SLE identifizieren zu können versuchten wir in der Folge die Letalität durch die 
Generierung von Knochenmarkschimären und Zelltyp-spezifischen Knockouts zu 
umgehen. In einem ersten Transferexperiment waren fötale Leberzellen von E14.5 
Rnaseh2bKOF/KOF Embryonen vollständig kompetent letal-bestrahlte Rezipienten zu 
rekonstituieren. Wurde allerdings das Knochenmark dieser primären Rezipienten in letal-
bestrahlte sekundäre Rezipienten transferiert, so waren RNase H2-defiziente Zellen nicht 
mehr in der Lage diese Tiere zu rekonstituieren. Bei der Generierung Zelltyp-spezifischer 
Knockouts beobachteten wir ein ähnliches Ergebnis. Während der B Zell-spezifische 
Knockout (CD19Cre-mediiert) des Rnaseh2b Gens nur einen sehr geringen Einfluß auf B 
Zellen hatte, so führte ein VavCre-spezifischer Knockout in der frühen hematopoietischen 
Stammzelle zu einer massiven Reduzierung der B Zellzahlen im peripheren Blut. 
Basierend auf diesen Daten vermuten wir, dass in der Abwesenheit des RNase H2 
Enzyms ein unbekannter DNA-Schaden während jeder Zellteilung akkumuliert der nur 
eine begrenzte Anzahl von Zellzyklen erlaubt.  
Wir generierten schließlich einen Epidermis-spezifischen Knockout des Rnaseh2b Gens. 
Dieser Knockout wies den dramatischsten Phänotyp auf und war makroskopisch durch 
Hyperpigmentation, Haarverlust und spontane Ulzerationen charakterisiert. Mikroskopisch 
fiel neben einer moderaten Verdickung der Epidermis, die stark veränderte Dermis auf, 
die eine milde Leukozyten-Infiltration, Interface Dermatitis und erhöhte 
Kollagenablagerungen aufwies. Die Rückkreuzung des Epidermis-spezifischen Knockouts 
auf einen p53-defizienten Hintergrund führte in großen Teilen zum Rückgang der 
Pathologie auf Wildtyp-Niveau. Präliminäre Daten zeigten außerdem, dass die 
gleichzeitige Abwesenheit des p53 Gens die Bildung von kanzerogenen 
Gewebsveränderungen und die Tumorbildung begünstigt. Diese Daten zeigen, dass auch 
die Abwesenheit des RNase H2 Enzyms in der Haut zu einer p53-mediierten DNA 
Schadensantwort führt und dass das RNase H2 Enzym eine wichtige Rolle bei der 
Tumorsuppression einnimmt. 
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1. Introduction 
1.1 The immune system 
The human body is constantly exposed to a plethora of pathogens (bacteria, viruses or 
fungi) that pose a huge threat for the individual fitness. Inability to defend the organism 
against this danger would inevitably cause severe diseases or even death. The human 
organism is therefore well equipped with an effective protection system that guards him 
from invading pathogens and thus preventing the development of harmful diseases 
(Akira et al., 2006).  
The skin represents the first line of defense by forming a physical and mechanical barrier 
that separates the human body from the surrounding environment (Madison, 2003; Watt, 
2014). The tight organization of the epidermis in combination with the secretion of 
different secretes, like sweat, proteases or mucus, does not allow the penetration by 
invading pathogens. The second line of defense is represented by the immune system, a 
large protection system that is composed of cellular and soluble mediators. Thus, even 
once the first barrier is crossed, so due to a skin lesion that allows penetration by the 
pathogen, the human organism still has access to the power of the entire components of 
immune system. The human immune system is composed of two different protection 
systems that can act separately but usually act in concert to defend the human body, the 
innate and the adaptive immune system (Janeway and Medzhitov, 2002). The interplay 
of both, together with the barrier function of the skin, represents a huge wall of defense 
that can be hardly mounted by an invading pathogen in a healthy human organism. The 
maintenance of the immune system is thus of particular importance to prevent frequent 
pathogen infections. 
The innate immune response depicts the first line of defense within the immune system 
(Akira et al., 2006; Kumar et al., 2011; Hoffmann and Akira, 2013). A myriad of different 
proteins, like acute phase proteins or components of the complement system contribute 
to the effective pathogen clearance. However, the cellular innate immune response is 
activated by the detection of so-called pathogen-associated molecular patterns (PAMPs) 
(Janeway and Medzhitov, 2002). PAMPs are conserved pathogen structures that do not 
succumb rapid evolutionary changes, as they are often indispensible for pathogen 
infectivity or vitality. PAMPs are detected by a huge number of germline-encoded pattern 
recognition receptors (PRRs) (Kawai and Akira, 2011; Broz and Monack, 2013). Another 
concept for the activation of the innate immune response comprises the detection of 
danger-associated molecular patterns (DAMPs) (Matzinger, 1994; Matzinger, 2002). In 
striking contrast to PAMPs, DAMPs are host-derived structures that are presented in the 
context of a danger signal. Necrotic cells display an important source of DAMPs, since 
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necrosis leads to concomitant release of endogenous proteins and nucleic acids that 
represent a very potent danger signal in this context. The activation of innate immune 
system is a very fast process, since PAMP-binding to the respective PRR can elicit the 
immediate release of preformed mediators or the rapid de novo synthesis and 
expression of mediators that subsequently interfere with the pathogen. Activation of the 
receptors of the innate immune system most commonly causes the release of pro-
inflammatory cytokines and chemokines. Of particular note is the induction of a type I 
interferon response upon detection of non-self or mislocalized nucleic acid species that 
confer a potent antiviral state to the infected host. However, since the activation of PRRs 
causes the elicitation of a monotonous immune response, the innate immune response 
has to be regarded as being unspecific and in case pathogens have adopted immune 
evasion mechanisms (Iannello et al., 2006; Bowie and Unterholzner, 2008), the effector 
functions of the innate immune system are less effective. The reduced specificity of the 
innate immune system is partly compensated for by the strength of the innate immune 
response that is efficient to eliminate the pathogen but that also increases the risk of 
collateral damage. 
Cells that display effector functions during the innate immune response belong to the 
myeloid lineage of the hematopoietic system. Important members are dendritic cells 
(DCs) and macrophages (Liu, 2001; Mellman and Steinman, 2001). Both cell types are 
equipped with the full set of PRR and are therefore the most important sensors of 
pathogen invasion. Among their various functions, they patrol through the tissue of the 
human body to sample for the presence of pathogenic structures. Due to their unique 
ability to phagocytize apoptotic and necrotic cells as well as other insoluble components, 
these cells take a center stage in the detection of pathogen infection and during the 
subsequent activation of the adaptive immune system (Fearon and Locksley, 1996; 
Medzhitov and Janeway, 1997; Liu, 2001). Important characteristic of DCs and 
macrophages is their ability to present components of the phagocytized material, the 
antigens, to cells of the adaptive immune system. For this reason, DCs and 
macrophages (and also B cells) are termed professional antigen-presenting cells 
(APCs). Antigen-presentation by activated APCs to T cells of the adaptive immune 
system leads to the activation of the adaptive immune system. In contrast to the innate 
immune response, the adaptive immune response is specific and effective in the 
clearance of the invading pathogen. But, since the adaptive immune system is activated 
by the innate immune system, effector functions of the adaptive immune system are 
exerted with a delay of some days. However, since the adaptive immune system is 
capable to built up an immunological memory, the adaptive immune system efficiently 
protects the human organism during subsequent infections. Key effector cells of the 
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adaptive immune system are the T cells and B cells. Their function is either to efficiently 
kill infected cells directly by cytotoxic T cells or to generate an antibody-mediated 
clearance of the infection via helper T cells and B cells. 
Deregulation or defects of the immune system ultimately lead to the development of 
severe diseases, even in the absence of a pathogen infection. While defects in the 
innate immune system cause the generation of autoinflammatory diseases, defects in 
the adaptive immune system lead to autoimmunity. However, there are only few 
examples of diseases that clearly categorize to either of both types of disease. Most 
diseases display a combination of autoinflammation and autoimmunity, simply becuase 
mediators of the innate immune system often influence deregulation of the adaptive 
immune system. Autoimmunity is characterized by the T cell and B cell-mediated 
destruction of self-structures, usually prevented by several tolerance mechanisms. In 
case tolerance is disturbed or incomplete, T cells and B cells with self-specificity promote 
the generation of autoimmunity. 
 
1.1.1 Nucleic acid sensing 
Vertebrate cells are well equipped with a large set of sensors, competent to detect 
invading pathogens. Since these sensors detect invariant structures of the pathogen, 
termed pathogen-associated molecular patterns (PAMPs), the respective sensors are 
called pattern recognition receptors (PRRs). The large group of germline-encoded PRRs 
can be subdivided according to their cellular localization and most importantly, by the 
PAMP they are detecting. While there is only a limited number of PRRs that detect 
invariant surface structures of pathogens, like lipopolysaccharide (LPS) from gram-
negative bacteria (TLR4) or flagellin from flagellated bacteria (TLR5), there is a huge 
group of PRRs that detect nucleic acid species (Medzhitov, 2007; Takeuchi and Akira, 
2010). Among the PRRs that sense the presence of nucleic acids, a small number is 
bound to the endosomal membrane (TLR 3, 7, 8 and 9), whereas most are located in the 
cytoplasm. Among the large group of cytosolic PRRs only a few are solely activated by 
non-self nucleic acid species. However, most cytosolic PRRs can be activated by self- 
as well as non-self nucleic acids, but since the cytosol is usually free from endogenous 
nucleic acids, their activation mostly occurs in the context of a pathogen infection 
(Gurtler and Bowie, 2013). 
The different pathogen sensors can be divided into two main groups, the Toll-like 
receptors (TLRs) and the Rig-like receptors (RLRs). The group of TLRs consists of ten 
human and 13 mouse members. TLRs are membrane-bound receptors that are either 
located on the cell surface or in the membrane of the endosomes, with the receptor 
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facing the endosomal lumen (Kawai and Akira, 2010). The group of cell surface TLRs 
encompasses the TLR-1, 2, 4, 5 and 6. These TLRs monitor the extracellular space and 
mainly sense bacterial structures (as exemplified above). The group of endosomal TLRs 
contains TLR-3, 7, 8, 9 and 13 (TLR-8 is absent in the mouse) characterized by the 
specificity for different nucleic acid species. TLR-3 detects double-stranded RNA 
(dsRNA), TLR-7 and TLR-8 sense single-stranded RNA (ssRNA), TLR-9 detects the 
unmethylated CpG motif of double-stranded DNA and TLR-13 is activated by the 23S 
ribosomal RNA from bacteria (Kawai and Akira, 2010; Oldenburg et al., 2012). Ligand 
binding to TLR-7, 8, 9 and 13 leads to the activation of the downstream molecule 
MyD88, while ligand binding to TLR-3 causes the activation of TRIF. However, activation 
of MyD88 and TRIF activates the NF-κB pathway that leads to IRF3 (interferon 
regulatory factor 3) activation in case of TRIF and to IRF7 activation in case of MyD88. 
Finally, activation of both pathways causes the induction of a type I interferon response 
(Kawai and Akira, 2010).  
RLRs are cytosolic sensors with RNA specificity that scan the cytoplasm for nucleic 
acids from invading microbes. The group of RLRs consists of RIG-I (retinoic acid-
inducible gene-I), MDA5 (melanoma differentiation associated gene 5) and LGP2 
(laboratory of genetics and physiology 2) (Yoneyama et al., 2005; Loo and Gale, 2011). 
Long double-stranded RNA that is absent under physiological conditions in eukaryotic 
cells activates RIG-I and MDA5. While RIG-I is activated by dsRNA of about 300 bp, 
MDA5 prefers dsRNA longer than 4 kb (Kato et al., 2008). However, the actual RIG-I 
substrate is a 5` triphosphate RNA that further contains a panhandle structure (Hornung 
et al., 2006; Pichlmair et al., 2006; Schlee et al., 2009). A 5` triphosphate is virtually 
absent in eukaryotes since eukaryotic RNA (messenger RNA) possesses a 5` Cap 
structure that stabilizes the RNA and prevents it from being degraded. Further RIG-I 
substrates are 5` hydroxyl RNA and 3` monophosphoryl RNA with a double-stranded 
stem, a product of RNase L activity. Most recent data could show that a 5`-diphosphate 
can also efficiently trigger RIG-I activation (Goubau et al., 2014). An important feature of 
RIG-I and MDA5 is the presence of a N-terminal CARD domain (caspase activation and 
recruitment domain) whose repression during steady state is released upon ligand 
binding, allowing the oligomerization of four RIG-I molecules and subsequent activation 
of downstream signaling molecules (Jiang et al., 2012). The downstream adaptor 
molecule of RIG-I and MDA5 is the MAVS molecule (mitochondrial antiviral signaling; 
also known as IPS, CARDIF or VISA) that comprises an N-terminal CARD motif, 
necessary for the interaction of RIG-I or MDA5 and MAVS via a CARD-CARD interaction 
(Kawai et al., 2005; Meylan et al., 2005; Seth et al., 2005). The C-terminus of the MAVS 
molecule is linked to the outer mitochondrial membrane and this association was shown 
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to be important for subsequent signaling pathway activation. Activation of MAVS in turn 
leads to the activation of the cytosolic kinases TBK1 (tank binding kinase 1) and IKK 
(inhibitor of nuclear factor kappa). While TBK1 leads to the transcription of type I 
interferon genes via phosphorylation of the transcription factor IRF3, type I interferon 
genes and genes encoding for pro-inflammatory cytokines are activated by the 
transcription factor NF-κB upon IKK activation (Sun et al., 2006).  
A third group of nucleic acid sensors comprises the cytosolic DNA sensors that were 
recently discovered and that do not display a uniform structure. Cytosolic DNA can be 
detected by the RNA polymerase III / RIG-I pathway (Ablasser et al., 2009; Chiu et al., 
2009). Strangely, cytosolic DNA is first transcribed into dsRNA with a 5` triphosphate 
moiety by the RNA polymerase III, generating an ideal substrate for the RIG-I sensor. 
Binding of the 5` triphosphate dsRNA molecule to RIG-I leads to the activation of type I 
interferon genes via the adaptor molecules MAVS and TBK1, and the transcription factor 
IRF3. Most recently the role of the cyclic GMP/AMP synthase (cGAS) to sense cytosolic 
nucleic acids was elucidated (Sun et al., 2013; Wu et al., 2013). Similar to the 2`, 5`- 
oligoadenylate synthethase (OAS), activation of cGAS leads to the generation of a 
second messenger that activates the stimulator of interferon genes (STING) (Ishikawa 
and Barber, 2008; Zhong et al., 2008; Sun et al., 2009). Upon binding of dsDNA to 
cGAS, the second messenger 2`3`- cyclic GMP/AMP (cGAMP) is synthesized from the 
nucleotides GTP and ATP. Activation of STING leads to the expression of type I 
interferon genes via the adaptor molecule TBK1 and the transcription factor IRF3. Other 
sensors of nucleic acids are the DNA-dependent activator of IRFs (DAI), IFI16, DDX41 
and AIM2 (absent in melanoma 2). While DAI, IFI16 and DDX41 seem to have 
redundant functions in the activation of type I interferon genes, AIM2 represents the sole 
cytoplasmatic DNA sensor that leads to the formation of the AIM2 inflammasome and 
subsequent IL-1β and IL-18 expression (Wu and Chen, 2014) 
 
1.1.2 Type I interferon response 
All mammalian cells express a large set of cytosolic nucleic acid sensors that enable 
them to sense pathogen infection. However, since not all cells express TLRs 
concomitantly, they are not able to detect the presence of pathogens in the extracellular 
space or sense the infection of neighboring cells. To compensate for this inability, 
professional antigen presenting cells (APCs), like dendritic cells (DCs), macrophages or 
B cells (with some minor exceptions) express the complete repertoire of PRRs and are 
thus capable to sample the extracellular space. Moreover, the unique property of DCs, 
macrophages and B cells to engulf apoptotic cells by phagocytosis allows them further to 
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scan these cells for the presence of viral components. As described above, nucleic acid 
binding to the respective PRR leads to the expression of type I interferon via different 
signaling pathways. De novo synthesized type I interferon is released from the cell 
where it binds to the interferon alpha receptor (IFNAR) in an autocrine and paracrine 
fashion. Today, three different types of interferon are described (type I-III). Human and 
mouse type I interferons encompass 13 interferon alpha (IFNα) and one single interferon 
beta (IFNβ) as well as interferon epsilon (IFNε), kappa (IFNκ) and omega (IFNω) 
(Pestka et al., 2004). Genes encoding for type I interferon genes are located on 
chromosome 9 in humans and on chromosome 4 in mouse (Pestka et al., 2004; Chen et 
al., 2004). Type II interferons encompass a single cytokine, interferon γ. The gene 
encoding for IFNγ is located on chromosome 12 in humans and chromosome 10 in 
mouse (Pestka et al., 2004). After expression of type I interferon, autocrine and 
paracrine effects cause an anti-viral state in the surrounding tissue (Sadler and Williams, 
2008). Type I interferon binds to the type I interferon alpha receptor (IFNAR) that is 
located in the cell membrane of all cells of the human and mouse organism. It is 
composed of two subunits, IFNAR1 and IFNAR2. While IFNAR1 is associated with the 
tyrosine kinase 2 (TYK2), IFNAR2 is associated with the Janus activated kinase 1 
(JAK1). Binding of type I interferon to the receptor causes activation of the JAK-STAT 
pathway (Darnell et al., 1994; Stark and Darnell, 2012). Initially, type I interferon-binding 
leads to the autophosphorylation and activation of TYK2 and JAK1 which subsequently 
mediate the phosphorylation of downstream STAT (signal transducer and activator of 
transcription) molecules. Upon phosphorylation, activated STAT translocates to the 
nucleus where it activates the expression of interferon-stimulated genes (ISGs) 
(Schoggins et al., 2011). Interferon-stimulated genes cause the generation of an anti-
viral state, since their expression interferes at various levels with the replication cycle of 
the virus (Sadler and Williams, 2008). 
 
1.2 Interferonopathies 
1.2.1 Systemic lupus erythematosus (SLE) 
Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease that is clinically 
characterized by multi organ inflammation, encompassing organs like the skin or kidney. 
SLE pathology originates in consequence of the breakdown of self-tolerance, triggered 
by an unbalanced type I interferon response. Pathology is mediated by autoantibodies 
that are directed against nuclear self-antigens, while the site of immune complex 
deposition determines the organ involvement (Mok and Lau, 2003; Grammatikos and 
Tsokos, 2012). As many autoimmune diseases, SLE is a multi-factory disease that has a 
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genetic but also an environmental component (Agmon-Levin et al., 2012). Moreover, the 
genetic component itself is very heterogeneous and mutations in many different genes 
were shown to increase susceptibility to develop SLE pathology. While in rare cases 
SLE is caused by mutations in a single gene, most SLE patients have concomitant 
mutations in several genes. Moreover, some mutations in SLE patients are subclinical 
and need the trigger of an environmental stimulus, like UV light exposure. However, 
mutations alone or in combination with an environmental trigger cause an unbalanced 
type I interferon response that fuels the breakdown of self-tolerance. As a consequence 
of the breakdown, self-structures in combination with a danger-associated molecular 
pattern (DAMP) elicit an adaptive immune response that leads to the destruction of 
tissues and organs.  
A well-accepted model for SLE pathology is defined by the defective clearance of 
apoptotic and necrotic cells. Apoptosis describes the programmed cell death during 
diverse biological processes like tissue differentiation or pathogen defense. Programmed 
cell death can be activated by an intrinsic or extrinsic pathway, but both lead to the 
cleavage of several proteins and the fragmentation of the DNA. Since membrane 
integrity is maintained during apoptosis, it can be regarded as an immunologic ‘silent’ 
process that does not trigger an immune response. However, apoptotic cells need to be 
cleared by professional phagocytizing cells like macrophages or dendritic cells to prevent 
inflammation. Therefore, apoptotic cells secrete a “find me” signal to attract phagocytes 
and express an “eat me” signal in order to be phagocytized (Ravichandran and Lorenz, 
2007). In contrast to apoptosis, membrane integrity is not maintained during necrosis. 
Necrosis can be subdivided into primary and secondary necrosis, depending on the type 
of membrane disintegrity. Primary necrosis is a consequence of physical or chemical 
insults, while secondary necrosis can be observed in undegraded apoptotic cells that 
progressively loose membrane integrity (Poon et al., 2014). However, necrosis causes 
the release of cytoplasmic and nuclear components that might stimulate an immune 
response due to their strong immunogenicity. Of particular importance is thus the 
immediate degradation of nucleic acid species originating from the nucleus in order to 
prevent the activation of nucleic acid sensors that would inevitably cause the initiation of 
a type I interferon response. Thus, many SLE patients bear mutations in the genes 
encoding for proteins that play an important role in the degradation of dying cells. Among 
those, the important member of the complement system C1q is found to be mutated. 
C1q labels dying cells for the efficient degradation by macrophages. Deficiency for the 
C1q prevents phagocytosis and leads to the accumulation cell components like various 
types of nucleic acids that subsequently sensors and the induction of a type I interferon 
response. Deficiency for the desoxyribonuclease I (DNase I) (Chitrabamrung et al., 
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1981) and three prime repair exonuclease 1 (Trex1) (Lee-Kirsch et al., 2007) was also 
observed in human SLE patients. While DNase I plays an important role in the 
degradation of double-stranded DNA in the serum, Trex1 is supposed to degrade single-
stranded DNA in the cytoplasm and maybe nucleus.  
As a consequence of the defective clearance of dying cells, nucleic acid species trigger 
an unbalanced type I interferon response that supports the generation of an adaptive 
immune response directed against self peptides that are concomitantly released from 
dying cells. Complexes of nucleic acids and associated nuclear structures, like 
centromeres or histones, are thought to represent a potent stimulator for the generation 
of the adaptive immune response. The synthesis of antibodies directed against these 
structures might occur in autoreactive B cells in a T cell-independent fashion. Binding of 
the protein component to the membrane-bound B cell receptor provides the first signal 
for B cell activation and leads to its internalization and the compartmentalization in 
endosomes. Subsequent binding of the nucleic acid component to the respective toll-like 
receptor (TLR) in the endosome provides the second important signal for B cell 
activation and subsequent synthesis of autoantibodies (Leadbetter et al., 2002). SLE 
pathology is caused by the deposition of immune complexes consisting of the 
autoantibody and the respective antigen. Since autoantibodies in SLE are directed 
against nuclear antigens, immune complexes can only form after the disintegrity of the 
cellular membrane and the release of nuclear antigens. The inability to clear apoptotic 
and necrotic cells could lead to the chronic deposition of complexes. However, UV light 
exposure can also trigger SLE pathology by causing increased rates of apoptotic and 
necrotic cells. Immune complexes can cause organ failure by their deposition that block 
organ failure or by an immune response (antibody-dependent cellular cytotoxicity, 
ADCC) stimulated by the presence of the immune complexes. Local immune complex 
deposition in the skin or the kidney can cause organ failure, while systemic immune 
complex deposition might cause death. 
1.2.2 Aicardi Goutières Syndrome (AGS) 
In 1984, Jean Aicardi and Françoise Goutières were the first to describe a so far 
unknown disorder of the central nervous system in young children (Aicardi and 
Goutieres, 1984). They examined eight children of unrelated or consanguieous parents 
and diagnosed calcifications in the basal ganglia, brain atrophy, acquired microcephaly, 
elevated numbers of lymphocytes in the cerebrospinal fluid (CSF) and lethality in early 
childhood. Although the brain calcifications were highly reminiscent of that seen in 
congenital virus infections, Aicardi and Goutières stated already at that point that the 
calcification neither derived from virus infection nor from a rare syndrome of familial 
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calcifications or familial idiopathic hypoparathyroidism. They proposed that the reported 
cases might belong to a so far unknown or uncharacterized disorder that is inherited in 
an autosomal recessive Mendelian fashion.  
At present, the Aicardi-Goutières syndrome (AGS) is defined as an early-onset 
encephalopathy that is characterized by calcifications of the basal ganglia, brain atrophy, 
lymphocytosis and increased type I interferon levels in the CSF. The consequences of 
AHS are physical and mental retardation and often death in early childhood. Elevated 
type I interferon levels were first described by Lebon et al. (Lebon et al., 1988) and are 
now regarded as the hallmark of Aicardi-Goutières syndrome. Importantly, in patients 
suffering from the disorder, no virus infection can be found at any given time point that 
can account for the neurological and extra-neurological findings (Crow and Livingston, 
2008).  
The Aicardi-Goutières syndrome is a heterogeneous disease that can be caused by 
mutations in at least seven genes. The first AGS-causing gene locus (AGS1) was 
identified in 2006 by Crow et al., being the 3`- 5` repair exonuclease 1 (TREX1) (Crow et 
al., 2006a). Thereafter, mutations in any of the three subunits of the ribonuclease H2 
(RNase H2A, RNase H2B and RNase H2C) (AGS4, AGS2 and AGS3, respectively) 
(Crow et al., 2006b) and in the sterile alpha motif and HD domain containing protein 1 
(SAMHD1; AGS5) (Rice et al., 2009) were found in AGS patients. Most recently, 
mutations in the adenosine deaminase acting on RNA (ADAR; AGS6) (Rice et al., 2012) 
as well as in IFIH1 (melanoma differentiation-associated protein 5, MDA5; AGS7) (Rice 
et al., 2014) were found in patients suffering from AGS. While mutations in the genes 
AGS1-6 cause a partial loss-of-function, mutations in AGS7 create a gain-of-function. 
Still, there is the possibility that there are even more AGS-causing genes and it might be 
feasible to speculate that any mutation that causes the generation of an unbalanced type 
I interferon response could cause the development of AGS pathology. However, the 
current hypothesis is that the accumulation of nucleic acid species in patients deficient 
for any of the five proteins leads to the elicitation of a type I interferon response that 
triggers AGS pathology (Alarcon-Riquelme, 2006; Rigby et al., 2008; Crow and 
Rehwinkel, 2009). Mutations in IFIH1 are not supposed to lead to the accumulation of 
nucleic acid species, however, mutations cause chronic type I interferon expression 
independent of an accumulating nucleic acid species and important for the development 
of the disorder. TREX1, RNase H2, SAMHD1 and ADAR are enzymes with specificity for 
different nucleic acid substrates. TREX1 degrades single-stranded and double-stranded 
cytosolic DNA (Stetson et al., 2008; Ablasser et al., 2014), RNase H2 degrades the RNA 
moiety in RNA:DNA hybrids or removes a single ribonucleotide embedded in DNA 
duplex (Eder et al., 1993; Rydberg and Game, 2002; Cerritelli and Crouch, 2009) while 
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SAMHD1 is a desoxynucleoside triphosphate triphosphohydrolase that degrades 
endogenous nucleotides and thus has essential functions during HIV-1 restriction 
(Goldstone et al., 2011). More important, SAMHD1 displays nuclease activity with 
specificity for RNA (Ryoo et al., 2014). Adar deaminates adenosine to inosine in double-
stranded RNA that likely changes the RNA information as well as the structure that could 
inhibit RNA translation. The origin of the nucleic acid species that accumulate in the 
absence of TREX1, RNase H2, SAMHD1 and ADAR are so far unknown. It is speculated 
that the nucleic acid might be generated as byproducts of DNA replication or repair (Lan 
et al., 2014) or derive from the transposition activity of endogenous retroelements 
(Stetson et al., 2008; Beck-Engeser et al., 2011) The exception of this hypothesis is 
displayed by the gain-of-function mutations in the IFIH1 gene, encoding for the sensor of 
long double-stranded RNA. Two mutations were so far described, one that causes the 
constitutive activity of the receptor and another that reduces the specificity for the 
receptor ligand (Funabiki et al., 2014; Rice et al., 2014). However, both mutations cause 
type I interferon expression.  
Aicardi-Goutières syndrome is inherited as an autosomal recessive disorder. Thus, AGS 
patients mostly display homozygous mutations. However, compound heterozygous 
mutations can be found in patients with mutations in TREX1. Moreover, there are also 
two reports of de novo heterozygous TREX1 mutations that caused AGS. Both 
mutations were found to be an amino acid substitution affecting the same amino acid 
(D200N and D200H), indicating the important role of this amino acid in the nuclease 
function of Trex1 (Rice et al., 2007). Mutations in the TREX1 gene and the genes 
encoding for RNase H2 differ substantially, from a genetical but also from a phenotypical 
perspective (Rice et al., 2007). While null mutations (frameshift, nonsense mutations or 
mutations affecting splice-donor and splice-acceptor sites) can be observed in AGS 
patients with mutations in TREX1, null mutations have never been observed in AGS 
patients with mutations in the genes encoding for the RNase H2 enzyme. Since these 
AGS patients only display missense mutations, like amino acid substitutions, complete 
RNase H2 deficiency in humans likely causes embryonic lethality. Patients with 
mutations in the TREX1 gene display a neonatal form of AGS disease, while all other 
AGS patients display an early-onset form of the disease. These patients display AGS 
pathology few days after birth, most often after a period of normal growth normal growth. 
Most remarkably, a late-onset form of the disease characterizes AGS patients with 
mutations in the RNASEH2B gene. Patients with mutations in the RNASEH2B gene 
display pathology after normal growth of up to one year. In contrast to most other AGS 
patients, these patients do not display severe physical and mental retardation and 
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lethality is less frequent. Recently, patients with compound heterozygous mutations in 
SAMHD1 were also described to show a less severe phenotype. 
Comparison of SLE patients and AGS patients revealed a phenotypical overlap between 
both disorders (Ramantani et al., 2010). Most importantly, SLE and AGS cluster to the 
family of diseases that are called interferonopathies, since pathology in both diseases is 
mediated by an unbalanced type I interferon (Crow, 2011; Crow, 2014). Moreover, about 
40 % of AGS patients display cold-induced chilblain-like skin lesions that can also be 
found in a small fraction of SLE patients. A recent publication demonstrated even more 
common features of both disorders. Clinical common features were the lupus rash of the 
skin, oral ulcers and arthritis. Molecular features were anti nuclear antibodies ANAs, 
decreased complement levels, thrombocytopenia and leukocytopenia. Based on the 
molecular and phenotypic overlap, the Aicardi Goutières syndrome is now regarded as a 
monogenic variant of the systemic lupus erythematosus. AGS mouse models might 
therefore represent a versatile tool that allows for the elucidation of the pathomechanism 
in SLE disease.  
1.3 Ribonucleases H 
Ribonucleases H (RNase H) are small enzymes with RNA-specificity that can be found in 
all living organisms (Dirksen and Crouch, 1981; Frank et al., 1998). So far two RNase H 
molecules were described in eukaryotes, termed RNase H1 and RNase H2 that differ in 
their substrate specificity (Cerritelli and Crouch, 2009). While both enzymes can cleave 
the RNA moiety in RNA:DNA hybrids, RNase H1 is only capable to cleave at positions of 
at least four consecutive ribonucleotides in a DNA duplex (Eder and Walder 1999), 
whereas RNase H2 is competent to cleave even a single ribonucleotide embedded in a 
DNA duplex (Rydberg and Game, 2002). Three RNase H molecules can be found in 
prokaryotes, RNase HI-III. RNase HI and RNase HII show similar substrate specificity 
compared to the eukaryotic enzymes, while RNase HIII displays the same substrate 
specificity like RNase HI. 
 
1.3.1 Ribonuclease H1 
Human RNase H1 is a monomeric nuclease that is encoded by the RNASEH1 gene on 
chromosome 2. It is a 32 kDa (32.200 kDa) protein consisting of 286 amino acids. The 
murine RNase H1 enzyme is a 32 kDa (31.805 kDa) protein that consists of 285 amino 
acids, encoded by the Rnaseh1 gene on mouse chromosome 12. The typical organization 
of the eukaryotic RNase H1 enzyme consists of a N-terminal mitochondrial target 
sequence (MTS), followed by a hybrid binding domain (HBD), a connection domain (CD) 
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and a C-terminal RNase H domain (H domain) (Fig.1.1) (Cerritelli and Crouch, 2009). The 
N- as well as the C-terminus of the RNase H1 enzyme contains highly conserved regions 
encompassing the hybrid binding domain (N-terminus) and the RNase H domain (C-
terminus), indicating their important role for RNase H1 activity. The hybrid binding domain 
of the enzyme was shown to be important for the processive hydrolysis of the RNA:DNA 
substrate by the RNase H1 domain, as HBD-deficient RNase H1 from human and mouse 
cleaved RNA:DNA hybrids in a distributive manner. Mutations in the amino acids W43, 
K59 and K60 in human RNase H1 were also shown to reduce binding capacity and 
subsequent reduced cleavage efficiency (Cerritelli and Crouch, 2009). The messenger 
RNA (mRNA) of the RNase H1 transcript is characterized by two in-frame start codons. 
Translation from the first start codon includes the MTS domain leading to the 
mitochondrial localization of the RNase H1 enzyme, while translation from the second 
excludes the MTS domain causing the retention of the protein in the nucleus (Cerritelli et 
al., 2003; Cerritelli and Crouch, 2009; Suzuki et al., 2010) While human and mouse 
RNase H1 transcripts contain a MTS domain, transcripts from Saccharomyces cerevisiae 
(S. cerevisiae) and Caenorhabditis elegans (C. elegans) are deficient for the domain. 
However, deficiency for mitochondrial RNase H1 in these organisms is compensated by 
other mechanisms (Cerritelli and Crouch, 2009).  
 
 
Figure 1.1: General composition of the RNase H1 enzyme. The RNase H1 enzyme is 
composed of four domains, encompassing the mitochondrial target sequence (MTS), the hybrid 
binding domain (HBD), the cluster domain (CD) and the RNase H domain (H-Domain). Due to the 
absence of the MTS domain in S. cerevisiae and C. elegans, RNase H1 deficiency does not cause 
lethality as in RNase H1-deficient mice. Adopted from “RNase H, the enzymes in eukaryotes” 
(Cerritelli and Crouch, 2009). 
 
Deficiency for the RNase H1 enzyme in the yeast strain Saccharomyces cerevisiae (S. 
cerevisiae) did not have any impact on cell viability, but RNase H1-deficient yeast 
displayed increased sensitivity upon treatment with the alkylating agent EMS (ethyl 
methanesulfonate), while sensitivity towards hydroxy urea (HU) and caffeine remained 
mostly unaltered (Arudchandran et al., 2000). Experiments could further show that in the 
absence of the RNase H1 enzyme, RNase H2 expression was up-regulated, most likely in 
order to compensate for the RNase H1 deficiency in degrading the RNA moiety of 
RNA:DNA hybrids (Arudchandran et al., 2000). However, mice deficient for the RNase H1 
(Rnaseh1-/-) enzyme are embryonic lethal and display developmental arrest at embryonic 
day 8.5 (E8.5) (Cerritelli et al., 2003). Rnaseh1-/- mice are characterized by reduced 
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mitochondrial DNA content followed by increased apoptosis. Thus, RNase H1 plays an 
important role during the replication of the mitochondrial DNA (mtDNA), most likely by 
removing ribonucleotides inserted into the genomic DNA during replication. Due to the 
absence of the MTS domain in S. cerevisiae RNase H1, RNase H1 is not located in 
mitochondria of this organism and might be compensated by other proteins. Thus, RNase 
H1 deficiency in yeast does not display the same severe phenotype as observed in 
RNase H1-deficient mice (Arudchandran et al., 2000). 
 
1.3.2 Ribonuclease H2  
In contrast to the RNase HII enzyme from prokaryotes, eukaryotic RNase H2 is a 
heterotrimeric enzyme consisting of the subunits A, B and C that are encoded on different 
chromosomes of the respective organism (Frank et al., 1998; Jeong et al., 2004). The 
human RNase H2 consists of the 299-amino acid RNase H2A (Chr. 19; 33.400 kDa), the 
308-amino acid RNase H2B (Chr. 13; 34.800 kDa) and the 164-amino acid RNase H2C 
(Chr. 11; 17.800 kDa) proteins, whereas the mouse RNase H2 consists of the 301-amino 
acid RNase H2A (Chr. 8, 33.513 kDa), the 308-amino acid RNase H2B (Chr. 14; 34.725 
kDa) and the 166-amino acid RNase H2C (Chr19; 17.823 kDa) subunit. The 
heterotrimeric RNase H2 complex in human and mouse displays an elongated 
arrangement with the RNase H2C subunit located in the middle of the complex (Fig. 1.1) 
(Figiel et al., 2011; Reijns et al., 2011). The central RNase H2C subunit interfaces with the 
N-terminus of the RNase H2B subunit and the C-terminus of the RNase H2A subunit. The 
RNase H2A subunit possesses the active site that mediates hydrolysis of ribonucleotides 
embedded in DNA. The B and C subunit of the RNase H2 enzyme are supposed to have 
mainly structural and stability functions. Whereas the heterotrimeric RNase H2 enzyme in 
eukaryotes display processive cleavage, the prokaryotic, monomeric RNase HII enzyme 
display distributive cleavage, indicating that the B and C subunit may contribute to the 
processivity of the enzyme. The B subunit of the RNase H2 enzyme further contains a 
nuclear localization sequence (NLS) as well as a PIP (PCNA-interacting peptide)-box, a 
classical PCNA (proliferating cell nuclear antigen) binding motif (Bubeck et al., 2011). 
After its synthesis, RNase H2C first interweaves with RNase H2B before the complex 
consisting of the B and C subunit interfaces with the A subunit and the heterotrimeric 
complex is shuttled to the nucleus. However, since the A subunit is insoluble in the 
absence of the complex of the B and C subunit, the expression of the B and C subunit 
determine the generation of the RNase H2 enzyme complex (Chon et al., 2009). 
Moreover, all three subunits are necessary for enzyme activity (Chon et al., 2009; Reijns 
et al., 2011). Although RNase H1 and RNase H2 share the common feature of degrading 
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the RNA moiety in RNA:DNA hybrids, only the RNase H2 enzyme is capable to cleave a 
single ribonucleotide in a DNA duplex. 
 
 
Figure 1.2: Chrystal structure of the heterotrimeric RNase H2 enzme. Ribbon diagram reveals 
linear orientation of the three subunits composing the heterotrimeric complex. The RNase H2A 
subunit forms the center of the RNase H2 complex and is enframed by the B subunit (green) and C 
subunit (blue). While the A subunit possesses the catalytic center, the B and C subunit are 
supposed to contribute to the stability and processivity of the enzyme. The B subunit further 
contains a nuclear localization sequence (NLS) that directs the complex to the cell nucleus and a 
PIP-box that allows interaction with PCNA. Adopted from Reijns et al. (Reijns et al., 2011) 
 
Deficiency for the RNase H2 enzyme in S. cerevisiae was shown to have no consequence 
on cell viability. RNase H2-deficient cells become modestly sensitive upon treatment with 
HU or EMS but remain unaffected upon caffeine treatment (Arudchandran et al., 2000). 
Mutations in the human RNase H2 enzyme have also been described in the type I 
interferonopathies Aicardi-Goutières syndrome (AGS) and systemic lupus erythematosus 
(SLE) (Crow et al., 2006b; Crow, 2011; Crow, 2014; Günther et al., 2015). In patients 
suffering from AGS, mutations in the genes encoding for the RNase H2 enzyme are found 
to be homozygous. All mutations are described to be missense mutations that cause 
reduced enzyme activity only in some cases (G37S mutation in the RNase H2A subunit) 
(Perrino et al., 2009; Reijns et al., 2011). The consequences for most other mutations are 
still not understood. However, since null mutations have never been observed in AGS 
patients, complete deficiency likely cause embryonic lethality (Rice et al., 2007). While 
mutations in the genes encoding for the RNase H2 enzyme are found to be homozygous, 
mutations in SLE patients are found to be heterozygous non-synonymous and splice site 
RNASE2A
RNASE2B
RNASE2C
PIP-box
NLS
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mutations (Günther et al., 2015). Mutations in SLE patients were shown to cause impaired 
enzyme activity, reduced complex stability or even mislocalization (Günther et al. 2015). 
Heterozygous mutations in SLE patients cause the accumulation of genomic 
ribonucleotides that initiates a p53-mediated DNA damage response and impaired cell 
proliferation. Additionally, exogenous stimulation of patients` cells with UVC and poly I:C 
caused a more persistent type I interferon response when compared to cells from healthy 
patients, indicating increased sensitivity of these cells to produce type I interferon.  
 
1.3.2.1 Ribonucleotide excision repair (RER) 
Mouse data has shown that in the absence of the RNase H2 enzyme one ribonucleotide is 
incorporated every 7600 nucleotides (nt) causing an overall ribonucleotide load of about 
one million per mouse genome during a single round of replication (Reijns et al., 2012). 
Therefore, the persistence of ribonucleotides represents the most frequent mutation of the 
DNA and causes a massive threat for the genomic information, since genomic 
ribonucleotides render the DNA sensitive for cleavage. In eukaryotes, ribonucleotides are 
efficiently removed by the concerted activity of the RNase H2 (RNH201 in yeast) and the 
Flap endonuclease 1 (FEN-1) (RAD27 in yeast) enzyme (Eder et al., 1993; Rydberg and 
Game, 2002; Cerritelli and Crouch, 2009). Early in vitro-studies using human and yeast 
cell-free extracts have shown that the RNase H2 enzyme incises the DNA backbone 5-
prime of the incorporated ribonucleotide and subsequent cleavage of the FEN-1 enzyme 
3-prime of the ribonucleotide leads to the formation of a gap that can be perfectly sealed 
by human DNA polymerase β and DNA ligase III in association with XRCC1 (Rydberg and 
Game, 2002). In contrast to RNase H2, RNase H1 is not capable to cleave at positions of 
single ribonucleotides in double-stranded DNA and needs at least four succeeding 
ribonucleotides for cleavage (Rydberg and Game, 2002; Cerritelli and Crouch, 2009). 
Therefore, RNase H1 cannot compensate for RNase H2 deficiency to remove single 
ribonucleotides from the DNA. In contrast, Exo1 could replace FEN-1, although FEN-1 
showed a more than twofold efficiency. Due to the PIP box in the B subunit of the RNase 
H2 enzyme, RNase H2 was thought to localize at places of DNA replication and repair via 
PCNA. Structural analysis could confirm the interaction between both concluding that 
PCNA directs RNase H2 on DNA replication and DNA repair substrates (Bubeck et al., 
2011). RNase H2, FEN-1, DNA polymerase δ and DNA ligase I from S. cerevisiae all 
contain a PIP box allowing for the interaction with PCNA. While PCNA greatly stimulated 
ribonucleotide excision repair, repair was independent of the PIP box, since deletion did 
not alter RER efficiency (Sparks et al. 2012). This data shows that the interaction of the 
RNase H2 enzyme via the PIP box is dispensable for RER.  
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1.3.2.2 Ribonuclease activity of DNA topoisomerase I 
DNA topoisomerases are enzymes with important functions in relieving torsional stress as 
a consequence of DNA replication and transcription (Vos et al., 2011). DNA 
topoisomerases can be divided into two main groups, but all share the common feature of 
a nucleophilic tyrosine in the active site that initiates the transesterification reaction by 
attacking a phosphodiester bond of the DNA. While type I topoisomerases cleave a single 
DNA strand, type II topoisomerases are capable to cleave both strands of the DNA. Of 
particular importance are the type IB topoisomerases (swivelases) that nick one strand to 
allow the rotation of the single strand around the other and thereby facilitating relaxation. 
In a first transesterification reaction, the reactive hydroxyl-group of the topoisomerase IB 
attacks the phosphodiester bond of the DNA strand, causing the formation of a covalent 
complex of the topoisomerase and the DNA via a 3`-phosphotyrosyl bond. In this 
conformation, rotation and relaxation can occur. In a second transesterification reaction, 
the hydroxyl-group attacks the phosphodiester bond of the topoisomerase I-DNA complex 
in order to release the topoisomerase I enzyme and to re-ligate the nicked DNA strand.  
Beside the above function, Sekiguchi et al. showed in 1997 that topoisomerase IB from 
vaccinia and humans displays also ribonuclease activity and catalyzes the site-specific 
cleavage of a ribonucleotide embedded in a DNA:DNA duplex (Sekiguchi and Shuman, 
1997). They could show that cleavage proceeds via two transesterification reactions 
leading to a cleavage product containing a 2`, 3`cyclic phosphate and 5`-OH terminus. In 
a first step, the active site tyrosine of topoisomerase IB attacks the scissile 
phosphodiester, forming an intermediate, with the topoisomerase IB covalently linked to 
the ribonucleotide via a 3`- phosphotyrosyl bond. In a second step, this 3`- phosphotyrosyl 
bond is attacked by the 2`- OH of the ribose that causes the release of the topoisomerase 
and leading to a 2`, 3` cyclic phosphate end as well as a 5`-OH group at the other side of 
the nick. Moreover, they could demonstrate that a single ribonucleotide embedded in a 
DNA:DNA duplex is sufficient to initiate ribonuclease activity of the topoisomerase IB. 
Studies using a RNase H2-deficient yeast strain (rnh201∆) showed increased 
ribonucleotide levels in the genomic DNA that were even more increased when wild type 
DNA polymerase ε was replaced by a mutated DNA polymerase (pol2-M664G) (Nick 
McElhinny et al., 2010). A pol2-M644G rnh201∆ yeast strain was characterized by slow 
progression through the S phase and G2/M of the cell cycle, increased 
desoxyribonucleotide (dNTP) levels and 2- to 5-bp deletions in repetitive sequences 
(McElhinny et al. 2010). However, the 2- to 5-bp deletions were subsequently shown to be 
completely dependent on topoisomerase I, since concomitant deletion of the 
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topoisomerase I gene (top1), reverted the numbers of deletions to wild type levels (Kim et 
al., 2011).  
As a consequence of topoisomerase I-mediated cleavage at positions of embedded 
ribonucleotides 2`, 3`- cyclic phosphate ends are formed that cannot be ligated. During the 
repair process of 2`, 3`- cyclic phosphate ends, unligatable DNA ends are processed 
causing the formation of a gap that facilitates misalignment in repetitive sequences 
followed by ligation and subsequent deletion of DNA sequence. In addition, activation of 
the S phase checkpoint as well as increased dNTP levels were also shown to be 
dependent on topoisomerase I cleavage, since a pol2-M644G rnh201∆ top1∆ yeast strain 
displayed reduced cell numbers in G2/M and lower dNTP levels. Collectively, absence of 
the ribonuclease H2 in yeast causes increased genomic ribonucleotide levels that are in 
part removed by the ribonuclease activity of the topoisomerase. It was shown that 
topoisomerase I cleavage causes the generation of unligatable 2`, 3` cyclic phosphate 
ends that leads to the formation of 2- to 5-bp deletions, increased dNTP levels and S 
phase checkpoint activation. Therefore, topoisomerase I cleavage represents an imperfect 
mechanism to remove genomic ribonucleotides.  
 
1.3.2.3 Ribonucleotide incorporation into genomic DNA 
The maintenance of genome integrity is of particular importance in order to allow healthy 
life of subsequent generations. Therefore, several mechanisms have been evolved to 
prevent the generation, accumulation and propagation of mutations in the genomic 
information. Among the various assaults that might cause mutations of the DNA 
sequence, the incorporation of ribonucleotides into the genomic DNA represents the 
biggest threat for the maintenance of the genomic information, since the presence of 
genomic ribonucleotides renders the DNA double-strand susceptible to DNA cleavage. 
Ribonucleotide incorporation represents the most frequent DNA lesion and occurs in 
consequence of the essential cellular processes of DNA replication and transcription. 
RNase H2 activity takes center stage during these processes since it was shown to 
efficiently remove incorporated ribonucleotides and thus maintaining genome stability. 
 
1.3.2.3.1 Frequent ribonucleotide incorporation during DNA replication 
DNA polymerases display high fidelity in discriminating ribonucleotides from their 
incorporation into the DNA double-strand during DNA replication (Joyce, 1997). Their 
preference for desoxyribonucleotides is accomplished by the presence of a bulky amino 
acid (mostly phenylalanine or tyrosine) that builds a steric gate in the active site of DNA 
polymerases.  This steric gate allows the integration of desoxyribonucleotides while it 
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would clash with bigger substrates. Ribonucleotides differ from desoxyribonucleotides by 
the presence of a hydroxyl group at the C2 atom of the sugar ring that renders the 
ribonucleotide too bulky to enter the DNA polymerases` active site. However, frequent 
incorporation of ribonucleotides can be observed in vivo and in vitro, despite the high 
fidelity of DNA polymerases. One reason is the different stringency of DNA polymerases 
to discriminate ribonucleotides (Joyce, 1997) that can be even more shifted in the 
presence of different cofactors. Eukaryotic replication of the genomic DNA is managed by 
three B family polymerases, Pol α, δ and ε. While polymerase ε copies the leading strand, 
polymerase α and δ are involved in lagging strand DNA synthesis. Due to the deficiency of 
a proofreading exonuclease, polymerase α is much more inaccurate and less processive 
than the other polymerases and its likely function is to initiate lagging strand synthesis that 
is continued by polymerase δ. Data from S. cerevisiae has shown that polymerase α 
displays the highest frequency of ribonucleotide incorporation (1/625) followed by 
polymerase ε (1/1250) and polymerase δ (1/5000) (Williams and Kunkel, 2014). 
Collectively, replication of the genomic DNA by the activity the three eukaryotic 
polymerases cause the integration of about 14000 ribonucleotides into the yeast genome 
during a single generation. Extrapolating this value to the human genome would lead to 
the integration of more than two or three million ribonucleotides during a single round of 
replication (Williams and Kunkel, 2014). The other reason for the frequent integration of 
ribonucleotides is the high concentration of ribonucleotides in the cell that exceeds the 
concentration of desoxyribonucleotides (Traut, 1994; Nick McElhinny et al., 2010). This 
ratio is even more shifted to increased ribonucleotide concentrations in post-mitotic cells 
in which the cellular dNTPs are reduced. Finally, the availability of the four different 
dNTPs changes during the cell cycle (Chabes et al., 2003), increasing the probability of 
the integration of a certain ribonucleotide during a certain phase of the cell cycle. This 
difference in concentration levels in different phases of the cell cycle or different cell states 
renders the discrimination between desoxyribonucleotides and ribonucleotides imperfect.  
 
1.3.2.3.2 Initiation of lagging strand synthesis by RNA primers 
Replication of the leading DNA strand is a continuous process, since DNA polymerases 
are competent to replicate the template DNA in 5` to 3` direction while the replication fork 
migrates along the double-stranded DNA. In very contrast to leading strand synthesis, 
replication of the lagging strand is a discontinuous process due to the inability of DNA 
polymerases to replicate DNA in a 3` to 5` direction. To replicate the lagging strand of the 
DNA, DNA polymerases require short nucleotide-primers as initiation start for replication 
in 5` to 3` direction. In eukaryotes, these primers are oligonucleotides consisting of 7-14 
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ribonucleotides synthesized by the enzyme primase, a subunit of the DNA polymerase α 
(Kuchta and Stengel 2010). The newly synthesized DNA fragments between two RNA 
primers is termed Okazaki fragment and encompasses about 200 to 300 nucleotides. 
Estimations amount the number of ribonucleotides that are incorporated into the genomic 
DNA as a consequence of lagging strand synthesis to about 150 million (Williams and 
Kunkel, 2014). Therefore, lagging strand synthesis represents by far the biggest source of 
ribonucleotide incorporation. However, since the DNA is exclusively made of 
desoxyribonucleotides, ribonucleotides of the RNA primer have to be removed. Due to 
their ribonucleotide-specificity, the RNase H endonucleases were supposed to play an 
important role in the removal of the RNA primers. Using model substrates, several authors 
could demonstrate that the RNase H2 enzyme together with the flap endonuclease 1 
(FEN-1) removes RNA-primers for the initiation of lagging strand synthesis. In this 
process, RNase H2 degrades the RNA primer leaving a single ribonucleotide attached 5-
prime to the subsequent Okazaki fragment. This product is an ideal substrate of the 
Okazaki fragment maturation system encompassing the FEN-1 enzyme that cuts 3`-prime 
of the ribonucleotide while the replication fork migrates along the unwinding DNA double-
strand. 
 
1.3.2.3.3 R loops as transcriptional byproducts 
Unwinding of the DNA double helix is necessary to allow RNA transcription, a process in 
which the RNA polymerase complex moves along the coding DNA strand in order to 
transcribe the genetic information into a messenger RNA transcript that is later translated 
into a polypeptide. During transcription, a hybrid of eight base pairs (bp), consisting of the 
nascent RNA transcript and the template DNA, is formed within the transcription bubble 
(Nudler et al., 1997). This interaction is immediately resolved and two separated exit 
channels for the RNA transcript and the reforming DNA double-strand in the RNA 
polymerase complex prevent the formation of hybrid structures (Westover et al., 2004). 
However, there is emerging evidence that the nascent RNA strand can invade the DNA 
strands outside the RNA polymerase complex before the DNA double-strand winds up 
again. This model for the formation of a three-stranded nucleic acid structure, termed the 
R loop, is called the “thread back” model (Roy et al., 2008). In contrast to the “thread 
back” model, there is also the probability that R loops are constantly formed by the 
extension of the eight base pair RNA:DNA hybrid in the transcription bubble while the 
RNA polymerase complex moves further along the DNA (Aguilera and Garcia-Muse, 
2012). RNA:DNA hybrids in R loops are more stable compared to double stranded DNA 
(dsDNA) (Roberts and Crothers, 1992), indicating the importance to prevent their 
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formation or to efficiently resolve these structures in order to avoid detrimental 
consequences. Factors that positively influence the formation of R loops are a high GC-
content, DNA supercoiling and DNA strand breaks (Roy and Lieber, 2009; Roy et al., 
2010). 
The current opinion is that R loop formation promotes genome instability. Displacement of 
the non-coding DNA strand by the nascent RNA transcript is believed to render the 
unpaired strand susceptible to DNA lesions and transcription-associated mutagenesis 
(TAM) or transcription-associated recombination (TAR) (Skourti-Stathaki and Proudfoot, 
2014). The precise mechanisms that account for the generation of DNA damage upon R 
loop formation are only poorly understood. Important insights came from the mechanism 
of class switch recombination (CSR), an important event during the development of 
adaptive immune responses against pathogens. Increased transcription of GC-rich switch 
regions leads to the formation of R loops, where the nascent RNA transcript displaces the 
complementary DNA strand to form a RNA:DNA hybrid. The activation-induced cytidine 
deaminase (AID) subsequently catalyzes the deamination of cytidine to uracil in the 
displaced DNA strand and repair processes cause the generation of double-strand breaks 
that are necessary for CSR (Xu et al., 2012). According to the mechanisms during R loop-
mediated class switch recombination, non-beneficial R loop formation might also go along 
with genetic modifications of the unpaired DNA strand. However, these processes are not 
well understood so far. More importantly, R loops can induce genome instability by 
blocking replication folk progression. Results of R loop formation are replication folk 
collapse, recombination and chromosomal breaks. Again, the exact mechanisms that 
cause genome instability in consequence of replication folk collapse are still to be defined. 
However, R loops adopt an intermediate conformation between the B form of dsDNA and 
the A form of double stranded RNA (dsRNA) (Shaw and Arya, 2008). This special 
conformation might allow for the identification of R loops and their subsequent removal. 
Beside the efficient clearance of the R loop by the ribonucleases H1 and H2 that both 
degrade the RNA moiety in the RNA:DNA hybrid, other mechanisms contribute to the 
prevention of R loop formation. Topoisomerases relax the supercoiled DNA strand in front 
of the transcription machinery in order to prevent interaction between RNA transcript and 
the DNA double-strand. Moreover, other helicases, like the DNA helicase Pif1, the RNA 
helicase DHX9 and Sen1, are competent to degrade RNA:DNA hybrids (Aguilera and 
Garcia-Muse, 2012).  
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1.3.2.4 Benefits of ribonucleotide incorporation 
Complete deficiency for the RNase H2 enzyme was shown to cause early embryonic 
lethality in mouse and human, whereas RNase H2 deficiency does not have any impact 
on the viability of the yeast S. cerevisiae. Homozygous loss-of-function mutations in the 
genes encoding for the RNase H2 enzyme that reduce enzyme activity cause the rare 
recessive encephalopathy Aicardi-Goutieres Syndrome (AGS), whereas heterozygous 
mutations are associated with the common autoimmune disease Systemic Lupus 
Erythematosus (SLE). Both diseases are characterized by bad prognosis, leading to early 
mortality in particular in case of AGS. Due to these consequences of RNase H2 
deficiency, accumulation of ribonucleotides in the genome of mammalian organisms was 
believed to have detrimental effects. However, recent data likely demonstrated that 
ribonucleotide incorporation might also have a beneficial impact (Potenski and Klein, 
2014; Williams and Kunkel, 2014).  
Mismatch repair (MMR) of misincorporated desoxyribonucleotides requires the targeting 
of the MMR machinery to the nascent DNA strand and strand discontinuities are needed 
to serve as initiation start. Gaps between Okazaki fragments were supposed to target to 
the nascent DNA to the lagging strand and concomitantly serve as inititation start for MMR 
(Claverys and Lacks, 1986). Subsequent studies have shown that exonuclease 1 (EXO1) 
can interact with PCNA allowing for the introduction of additional strand discontinuities 
(Pena-Diaz et al., 2012). However, since EXO1 has 5` to 3` polarity, cleavage of the 
leading strand could not be readily explained by EXO1 activity, since EXO1 would have to 
migrate several hundred nucleotides from the 3`-terminus to or even across the mismatch 
and would also have to compete with nucleosome loading behind the replication fork 
(Schöpf et al., 2012). Ghodgaonkar et al. could finally demonstrate that eukaryotic 
mismatch repair (MMR) is initiated by single strand breaks generated by RNase H2-
mediated. Due to the high frequency of ribonucleotide incorporation by the polymerase ε, 
RNase H2-mediated ribonucleotide cleavage of the nascent leading strand serves as 
entry site for the EXO1 that facilitates MMR.  
Another beneficial impact of ribonucleotide incorporation can be found during “Mating type 
switching” in S. pombe. Data shows that a two-ribonucleotide imprint might initiate the 
recombination process that is necessary for the switch of the mating type (Williams and 
Kunkel, 2014). 
 
1.4 DNA damage response (DDR) 
The maintenance of genome integrity is of particular importance in order to allow the 
propagation of the accurate genomic information to subsequent generations. However, 
the genomic DNA is constantly exposed to endogenous as well as exogenous threats that 
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can cause damage of the genomic information. Therefore, efficient repair pathways have 
been evolved to prevent the generation of mutations in the genomic information. Among 
the different threats, genomic ribonucleotides represent by far the most frequent DNA 
lesion. Studies in RNase H2-deficient yeast have shown that ribonucleotides are 
incorporated during basic cellular processes like replication and transcription. 
Investigation of the ribonucleotide incorporation rate of the three different DNA replicases 
demonstrated various frequencies causing the total incorporation of about 14000 
ribonucleotides during a single replication cycle (Williams and Kunkel, 2014). 
Extrapolation to the human or mouse genome might indicate that several million 
ribonucleotides are possibly integrated during the process of replication only. However, 
under normal conditions, ribonucleotides are efficiently removed by the simultaneous 
activity of RNase H2 and FEN-1 (Rydberg and Game, 2002). The most threatening DNA 
damage is represented by DNA strand breaks, as they might induce apoptosis (Rich et al., 
2000) or could lead to cancer. On the other hand, DNA double-strand breaks are naturally 
occurring during class-switch recombination in B cells or during meiosis. However, 
endogenous factors like stress-induced reactive oxygen species or exogenous UV light 
can also cause DNA strand breaks. To maintain genome integrity and to prevent cancer 
formation, the DNA damage response (DDR) pathway, an extensive signaling network 
that responds to DNA lesions, has been evolved to efficiently and accurately repair DNA 
strand breaks (Harper and Elledge, 2007). Not surprisingly, mutations in genes that 
encode for important players of the DDR pathways, like BRCA1 or p53, are strongly 
associated with cancer formation. The repair pathway that is elicited upon DNA strand 
breaks is hierarchically organized, with the sensor of the DNA damage on top of the 
hierarchy, followed by mediators and transducers of the DNA damage repair pathway and 
effector molecules that ultimately cause cell cycle arrest and the repair of the damage. 
Most importantly, signal transduction is conferred by post-transcriptional modifications, 
mostly phosphorylation, dephosphorylation and ubiquitination.  
The Trex1-deficient mouse model displayed activation of the DNA damage response 
triggered by short ssDNA that was supposed to be derived from replication intermediates. 
As a consequence of Trex1 deficiency, these replication intermediates caused ATM-
dependent checkpoint activation via Chk2 and p53 (Yang et al., 2007). 
 
1.4.1 Double-strand break (DSB) repair 
DNA double-strand breaks (DSBs) are detected by the trimeric MRN (Mre11-Rad50-Nbs1) 
complex in mammalian cells. The importance of this complex is reflected by the 
observation that mutations in the genes encoding for Mre11, Rad50 and Nbs1 cause 
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increased DNA damage sensitivity, genomic instability and telomere shortening 
(D'Amours and Jackson, 2002). Moreover, mice completely deficient for Mre11, Rad50 or 
Nbs1 are embryonic lethal. As sensor of DNA damage, MRN recruits the 
phosphatidylinositol 3-kinase-like kinase (PIKK) ATM (Ataxia telangiectasia mutated) to 
the DNA lesion. Another function is to generate regions of single-stranded DNA in order to 
amplify the signal needed for checkpoint activation. Upon recruitment, the inactive ATM 
dimer divides and subsequent autophosphorylation at different residues leads to the 
active form of ATM. Phosphorylation at serine 1981 was shown to occur early during DNA 
damage response, although this particular modification was not enough for activation 
(Bakkenist and Kastan, 2003). Subsequently, active ATM phosphorylates various 
downstream mediator molecules as well as the MRN complex that in turn leads to the 
oligomerization of the complex. An immediate target of the ATM molecule is the histone 
H2AX. Phosphorylation of amino acid serine 139 (γH2AX) and concomitant 
dephosphorylation of tyrosine 142 (constantly phosphorylated in the absence of DNA 
damage) leads to the recruitment of MDC1 (mediator of DNA damage checkpoint protein 
1) (Lukas et al., 2011). MDC1 is subsequently phosphorylated by various kinases and its 
function is to prevent dephosphorylation of H2AX as well as to mediate the spreading of 
phosphorylated H2AX to neighboring nucleosomes by tethering ATM to the lesional DNA. 
Accumulation of these proteins at the DNA lesion cause the formation of DNA damage-
induced foci and subsequent unwinding of the DNA double-strand allows repair proteins to 
gain access to the lesion. CHK2 (checkpoint kinase 2) is another important downstream 
target of the ATM kinase. ATM-mediated phosphorylation of CHK2 is followed by 
phosphorylation of the transcription factor p53. p53 in turn is a very potent transcription 
factor that is kept outside the nucleus by various mechanisms. MDM2, an E3 ubiquitin 
ligase keeps p53 expression on a low level, by labeling p53 for degradation. Furthermore, 
MDM2 inhibits p53 translation by ubiqutination of the positive regulator of p53, RPL26. 
However, phosphorylation of various downstream molecules by ATM leads to increased 
p53 transcription and protein stabilization that allows for the translocation of p53 into the 
nucleus where it activates the expression of different effector molecules. p53-dependent 
activation of p21 leads to cell cycle arrest in G1 or G2/M, by inhibiting cyclin-dependent 
kinases important for cell cycle progression, while p53-dependent activation of BAX 
induces apoptosis.  
DNA double strand breaks are repaired by one of two possible repair pathways, 
homologous recombination (HR) or non-homologous end joining (NHEJ). During NHEJ, 
ends of the broken DNA are tethered together via the Ku protein complex that immediately 
binds to the DNA ends during G1. In contrast to NHEJ, HR is dependent on DNA end 
resection to generate a 3` single-strand overhang that can invade the DNA double-strand 
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of the sister chromatids in order to repair the damage. The choice between both is 
dependent on the cell cycle phase. HR of DNA double-strand breaks is only possible 
during S/G2 phase of the cell cycle, since HR requires the presence of the sister 
chromatids that serve as template for the repair of the double-strand break. During G1 
phase of the cell cycle, DNA double-strand breaks are preferentially repaired by NHEJ. 
Two important mediators of the DRR mediate the pathway choice. While the p53-binding 
protein (53BP1) mediates NHEJ, the breast cancer-associated gene 1 (BRCA1) directs 
the repair to HR. 53BP1 is an immediate target of the PIKK ATM. However, MDC1-
mediated phosphorylation of 53BP1 promotes its recruitment to the DNA lesion, where it 
participates in the generation of DNA damage foci. Binding to the DNA adjacent to the 
lesion inhibits DNA end resection, thus preventing the generation of a substrate for HR. At 
this time point BRCA1 is also bound to the damaged DNA strand, but its concentration is 
supposed to be too low to mediate HR. During the phase transition from G1 to S/G2, 
BRCA1 binds to the DNA in proximity of the damaged site and displaces 53BP1 allowing 
for DNA end resection by the 5`- to – 3` exonuclease (EXO1), the flap-endonuclease 
DNA2 together with BLM (Bloom syndrome RecQ helicase-like) and MRE11 (part of the 
MRN complex). While MRE11 is important in initiating DNA end resection, EXO1 and 
DNA2 perform long-range resection. The switch between NHEJ in G1 to HR in S/G2 is 
thought to be mediated by phosphorylation of CtIP. Phosphorylation of CtIP leads to the 
formation of the complex CtIP-MRN-BRCA1 that displaces 53BP1 from the lesional DNA. 
However, it turned out that NHEJ could be the preferred pathway independent from the 
cell cycle most likely due to increased availability of members of the NHEJ pathway.  
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Figure1.3: Schematic overview of the DNA damage response upon DNA double-strand and 
single-strand breaks. While DNA double-strand breaks are sensed by the MRN (MRE11-NBS1-
RAD50) complex that subsequently recruits the kinase ATM (Ataxia telangectasia mutated), RPA 
that anneals to single-stranded DNA recruits the kinase ATR (Ataxia telangectasia mutated and 
Rad3-related) upon single-strand breaks of the DNA. The activation of CHK2 by ATM and CHK1 by 
ATR/ATRIP leads to the activation of the tumor suppressor gene p53 that mediates a plethora of 
effector functions like apoptosis, cell cycle arrest or senescence. Single-strand breaks as well as 
double-strand breaks cause the phosphorylation of the histone 2AX (H2AX) and is thus widely 
used as a DNA damage marker (Adopted from Meek et al. (Meek, 2009) 
 
1.4.2 Single-strand break (SSB) repair  
In contrast to the DDR in response to double-strand breaks whose repair is mediated by 
ATM activity, the repair of single-strand breaks is mediated by the DNA damage sensor 
ATR (ataxia telangiectasia mutated and Rad3-related) another member of the 
phosphatidylinositol-3-kinase-like kinase (PIKK) family. ATR is activated upon the 
presence of single strand breaks and thus plays an important role in the pathways of 
single-strand break repair, but also during replication folk stalling, since replication folk 
stalling is an ultimate consequence of single-strand breaks. Since single-strand breaks 
can also be present during the generation or repair of double-strand breaks, ATR is not 
exclusively activated upon single-strand break repair. However, ATR activity during DNA 
double-strand break repair is restricted to S/G2 phase of the cell cycle, since BRCA1-
mediated DNA end resection can only occur in this phase of the cycle. 
In consequence of single strand breaks, the replication protein A (RPA) binds to single-
stranded DNA (ssDNA) in order to prevent unwanted binding and degradation of the 
strand. The complex of ssDNA and RPA is detected by ATRIP (ATR-interacting protein), a 
protein that is regarded as an obligate subunit of ATR (Zou and Elledge, 2003). Although 
ATRIP directs ATR to the side of single-stranded DNA, ATR needs to be activated by the 
RAD9-RAD1-HUS1 (9-1-1) complex that further mediates the contact between ATR and 
TOPBP1 (topoisomerase-binding protein-1) (Lee et al., 2007). Single-strand break repair 
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is only initiated when both complexes, ATR/ATRIP and 9-1-1/TOPBP1, are recruited to 
the strand break. It is speculated that this mechanism represents a form of single-strand 
break repair regulation. However, upon activation, ATR phosphorylates several 
downstream molecules. Most importantly, CHK1 is phosphorylated at serine 317 and 345 
that promotes CHk1 activation. Interaction between ATR and CHK1 is mediated by 
Claspin and constitutive presence of Claspin maintains CHK1 phosphorylation. Upon 
activation CHK1 dislocates from the chromatin and phosphorylates downstream 
substrates. Most important substrates are the Cdc25 phosphatases that mediate cell cycle 
progression by dephosphorylating cyclin-dependent kinases (Cdks). Thus, 
phosphorylation of Cdc25 leads to their inactivation and thus promoting cell-cycle arrest 
and allowing for the repair of the DNA damage. At the same time, CHK1 phosphorylates 
and activates Wee1, the kinase that phosphorylates and inactivates Cdks. Upon 
persistent DNA damage, ATR and CHK1 also phosphorylate p53, thus promoting 
sustained cell cycle arrest or apoptosis (Taylor and Stark, 2001). In order to repair single 
strand breaks, ATR phosphorylates several mediators of homologous recombination, like 
BRCA1, WRN (Werner syndrome ATP-dependent helicase) and BLM (Bloom syndrome 
RecQ helicase-like). The restricted expression and activation of CHK1 during S/G2 
implicates repair of single-strand breaks by homologous recombination only. 
 
1.5 Aim  
Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease that is 
characterized by an uncontrolled type I interferon response. It can be caused by mutations 
in various different genes, but environmental factors, like UV light, were also shown to 
influence at least the onset of the disease. However, the heterogeneity as well as the 
impact of non-genetic factors massively impedes the investigation of pathomechanisms 
underlying the disease. The rare autosomal recessive encepalopathy Aicardi-Goutières 
Syndrome (AGS) is also characterized by an uncontrolled type I interferon response and 
shares genetic, molecular and clinical features with SLE. Due to the overlap, AGS is 
currently regarded as a monogenic variant of SLE and might thus be a valuable tool to 
elucidate mechanisms of SLE pathology. 
The aim of this doctoral thesis was to generate a mouse model for the Aicardi-Goutières 
Syndrome to allow for the investigation of pathomechanisms of AGS and SLE disease. To 
this end, we wanted to generate and analyze mice deficient for the RNase H2 enzyme that 
is mutated in a major portion of human AGS patients, but also in a small fraction of SLE 
patients. The RNase H2 enzyme is heterotrimeric nuclease that is only functional as a 
complex. In a first approach, we thus planed to inactivate the RNase H2 enzyme in mice by 
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deleting the Rnaseh2c gene that encodes for the smallest subunit of the enzyme. Together 
with the Rnaseh2b KOF mouse line that became commercially available from the 
EUCOMM consortium, the Rnaseh2c knockout mouse allowed for the investigation of 
complete RNase H2 deficiency. We hoped that these mice will recapitulate the uncontrolled 
type I interferon response of AGS patients in order to investigate the underlying cell-intrinsic 
mechanisms that cause the imbalance. Furthermore, since the Rnaseh2b KOF mouse line 
could also be used for the cell type-specific deletion of the Rnaseh2b gene, we also had a 
powerful tool available that allowed for the investigation of RNase H2 deficiency in different 
cell types. We were eventually interested if the deficiency of the RNase H2 enzyme in one 
particular cell type would be capable to trigger AGS pathology. 
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2 Material and Methods 
2.1  Material 
2.1.1 Primers 
Genotyping PCR 
allele name sequence 
Rnaseh2b KOF 
Rnaseh2b_40844_F 5`-CCTGAGAATGTCTGCATGGC-3`  
CAS_R1_Term 5`-TCGTGGTATCGTTATGCGCC-3` 
Rnaseh2b_40844_R 5`-GCTCATCTTGTGAGGAGGGC-3` 
Rnaseh2c ko 
Typing H2c wt for 5`-CACAGATCCCTTCTCACCACTTGGA-3` 
Typing H2c neo for 5`- CTGCTTGCCGAATATCATGGTGGAA-3` 
Typing H2c rev 5`-CCGAAGAACAGACCCAAGAGGAGAA-3` 
Rnaseh2b 
floxed/deleted 
5` check delta LacZ 5`-TCATCTGATGGCTCTCGGAGGAATG-3` 
3` check delta LacZ 5`-GGAGGGCACTCTAAAGAGCAAGCTA-3` 
3` check delta Exon5 5`-CTGTTGAACTGATGGCGAGCTCAGA-3` 
LacZ 5` Typing LacZ h2b 5`-GGAGAATCCCGGCCCTGGGATCTGG-3` 
3` Typing LacZ h2b 5`-CTTCTGGTGCCGGAAACCAGGCAAAG-3` 
p53 
p53 common for 5`-ACAGCGTGGTGGTACCTTAT-3` 
p53 wild type rev 5`-TATACTCAGAGCCGGCCT-3` 
p53 mutant rev 5`-CTATCAGGACATAGCGTTGG-3` 
Rag1 
oIMR1746 (wt for) 5`-GAGGTTCCGCTACGACTCTG-3` 
oIMR3104 (common) 5`-CCGGACAAGTTTTTCATCGT-3` 
oIMR8162 (mutant for) 5`-TGGATGTGGAATGTGTGCGAG-3` 
Ifnar1 
Ifnar-upE3-for 5`-GCCCATGTATACATTTGCTCATTCCG-3` 
Ifnar-Neo-rev2 5`-CCAAGCGAAACATCGCATCGAGCGAG-3` 
Ifnar-E3-rev 5`-CGGATCAACCTCATTCCACGAAGATG-3` 
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Quantitative real time PCR (qRT PCR) 
 
allele name sequence 
Rnaseh2b 5` qRT Rnaseh2b E7/9 5`-AGGTTTCCAGGGACAAGGAAGAGGA-3` 
3` qRT Rnaseh2b E7/9 5`-GTCAATGAAGCTGGAGGTTCTGGAAG-3` 
beta actin 5` qRT beta actin E3/4 5`-TGACCCAGATCATGTTTGAGACCTTCA-3` 
3` qRT beta actin E3/4 5`-GGAGTCCATCACAATGCCTGTGG-3` 
Cdkn1a 5` p21 5`-GCAGATCCACAGCGATATCC-3` 
3` p21 5`-CAACTGCTCACTGTCCACGG-3` 
Phlda3 5` Phlda3 5`-TTCGCCCGCATCAAAGCCGT-3` 
3` Phlda3 5`-AGGGGGCAGCGGAAGTCGAT-3` 
Zmat3 5` Zmat3 qRT E4/6 5`-GAGTCACTCATTCTCGGACTCCGC-3` 
3` Zmat3 qRT E4/6 3`-GAGCGGGCATTGAAGTAAGGGC-3` 
ISG15 5` ISG15 5`-GGTGTCCGTGACTAACTCCAT-3` 
3` ISG15 5`-TGGAAAGGGTAAGACCGTCCT-3` 
Oligoadenylat -
synthetase 1 
(OAS1) 
OAS-P1 5`-CCATCTGCATCAGGAGGTGGAG-3` 
OAS-P2 5`-GGAGGTACATTCCTCGATGAGGATG-3` 
Rsad2 Vip-F-new 5`-CAAGCGAGGACTGCTTCTGCTC-3` 
Vip-R-new 5`-GCAGAATCTCACAAGCTTGCCC-3` 
Ifi44 Ifi44-For 5`-GGCACATCTTAAAGGGCCACACTC-3` 
Ifi44-Rev 5`-CTGTCCTTCAGCAGTGGGTCATG-3` 
Generation of Rnaseh2c targeting vector 
allele name sequence 
homology 
region 1 
5` HR up (XbaI) 
5`-
GGACTTCTAGATGGTACTTTGCAAGCAGCCCCTGGAGGAGA
-3` 
5` HR down (BamHI) 
5`-
CGTACCGGATCCGTGATGAGGATTGGACTCAGGGCCTTGG
AC-3` 
homology 
region 2 
3` HR up (HindIII) 5`TATGGTGTCCTAGGCTTTAGCTAGTCGCAGTCATTAAGCTTCTTTGGTCCACGTGTTCAGAGCGGACCTGG-3` 
3` HR down (XhoI) 5`CCTAATGAATTGGCCTGTAGCTGGTAGTCTATCCATCTCGAGACTCCGCCTCCTGTGCTCTATTGCTTTAGG-3` 
DT gene 
cassette 
DT-XhoI-For-New (XhoI) 
5`-
GCTAGCTCGAGCCGTCGACGGTATCGATAAGCTTGATATCG
AATT-3` 
DT-XhoI-Rev-New (XhoI) 
5`-
GCTAGCTCGAGCCCACCCCCCAGAATAATAGAATGACACCT
ACT-3` 
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Sequencing primers 
allele name sequence 
homology 
region 1 
HR1seq1 for 5`-CTGCAAGGCGATTAAGTTGGGTAA-3` 
HR1seq1 rev 5`-GCACATGTCCTACCAGCTCACACTG-3` 
HR1seq2 for 5`-CATGTGCAGTGAGCTGGTGGGACAT-3` 
HR1seq2 rev 5`-CTACCGGTGGATGTGGAATGTGTGC-3` 
homology 
region 2 
HR2seq1 for 5`-GAATAAAGACCGACCAAGCGACGTC-3` 
HR2seq1 rev 5`-CCTCCTATCCTACCGAAGTTACTGG-3` 
HR2seq2 for 5`-GGAACAGACAGACCAAACCACAACC-3` 
HR2seq2 rev 5`-CACACAGGAAACAGCTATGACCATG-3` 
Test for homologous recombination of the targeting vector 
allele name sequence 
Screening PCR 
HR2seq1 for 5`-GAATAAAGACCGACCAAGCGACGTC-3` 
HR2-est. 5`-GTGCTTGGATCATCACGAGGCCAGTAG-3` 
upstream 
probe 
T7-H2c probe1 up for 
5`TAATACGACTCACTATAGGGAGACTGAAACGAGATGGAG
TGACCATGAGGAC-3` 
SP6-H2c probe1 up rev 
5`ATTTAGGTGACACTATAGAAGCGGTCCTAATAGGGACAG
GAAATTGCTCTG-3` 
downstream 
probe T7-H2c probe1 down for 
5`TAATACGACTCACTATAGGGAGACAGTGTCATCAGTTTAG
CTGCGATCC-3` 
 
SP6-H2c probe1 down 
rev 
5`ATTTAGGTGACACTATAGAAGCGGTAAGGCTAGTCTCTGA
GAACCGACG-3` 
 
2.1.2 Kits 
 
Kit product number Vendor 
   DIG RNA Labeling Kit (SP6/T7) 11175025910 
Roche Diagnostics GmbH, 
Mannheim 
DIG Wash and Blocking buffer set 11585762001 
Roche Diagnostics GmbH, 
Mannheim 
FastStart Universal SYBR Green Master (Rox) 4913914001 
Roche Diagnostics GmbH, 
Mannheim 
MEGAclear™ Transcription Clean-Up Kit AM1908 Life Technologies GmbH, Darmstadt 
Peroxidase Substrate Kit DAB SK-4100 Vector Laboratories, Inc., Burlingame, California 
RevertAid™ H Minus cDNA Synthesis Kit K1631 
Life Technologies GmbH, 
Darmstadt 
RNeasy Fibrous Tissue Mini Kit 74704 Qiagen GmbH, Hilden 
RNeasy Mini Kit 74104 Qiagen GmbH, Hilden 
Trichrome Stain (Masson) Kit  HT15-1KT 
Sigma-Aldrich Chemie GmbH, 
München 
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2.1.3 Buffers and solutions 
 
buffer reagents 
  1x PBS 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4 (pH 7.4) 
1x TBS 50 mM Tris HCl (pH 7.5), 150 mM NaCl 
50x TAE 2 M Tris, 50 mM EDTA (pH 8), 5.7% acetic acid 
TE buffer 10 mM Tris HCl, 1 mM EDTA (pH 7.6) 
1x lysis buffer 0.1 M Tris-HCl, 0.2 M NaCl, 0,2% SDS, 5 mM EDTA (pH 8) 
ES cell lysis buffer 10 mM NaCl, 10 mM Tris-HCl (pH 7.5), 10 mM EDTA, 0.5% sacrosyl,  0.4 – 1 mg /ml proteinase K 
Red blood cell  
lysis buffer 155 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA 
Denature buffer 1.5 M NaCl, 0.5 M NaOH 
Neutralization buffer 1.5 M Tris, 1.5 M NaCl (adjusted with HCl to pH 7.6) 
20x SSC 3 M NaCl, 0.3 M tri-sodium citrate (adjusted with HCl to pH 7) 
Wash buffer 1 2 x SSC, 0.1% SDS 
Wash buffer 2 0.2 x SSC, 0.1% SDS 
Blocking buffer (Ki67) 1% BSA, 0.1% cold fish skin gelantin, 0.5% Triton X-100, 0.05% sodium azide, 0.01 M PBS (pH 7.2) 
Steamer buffer 2 mM tri-sodium citrate, 0.05% Tween 20 (pH 6) 
solution D 4 M guanidinium thiocyanate, 25 mM sodium citrate (pH 7), 0.5% Sarkosyl, 0.1 M β-mercaptoethanol 
FACS buffer 2% fetal calf serum in 1 x PBS 
Protein extraction buffer 
50 mM Tris (pH 8), 280 mM NaCl, 0.5% NP40, 0.2 mM EDTA,  
0.2 mM EGTA, 10% (v/v) glycerol, 0.1 mM sodium vandate,  
1 mM DTT*, 1 mM PMSF* (*freshly added) 
Cytoplamic buffer 20 mM HEPES, 10 mM KCl, 1 mM EDTA, 0.1 mM sodium vandate,  1 mM DTT*, 1 mM PMSF* (*freshly added) 
Anesthetization solution  10 mg/ml xylazine, 1 mg/ml ketamine in 0.7% physiologic salt solution 
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2.1.4 Antibodies 
cell type epitope fluorochrome clone isotype dilution 
hematopoietic cells CD45 FITC 30-F11 rat IgG2b, κ 1:400 
eFluor450 30-F11 ratIgG2b, κ 1:400 
V500 30-F11 ratIgG2b, κ 1:200 
CD45.1 FITC A20 mouse IgG2a, κ 1:400 
PECy7 A20 mouse IgG2a, κ 1:100 
CD45.2 PE 104 mouse IgG2a, κ 1:100 
neutrophilic 
granulocytes CD11b FITC M1/70 rat IgG2b, κ 1:1600 
Biotin M1/70 rat IgG2b, κ 1:800 
Ly6C/G (Gr1) PerCP Cy5.5 RB6-8C5 rat IgG2b, κ 1:1200 
Biotin RB6-8C5 rat IgG2b, κ 1:800  
antigen-presenting 
cells (APCs) MHC II I-A/I-E eFluor 450 M5/114.15.2 rat IgG2b, κ 1:200 
MHC II I-AB FITC AF6-120.1 mouse IgG2a, κ 1:500 
B cells CD19 PECy7 eBio1D3 rat IgG2a, κ 1:200 
eFluor450 eBio1D3 rat IgG2a, κ 1:400 
Biotin eBio1D3 rat IgG2a, κ 1:800 
CD45R (B220) APC RA3-6B2 rat IgG2a, κ 1:200 
FITC RA3-6B2 rat IgG2a, κ 1:200 
Biotin RA3-6B2 rat IgG2a, κ 1:400 
α/β-T cells CD3e APC 145-2C11 IgG 1:100 
Biotin 145-2C11 IgG 1:400 
CD4 PE GK1.5 rat IgG2b, κ 1:500 
Biotin GK1.5 rat IgG2b, κ 1:400 
CD8a APC-eFluor 780 53-6.7 rat IgG2a, κ 1:200 
Biotin 53-6.7 rat IgG2a, κ 1:800 
NK cells NK1.1 Biotin PK136 rat IgG2a, κ 1:800 
erythrocytes Ter119 Biotin TER-119 rat IgG2b, κ 1:800 
hematopoietic stem 
cells CD150 PECy7 
TC15-
12F12.2 rat IgG2a, α 1:200 
CD48 APC HM48-1 IgG 1:100 
FITC HM48-1 IgG 1:100 
CD117 (c-kit) APC-eFluor 780 2B8 rat IgG2b, κ 1:1600 
Ly6A/E (Sca1) PerCP Cy5.5 D7 rat IgG2a, κ 1:400 
V500 D7 rat IgG2a, κ 1:200 
hematopoietic stem 
cells, skin stem cells CD34 eFluor 660 RAM34 rat IgG2a, κ 1:25 
keratinocytes CD49f PE eBioGoH3 rat IgG2a, κ 1:400 
CD104 Biotin 346-11A rat IgG2a, κ 1:100 
Langerhans cells 
CD205 
(DEC205) PerCP-eFluor 710 205yekta rat IgG2a, κ 1:200 
CD207 
(Langerin) PE eBioL31 IgG2a 1:100 
CD103 APC 2E7 IgG 1:200 
γ/δ-T cells γ/δ TCR FITC 
eBioGL3               
(GL-3, GL3) IgG 1:100 
blocking antibody CD16/32 unconjugated 93 rat IgG2a, λ 1:200 
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2.2 Animal experiments 
2.2.1 Mouse husbandry  
All mice were housed at the Experimental Centre of the University of Technology 
Dresden (Medical Faculty Carl Gustav Carus) in individually ventilated cages (IVCs) 
and under specific-pathogen-free conditions (SPF). Pathogen-free conditions were 
regularly tested according to the Federation for Laboratory Animal Science (FELASA). 
At most five adult mice of the same gender were kept in a single Ehret type 2L cage 
(Ehret, ≈ 500cm2). Mice were housed at an ambient temperature of 22°C and a relative 
humidity of 50-60% during a day-night cycle of 12 hours each. Mice had constant 
access to food and water (acidified, pH 4.5) (ad libitum). To obtain newborn litter, mice 
older than 8 weeks were crossed. One male mouse was bred to one or two female 
mice. The newborn litter was weaned three weeks after birth. The newborns were ear-
tagged and a tail tip was cut with a heated scissor to allow for genotyping. Mouse 
housing was organized using the Phyton-based Relational Animal Tracking (PyRAT) 
software (Scionics Computer Innovation GmbH Germany, Dresden). All experimental 
procedures were according to the German animal welfare law approved by the 
Landesdirektion Dresden.  
 
2.2.2 Genotyping  
For genotyping of the newborn litter, isolated DNA was amplified according to standard 
PCR techniques (see below). An appropriate set of primers was used to amplify the 
particular gene locus (Table 2.1.1). PCR products were subsequently separated by gel 
electrophoresis in 1% agarose gels (Biozym LE Agarose, Biozym Scientific GmbH, 
Hessisch Oldendorf) in 1 x TAE buffer and visualized using the Molecular Imager® 
ChemiDoc™ XRS Imaging System (Bio-Rad Laboratories GmbH, München). Mouse 
genotypes were immediately registered in the PyRAT software.  
 
2.2.3 Mouse skin thickness 
Mice were anesthetized and the back was shaved using an electric shaver. To 
determine the skin thickness, the neck skin was grabbed using blunt forceps and the 
emerging skin fold was measured in triplicate using a caliper (Mitutoyo Deutschland 
GmbH, Neuss). In case of spontaneous ulcerations, the measuring point was placed 
more caudal. Ear thickness was determined at the un-tagged ear and also measured in 
triplicate. 
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2.3 Standard molecular techniques 
2.3.1 Isolation protocols 
2.3.1.1 Isolation of genomic DNA from mouse tail tips 
Tail tips were lysed in a 1.5 ml collection tube containing 500 µl lysis buffer and 5 µl 
Proteinase K (20 mg / ml). Lysis was performed for at least 2 hours at 56°C and 
constant shaking at 1000 rpm. Lysed tails were centrifuged for 10 minutes at 13000 
rpm and the supernatant was transferred into a new 1.5 ml collection tube containing 
500 µl isopropanol. DNA was precipitated by inverting the tube at least ten times and 
pelleted by centrifugation for 10 minutes at 13000 rpm. The supernatant was removed 
and the pellet was washed in 350 µl 70% ethanol. The pellet was dried to allow the 
evaporation of the ethanol and finally resuspended in 100 µl TE buffer. Resuspension 
was facilitated by incubation at 56°C for 2 hours a nd constant shaking at 800 rpm. In 
case DNA was isolated from larger tissues or organs, the reaction mixture was scaled 
accordingly.  
 
2.3.1.2 RNA isolation from newborn mouse epidermis 
To obtain RNA for gene expression analysis, newborn mice were prepared as 
described (2.4.2.2). To avoid unwanted RNA degradation, the Dispase (neutral 
protease, grade II, Roche Diagnostics GmbH, Mannheim) digest was reduced to 
2 hours at 4°C. The epidermis was manually separate d from the dermis by softly 
shifting the epidermis against the dermis using blunt forceps. RNA from the epidermis 
was subsequently isolated following the RNeasy Mini Kit protocol. Tissue was 
disrupted in 600 µl RLT buffer containing β-mercaptoethanol using the gentleMACS 
Dissociator (Miltenyi Biotec GmbH Germany, Bergisch Gladbach) and program 
RNA_01. RNA was finally eluted in 50 µl elution buffer.  
 
2.3.1.3 RNA isolation from murine fetal liver cells 
Fetal liver cells from E14.5 mouse embryos were isolated and immediately (≤ 30min) 
homogenized in 1 ml solution D using the gentleMACS dissociator (Miltenyi Biotec 
GmbH Germany, Bergisch Gladbach) and program RNA_01. Subsequent RNA 
isolation was performed by acid guanidinium thiocyanate-phenol-chloroform extraction 
according to Chomczinsky et al. (Chomczynski and Sacchi, 2006). To avoid 
contamination with phenol, the aqueous phase was pipetted generously. RNA was 
finally resuspended in 100 µl nuclease-free water.  
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2.3.1.4 RNA isolation from adult mouse skin 
Skin biopsies were collected using an 8 mm biopsy puncher (Stiefel, SmithKline 
Beecham Ltd. UK). The adipose tissue was carefully removed using scalpels and the 
skin was immediately placed in RNAlater RNA Stabilization Reagent (Qiagen, Hilden). 
The skin was homogenized in 600 µl RLT buffer containing β-mercaptoethanol using 
the gentleMACS Dissociator (Miltenyi Biotec GmbH Germany, Bergisch Gladbach) and 
program RNA_01. RNA was isolated according to the RNeasy Fibrous Tissue Kit 
protocol and finally eluted in 50 µl elution buffer. The optional on-column DNase I 
digest was omitted.  
 
2.3.2 Nucleic acid species 
2.3.2.1 Polymerase chain reaction (PCR) 
Gene loci of interest were amplified by polymerase chain reaction (PCR). Primers for 
amplification were chosen using the non-commercial Primer-BLAST software (The 
National Center for Biotechnology Information, Bethesda, Maryland) according to the 
preferences of the primer length of 25 bp, a GC content of 40-60% and an annealing 
temperature of 58°C. Standard PCR was performed in a total volume of 50 µl, 
containing 1 µl genomic DNA, 0.2 mM dNTPs, 1 x Taq polymerase buffer, 0.2 mM 5`-
primer, 0.2 mM 3`-primer, 1.5 µl Taq DNA polymerase and water. An expected PCR 
product of 500 bp was amplified with an initial denaturation step at 95°C for 5 min, 
followed by 35 cycles of denaturation at 95°C for 3 0 s, annealing at 58°C for 30 s and 
elongation at 72°C for 30 s (PCR-Cycler T3000 Therm ocycler, Biometra 
Biomedizinische Analytik GmbH, Göttingen). The annealing and elongation time of 
longer products were adjusted accordingly. Elongation time of 1 kb was set to 1 minute. 
PCR products were separated by gel electrophoresis in 1% agarose in 1x TAE buffer 
and visualized using the Molecular Imager® ChemiDoc™ XRS Imaging System (Bio-
Rad Laboratories GmbH, München) 
 
2.3.2.2 Isolation of PCR products from agarose gels 
PCR products were isolated according to the manual of the GENECLEAN Turbo Kit 
(MP Biomedicals Europe). For that purpose PCR products were cut from the agarose 
gel using the Molecular Imager® ChemiDoc™ XRS Imaging System (Bio-Rad 
Laboratories GmbH, München) and transferred into 1.5 ml collection tubes and the 
weight of the gel piece was determined. The extracted DNA was usually eluted in 30 µl 
elution buffer. 
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2.3.2.3 Quantification of nucleic acid concentrations 
Nucleic acid concentrations (DNA and RNA) were either measured using NanoDrop 
2000 (Thermo Fisher Scientific Germany, Frankfurt a. M.) or the Qubit® 2.0 
Fluorometer (Life Technologies Germany, Darmstadt) according to the 
recommendations of the vendor. In case nucleic acid concentrations were measured 
using the Qubit® 2.0 Fluorometer, 2 µl nucleic acid were put into the reaction.  
 
2.3.2.4 Sequencing of PCR products 
The gene locus to be sequenced was amplified using standard PCR techniques, PCR 
products were subsequently separated by gel electrophoresis in 1% agarose gels in 1 x 
TAE buffer and extracted from the gel as described (2.3.2.2). Finally, the DNA 
concentration of PCR products was determined using NanoDrop Technology. For the 
sequencing of a product of 400 bp, 72 ng PCR product were either mixed with the 
forward or the reverse primer in a total volume of 12 µl and send to Seqlab – Sequence 
Laboratories Göttingen GmbH. Sequencing results were displayed using Chromas Lite 
software (Technelysium Pty Ltd. Australia, Brisbane). Amount of PCR product was 
adjusted to the length of the PCR product. 
 
2.3.2.5 cDNA synthesis 
100 ng – 1 µg total RNA were reverse transcribed into cDNA using poly (dT)18 
oligonucleotides following the manufacturer`s instructions (RevertAid™ H Minus cDNA 
Synthesis Kit, Thermo Fisher Scientific Germany, Frankfurt a. M.). In brief, RNA and 
poly (dT)18 primers were mixed in a total volume of 12 µl and denatured at 65°C for 
5 min followed by an incubation for 5 min on ice. Additional reagents were added to a 
final concentration of 1 x reaction buffer, 20 units RiboLock™ RNase Inhibitor, 1 mM 
dNTP mix, 200 units RevertAid™ H Minus M-MuLV Reverse Transcriptase (RT) and 
water in a final volume of 20 µl. Reverse transcription was performed at 42°C for 
60 min. Reverse transcription was also performed without RNA (non-template control) 
and without reverse transcriptase (RT-). These samples were used to check for 
contamination and served as negative controls in subsequent quantitative real-time 
PCR. To avoid reverse transcription of DNA, intron-spanning primers were used. 
 
2.3.2.6  Quantitative real time PCR (qRT PCR) 
Quantitative real time PCR mix was prepared according to the FastStart Universal 
SYBR Green Master (Rox) protocol (Roche Diagnostics GmbH, Mannheim). 1 µl cDNA 
was added to a final reaction volume of 25 µl, containing 1 x SYBR Green, 6 µM 
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forward and reverse primer (Table 2.1.1), respectively. Target genes were amplified by 
polymerase chain reaction, initiated by denaturation for 15 min at 95°C and followed by 
40 cycles of denaturation for 15 s at 95°C, anneali ng for 30 s at 58°C and elongation 
for 30 s at 72°C. Incorporation of SYBR green was a nalyzed using the Mx3005P QPCR 
system (Agilent Technologies Sales & Services GmbH & Co.KG, Waldbronn) and the 
MxPro QPCR software (Agilent Technologies Sales & Services GmbH & Co.KG, 
Waldbronn). Non-template and RT- cDNA was used as control for DNA contamination. 
Fold change of transcript levels was calculated by pair-wise comparison of knockout 
versus wild type samples that were normalized to the reference gene beta actin.  
 
2.3.2.7 Microarray analysis 
Gene expression analysis was performed in collaboration with Julia Jarrells and Britta 
Schilling from the Max Planck Institute for Cell Biology and Genetics in Dresden. 
RNA quality was first determined using the 2100 Bioanalyzer Instruments (Agilent 
Technologies Sales & Services GmbH & Co.KG, Waldbronn). Samples with uneven or 
bad quality were rejected from the experiment. RNA was then reverse transcribed, 
amplified and biotin labeled using the Message Amp II-Biotin Enhanced Kit (Ambion, 
Life Technologies Germany, Darmstadt). Hybridization, staining and scanning of the 
GeneChip Mouse Genome 430 2.0 microarrays were performed according to the 
Affymetrix GeneChip Expression Analysis Technical Manual (P/N 702232 Rev. 3) 
(Affymetrix UK Ltd.) 
 
2.4 Cell cultivation  
2.4.1 Cell culture media 
2.4.1.1 Fibroblast medium 
Fibroblast medium: Gibco® Dulbecco`s modified Eagle medium (DMEM) (Life 
Technologies Germany, Darmstadt) supplemented with 10% fetal bovine serum 
(Biochrom, Merck KGaA Germany, Darmstadt), 100 u/ml penicillin, 10 µg/ml 
streptomycin (Biochrom, Merck KGaA Germany, Darmstadt), 1 x non-essential amino 
acids (Biochrom, Merck KGaA Germany, Darmstadt) and 100 µM β-mecaptoethanol 
(Sigma-Aldrich Chemie GmbH, München) 
 
2.4.1.2 Keratinocyte medium 
DMEM (2/3) + HAM`s F12 (1/3) (FZ9995, Biochrom, Merck KGaA Germany, 
Darmstadt) supplemented with 10% calcium free FCS Gold (PAA, GE Healthcare 
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Europe, Freiburg), 100 u/ml penicillin, 10 µg/ml streptomycin (Biochrom, Merck KGaA 
Germany, Darmstadt), 1 mM L-glutamine, 0.025 g sodium L-ascorbate (A4034, Sigma-
Aldrich Chemie GmbH, München), 10 ng/ml epidermal growth factor (EGF)(E9644, 
Sigma-Aldrich Chemie GmbH, München), 5 µg/ml insulin (11882, Sigma Aldrich), 
0.5 µg/ml hydrocortisone (H4001, Sigma-Aldrich Chemie GmbH, München), 10-10 M 
cholera toxin (C-8052, Sigma-Aldrich Chemie GmbH, München) and 1.8 x 10-4 M 
adenine (A3159; Sigma-Aldrich Chemie GmbH, München) 
 
2.4.1.3 B cell medium 
B cell medium: Gibco® RPMI 1640 (Life Technologies Germany, Darmstadt) 
supplemented with 10% fetal bovine serum (Biochrom, Merck KGaA Germany, 
Darmstadt), 100 u/ml penicillin, 10 µg/ml streptomycin (Biochrom, Merck KGaA 
Germany, Darmstadt), 2 mM L-alanyl-L-glutamine and 10 µM β-mecaptoethanol 
(Sigma-Aldrich Chemie GmbH, München) 
 
2.4.2 Cell preparation  
2.4.2.1 Preparation of mouse embryonic fibroblasts 
Timed breedings were set and embryos were collected by caesarian section 14.5 or 
18.5 days after detection of a vaginal plug. Embryos were decapitated and inner 
organs as well as all red tissue were removed. The embryos were minced with 
scissors, digested in 1 ml 1 x trypsin (0.25%, Life Technologies Germany, Darmstadt) 
for 10 minutes at 37°C and disaggregated by aspirat ion through a 1000 µl pipette tip. 
Embryonic cells were seeded in 10 ml complete DMEM medium on a 10 cm culture 
dish. The embryo`s tail was used for genotyping. 
 
2.4.2.2 Preparation of keratinocytes from newborns` skin 
Newborns were collected one or two days after birth, killed by decapitation and kept on 
ice. For disinfection, newborns were incubated for one minute each in Betaisodona® 
(1:1 in 1 x PBS, Mundipharma GmbH Germany, Limburg), 70% ethanol, 1 x PBS and 
1 x antibiotic-antimycotic (Life Technologies Germany, Darmstadt). All extremities were 
removed leaving short stubs and the tail was used to isolate genomic DNA for 
genotyping. Using a scissor, a sagittal cut was made along the dorsum and the skin 
was peeled off using blunt forceps. After digestion in 5 mg / ml Dispase (neutral 
protease, grade II, Roche Diagnostics GmbH, Mannheim) for about 15 hours at 4°C, 
the dermis was separated from the epidermis using blunt forceps and softly shifting the 
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dermis against the epidermis. The epidermis was then placed onto a droplet of 500 µl 
trypsin (TrypLE Express without phenol red, Life Technologies Germany, Darmstadt), 
with the basal membrane facing the trypsin. After digestion for additional 30 minutes at 
room temperature, keratinocytes were isolated from the epidermis by repeated flushing 
with complete keratinocyte medium. The cell suspension was collected, strained using 
a 100 µm nylon filter and centrifuged for eight minutes at 500 g. The supernatant was 
discarded and the cell pellet was resuspended in 2 ml complete keratinocyte medium. 
1 x 106 keratinocytes were seeded on a 6 cm petri dish pre-coated with 30 µg/ml 
Collagen G (Biochrom, Merck KGaA Germany, Darmstadt).  
 
2.4.3  In vitro cell assays 
2.4.3.1 3H-thymidine proliferation assay 
2.5 x 103, 5 x 103 and 10 x 103 mouse embryonic fibroblasts were seeded in triplicates 
into flat-bottom 96-well plates and cultivated in complete DMEM medium. After 48 
hours of incubation, 3.7 x 104 becquerel (Bq) 3H-thymidine (HARTMANN ANALYTIC 
GmbH Germany; Braunschweig) were added to each well and cells were cultivated for 
additional 48 hours. Finally, mouse embryonic fibroblasts were washed, detached from 
the 96-well plate and transferred onto “Printed Filtermat A” (Perkin Elmer Germany, 
Rodgau), lysed in water, washed to remove excess label and covered with MeltiLex™ 
A Melt-on Scintillator Sheets (Perkin Elmer Germany, Rodgau). Incorporation of 3H-
thymidinde was measured for one minute per well using the 1450 MicroBeta TriLux 
scintillation counter (Perkin Elmer Germany, Rodgau). 
 
2.4.3.2 Cell cycle analysis 
5 x 105 mouse embryonic fibroblasts were seeded into a 6-well plate and cultivated 
until confluency in complete DMEM medium. After 72 hours, supernatant was 
transferred to a new collection tube, cells were washed in 1 x PBS, incubated in 1 x 
trypsin (0.25%, Life Technologies Germany, Darmstadt) and then added to the 
collected supernatant. The cell suspension was then centrifuged at 1200 rpm for 5 min, 
the supernatant was discarded and the cell pellet was washed in 1 x PBS. Finally, cells 
were resuspended in 500 µl 1 x PBS and fixed by adding 4.5 ml 70% ethanol for at 
least 24 hours at -20°C. For DNA content analysis c ells were washed in 1 x PBS and 
resuspended in 0.5 mg/ml RNAse A (Sigma-Aldrich Chemie GmbH, München) and 
2.5 µg/ml propidium iodide (Sigma-Aldrich Chemie GmbH, München) and incubated for 
10-30 minutes at room temperature in the dark. Cells were analyzed using 
MACSQuant flow cytometer (Miltenyi Biotec GmbH Germany, Bergisch Gladbach). 
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2.4.3.3 In vitro LPS stimulation of splenic B cells 
Total spleen cells were isolated as described and seeded at a density of 3 x 105 cells in 
complete B cell medium containing 25 µg/ml LPS from Salmonella Minnesota Re 595 
(Sigma-Aldrich Chemie GmbH, München). For DNA content analysis, cells were 
harvested after three days and fixed as described for mouse embryonic fibroblasts. For 
the 3H thymidine incorporation assay, cells were seeded into 96 well plates and 
stimulated for 48 hours before 3H thymidine was added and cells were further cultivated 
for additional 24 hours. Cells were transferred onto “Printed Filtermat A” (Perkin Elmer 
Germany, Rodgau), lysed in water, washed to remove excess label and covered with 
MeltiLex™ A Melt-on Scintillator Sheets (Perkin Elmer Germany, Rodgau). 
Incorporation of 3H-thymidinde (HARTMANN ANALYTIC GmbH Germany; 
Braunschweig) was measured for one minute per well using the 1450 MicroBeta TriLux 
scintillation counter (Perkin Elmer Germany, Rodgau).  
 
2.5 Preparations of cell suspensions  
2.5.1 Peripheral blood cells 
Peripheral blood was collected from the retro-orbital bulbus and immediately mixed 
with an equivalent volume of heparin (1:10 in 1 x PBS, Merck KGaA Germany, 
Darmstadt). Red blood cells were lysed three times by incubating complete blood in red 
blood cell lysis buffer for 1 minute at RT. Reaction was stopped by adding an 
equivalent volume of PBS. Finally, blood leukocytes were resuspended in FACS buffer.  
 
2.5.2 Fetal liver / fetal thymus cells 
Fetal liver was isolated from E14.5 or E18.5 embryos and fetal thymus was isolated 
from E18.5 embryos, respectively. Organs were transferred to a 6 well plate containing 
2 ml FACS buffer per well. Fetal liver and fetal thymus was disaggregated by aspiration 
through an 18G x 1½ needle (Beckton Dickinson Germany, Heidelberg) for ten times 
before cells were further homogenized by aspiration through a 20G x 1½ needle 
(Beckton Dickinson Germany, Heidelberg) for additional ten times. Red blood cell lysis 
was not performed on fetal liver and thymus cells. The cell suspension was finally 
filtered through a 100µm mesh to remove tissue debris. 
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2.5.3 Spleen cells  
The spleen was immediately withdrawn from the mouse peritoneum and transferred 
into ice-cold 1 x PBS. Surrounding white tissue was carefully removed before the 
spleen was minced into small pieces and transferred onto a 100 µm nylon filter. The 
plunger of a 5 ml syringe was used to press the cells softly through the filter. The filter 
was subsequently washed with FACS buffer to obtain maximal spleen cell numbers. 
Cells were centrifuged for 5 min at 1200 prm and RT, the supernatant was removed 
and red blood cells were lysed in red blood cell lysis buffer. Lysis was stopped by 
adding 1 x PBS, cells were again centrifuged for 5 minutes at 1200 rpm and RT and 
the supernatant was removed. Cells were resuspended in 5 ml FACS buffer and finally 
filtered via a 100 µm nylon mesh. 
 
2.5.4 Bone marrow cells 
Femur and tibia were isolated and muscle tissue was carefully removed. Bones were 
subsequently crushed in a volume of 5 ml FACS buffer using mortar and pistil. Bone 
marrow cells were disaggregated by aspiration through a 23G x 1½ needle (Beckton 
Dickinson Germany, Heidelberg) and subsequently filtered through a 40 µm nylon 
mesh. Cell suspension was centrifuged for 5 minutes at 1200 rpm and RT, the 
supernatant was discarded and red blood cells were lysed by incubation in red blood 
cell lysis buffer for 1 minute at RT. Reaction was stopped by adding an equivalent 
volume of 1 x PBS, pelleted, resuspended in 2 – 3 ml FACS buffer and filtered through 
a 40 µm nylon filter. 
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2.5.5 Adult epidermal cells 
Epidermis cells from adult skin were isolated according to Jensen et al (Jensen et al., 
2010). Mice were first narcotized using anesthetization solution (100 µl per mg 
bodyweight), thoroughly shaved and killed by cervical dislocation. The dorsal skin was 
completely excised and the adipose tissue was carefully scraped using scalpels. The 
skin was placed on a layer of 1 x trypsin (0.25%, Life Technologies Germany, 
Darmstadt) with the dermis facing the liquid. After incubation for about 2 hours, the 
epidermis was separated from the dermis by slowly shifting the epidermis against the 
dermis using blunt forceps. The epidermis was subsequently minced with scalpels into 
small pieces and digested in 5 - 10 ml 1 x trypsin (0.25%, Life Technologies Germany, 
Darmstadt) for another hour. Reaction was stopped by adding an equal volume of 
complete keratinocyte medium (calcium-free) and cells were strained through a 40 µm 
nylon mesh. Cells were then centrifuged for 8 min at 500 g and RT and the pellet was 
finally resuspended in 2 ml FACS buffer. 
 
2.6 Southern Blot analysis 
2.6.1 DIG-labeled RNA probes for Southern Blot analysis 
The DNA sequence of the upstream and downstream probe was first amplified on BAC 
DNA (BAC RP23-156A18) (Osoegawa et al. 2000) using the appropriate set of primers 
(see table 2.1.1) and standard PCR techniques. PCR products were size-separated by 
gel electrophoresis and the correct PCR product was subsequently extracted from the 
agarose using the GENECLEAN Turbo Kit (MP Biomedicals Europe) following the 
recommendations of the vendor. Amplification of genomic DNA was performed using 
primers containing promoter sequences of RNA polymerase T7 and SP6 allowing for 
subsequent synthesis of DIG-labeled RNA probes. 1 µg DNA, 1x NTP labeling mixture, 
1x Transcription buffer, Protector RNase inhibitor, RNA polymerase SP6 and RNA 
polymerase T7, respectively, and water were added to a final volume of 20 µl. The 
reaction was incubated for 2 hours at 37°C. Templat e DNA was removed by digestion 
with DNase I for additional 15 minutes at 37°C befo re the reaction was stopped by 
adding EDTA (pH 8) to a final concentration of 0.1 M. DIG-labeled RNA probes were 
finally purified using the MEGAclear™ Transcription Clean-Up Kit (Life Technologies 
Germany, Darmstadt) and following the instructions of the protocol. The RNA probe 
was eluted in 50 µl elution solution. 
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2.6.2 Isolation of genomic DNA from mouse ES cells (96 well plate) 
Confluent ES cells were washed once with 100 µl PBS and subsequently lysed in ES 
cell lysis buffer at 56°C in a humidified chamber o ver night. After lysis, ES cells were 
cooled to RT for 1 h. Thereafter, additional 100 µl 100% ethanol were added to the ES 
cell lysate and DNA was allowed to precipitate for 1 – 2 hours before the supernatant 
was carefully discarded while the DNA remained attached to the bottom of the 96 well 
plate. DNA was subsequently washed three times in 70% ethanol. Finally DNA was 
dried for 10 – 15 minutes to allow ethanol evaporation and dissolved in 20 µl distilled 
water. In case DNA yield was too low, ES cells were expanded to 10 cm petri dishes to 
obtain maximal DNA yield. The isolation protocol was adjusted accordingly. 
 
2.6.3 Restriction enzyme digestion of genomic DNA 
For Southern Blot analysis of the DNA from gene-targeted mouse ES cells, different 
amounts of genomic ES cell DNA were digested with the restriction enzyme ApaLI 
(Thermo Fisher Scientific Germany, Braunschweig). The reaction mix of 60 µl 
contained different amounts of DNA, 1x buffer Tango (NEB), 1mM spermidine, 1mM 
DTT, 50 µg / ml RNAse A (Sigma-Aldrich Chemie GmbH, München) and 50 units 
ApaLI. The DNA was digested at 37°C overnight and t he next morning additional 10 
units ApaLI (in a total volume of 10 µl containing 1x buffer Tango) were added to the 
reaction and further incubated for two more hours.  
 
2.6.4 Southern Blot  
ApaLI-digested DNA was size-separated by gel electrophoresis in a 0.8% TAE agarose 
gel with 3 V/cm for about six hours. A 1 kb DNA marker (Thermo Fisher Scientific 
Germany, Frankfurt a. M.) and Digoxigenin-labeled DNA Molecular Weight marker III 
and VII (Roche Diagnostics GmbH, Mannheim) served as a size standard. After 
electrophoresis, the excess of the agarose gel was cut using the Molecular Imager® 
ChemiDoc™ XRS Imaging System (Bio-Rad Laboratories GmbH, München). DNA was 
then denatured twice for 15 minutes in denature solution followed by neutralization for 
15 minutes in neutralization buffer. To allow DNA transfer onto a nylon membrane via 
capillary blotting, the agarose gel was placed upside down onto three layers of 
moistened chromatography paper (3MM, GE Healthcare Europe, Freiburg) which were 
placed on a platform and whose ends submerged into a reservoir of 20 x SSC. The 
nylon membrane (positively charged, Roche Diagnostics GmbH, Mannheim), pre-
moistened in 2 x SSC to allow efficient transfer, was placed on the agarose gel. Three 
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moistened sheets of Chromatography paper and a pile of Apura paper was placed on 
top. To increase capillary forces, a weight was placed on the Apura paper. The DNA 
was blotted onto the nylon membrane overnight and thereafter cross-linked by 
incubation at 120°C for 30 minutes. For Southern Bl ot analysis, the membrane was 
pre-hybridized in DIG Easy Hyb Granules (Roche Diagnostics GmbH, Mannheim) for at 
least one hour at 50°C, before the DIG-labeled prob e was added and the membrane 
was further incubated overnight at 50°C. Unbound pr obe was removed by adding wash 
buffer 1 (2 x 5 minutes at RT) before the membrane was extensively washed with wash 
buffer 2 (2 x 15 minutes at 63°C). For secondary an tibody incubation, the membrane 
was first equilibrated for 5 minutes in DIG washing buffer (Wash and block buffer set, 
Roche Diagnostics GmbH, Mannheim), blocked for at least one hour and incubated in 
anti-Digoxigenin antibody labeled to alkaline phosphatase (AP) that was diluted in DIG 
blocking buffer. The membrane was incubated for additional two hours, before it was 
washed two times with DIG washing buffer for 15 minutes at RT. For the detection DIG-
labeled DNA, the membrane was equilibrated with DIG detection buffer for 5 minutes at 
RT before CDP-Star (Roche Diagnostics GmbH, Mannheim) was added. Hybridization 
of the probe was detected using the Luminescent Image Analyzer LAS-3000 Image 
analyzer (FUJIFILM Europe GmbH, Düsseldorf). 
 
2.7 Flow cytometry 
2.7.1 Determination of absolute cell numbers 
Cells were diluted 1:10 in FACS buffer containing 1 µg/ml propidium iodide (Sigma-
Aldrich Chemie GmbH, München) and counted using MACSQuant® Analyzer and 
MACQuantify™ software (Miltenyi Biotec GmbH Germany, Bergisch Gladbach). 
 
2.7.2 Peripheral blood chimerism 
To determine the peripheral blood chimerism, one capillary blood was taken from the 
retro-orbital bulbus of chimeric mice and immediately mixed with 100 µl heparin (1:10 
diluted in 1 x PBS, Merck KGaA Germany, Darmstadt) to avoid agglutination of the 
blood. To obtain white blood cells, 60 µl peripheral blood/heparin-mix was lysed three 
times in red blood cell lysis buffer. White blood cells were subsequently stained for 
CD11b+ Gr1+ polymorphonucleated cells (PMNs), B220+ B cells and CD3+ T cells. 
Donor, competitor and recipient cells were discriminated by staining for CD45.1 and 
CD45.2. 
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2.7.3 KSL SLAM staining of E14.5 fetal liver cells and adult bone marrow 
cells 
To enrich for hematopoietic stem cells (HSCs), fetal liver cells and bone marrow cells 
were incubated with a lineage antibody cocktail, containing biotinylated anti mouse 
CD19, B220, CD3e, CD4, CD8, CD11b, Nk1.1, Gr1. Cells were additionally incubated 
with rat immunoglobulin G (IgG) and CD16/32 to prevent unspecific antibody staining to 
Fc gamma receptor (FcγR). When fetal liver cells were stained for HSCs, CD11b was 
excluded from the lineage antibody mix. After incubation for 1 hour at 4°C in the dark, 
cells were washed three times with FACS buffer and subsequently incubated with 
CD117 APCeF780, Sca1 PerCP Cy5.5, CD48 APC, CD150 PE Cy7 and anti-biotin 
Streptavidin Pacific Blue for 1 hour at 4°C in the dark. In case donor, competitor and 
recipient had to be discriminated, anti mouse CD45.1 and CD45.2 were added. Cells 
were washed three times in FACS buffer and resuspended in at least 500 µl FACS 
buffer. Shortly before FACS analysis, propidium iodide (Sigma-Aldrich Chemie GmbH, 
München) was added to a final concentration of 1 µg/ml. FACS analysis was either 
performed on BD FACSAria™ II, BD FACSAria™ III or BD LSR II (Beckton Dickinson 
Germany, Heidelberg) and analyzed using FlowJo Single Cell Analysis Software 
(FLOWJO, LLC Data analysis software) 
 
2.7.4 Epidermal stem cell staining 
Stem cells from the epidermis were stained according to Jensen et al. (Jensen et al., 
2010). Epidermis cells were isolated as described (2.5.5) and subsequently stained in a 
total volume of 250 µl with CD45 FITC, CD34 eF660, Sca1 PerCP Cy5.5 and CD49f 
PE. Shortly before FACS analysis, propidium iodide (Sigma-Aldrich Chemie GmbH, 
München) was added to a final concentration of 1 µg/ml. The addition of CD45 allowed 
staining for Sca1 expression on epidermal hematopoietic cells. FACS analysis was 
either performed on BD FACSAria™ II, BD FACSAria™ III or BD LSR II (Beckton 
Dickinson Germany, Heidelberg) and analyzed using FlowJo Single Cell Analysis 
Software (FLOWJO, LLC Data analysis software). 
 
2.8 Histology 
2.8.1 Paraffin sections 
For the generation of paraffin sections, mouse tissues and mouse organs were isolated 
and fixed in a tenfold excess of 4% formaldehyde (pH 7.4) for at least one day. After 
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maximal fixation for three days, tissues and organs were trimmed into small samples 
and subsequently dehydrated using the “Semi-enclosed Benchtop Tissue Processor” 
Leica TP1020 (Leica Mikrosysteme Vertrieb GmbH Germany, Wetzlar). During the 
dehydration process, samples were first washed in PBS before sections were 
dehydrated by a series of ethanol with increasing percentages (70%, 80%, 96% and 
99%). Finally ethanol was replaced by xylene. Using the “Modular Tissue Embedding 
Center” Leica EG1150 (Leica Mikrosysteme Vertrieb GmbH Germany, Wetzlar), 
samples were casted in paraffin (Paraplast® Plus, Sigma-Aldrich Chemie GmbH, 
München) and subsequently cut into 6 µm sections using the “Automated Rotary 
Microtome” RM2265 (Leica Mikrosysteme Vertrieb GmbH Germany, Wetzlar). 
Depending on the following staining, sample sections were put onto different types of 
cover slips and dried over night at 37°C.  
 
2.8.2 Hematoxylin and eosin (H&E) staining 
Sample sections were placed onto uncoated glass slides and deparaffinized and re-
hydrated in a graded alcohol series. Sections were twice incubated for 5 minutes in 
xylene and subsequently incubated for 2 minutes in 99% ethanol, 96% ethanol, 80% 
ethanol, 70% ethanol and distilled water, respectively. For H&E staining, sections were 
first incubated for 2 minutes in Mayer`s hemalm solution before sections were exposed 
to warm tab water to allow staining of the nuclei. Afterwards, sections were stained with 
eosin for additional 2 minutes and excess of eosin was removed for 30 seconds in tab 
water. Finally, H&E stained sample sections were again dehydrated in a graded alcohol 
series and covered with Entellan (Merck KGaA Germany, Darmstadt). After H&E 
staining, nuclei appear dark blue or violet, while cytoplasm, elastin and collagen appear 
pink. Erythrocytes can be detected as yellow or orange dots. 
 
2.8.3 Masson`s trichrome staining 
Masson`s trichrome staining of mouse skin sections was performed according to the 
protocol of the Trichrome Stain (Masson) Kit (Sigma-Aldrich Chemie GmbH, München). 
Nuclei were stained black with the Weigert`s Iron Hematoxylin solution. Cytoplasm and 
muscle fibres appeared red, while collagen appeared blue after staining. 
 
2.8.4 Ki67 staining 
For Ki67 staining dorsal skin sections were mounted on poly-lysine coated glass slides 
(POLYSINE® SLIDES, Gerhard Menzel GmbH, Braunschweig). Paraffin-embedded 
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dorsal mouse skin sections were first deparaffinized at 56°C for 30 minutes and 
subsequently re-hydrated in a gradual alcohol series. Sections were three times 
incubated in fresh xylene for 10 minutes, followed by incubation for 10 minutes in 100% 
ethanol and 96% ethanol and for 20 minutes in 80% ethanol. Sections were finally 
washed for 10 minutes in tap water. For epitope exposure, sections were incubated in 
steamer buffer for one hour in hot steam. After three washing steps in 1x PBS for about 
3 minutes each, skin sections were treated with 3% hydrogen peroxide (H2O2) for 20 
minutes to inactivate endogenous peroxidase. After repeated washing in 1x PBS, 
sections were blocked for at least one hour in blocking buffer at RT. Sections were 
incubated with the primary antibody rat anti mouse Ki67 (1:50, DAKO GmbH Germany, 
Hamburg) at 4°C over night. Subsequently, sections were incubated with secondary 
antibody polyclonal rabbit anti rat IgG (biotinylated) (1:200, DAKO GmbH Germany, 
Hamburg) and tertiary streptavidin HRP (1:300, DAKO GmbH Germany, Hamburg) for 
at least 1 hour at RT. All incubation steps were performed in a humidified chamber and 
antibodies were diluted in blocking buffer. After antibody incubation, sections were 
extensively washed in 1x PBS 3-5 times for 5 minutes each. Ki67-positive cells were 
detected using the Peroxidase Substrate Kit DAB (Vector Laboratories, Inc., 
Burlingame), following the recommendations of the vendor. Substrate was left on the 
sections until Ki67-positive cells were sufficiently brown. Sections were finally counter-
stained with methyl green and mounted with Cytoseal 60 (Thermo Fisher Scientific 
Germany, Frankfurt a. M.).  
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2.8.5 Detection of phosphorylated H2AX (γH2AX) 
Aliquots of 1 x 105 cells were washed, centrifuged at 1200 rpm for 5 minutes at RT and 
resuspended in 200 µl 1% Albumin bovine Fraction V, pH 7.0 (SERVA Electrophoresis 
GmbH Germany, Heidelberg) in 1 x PBS. Cytospins were generated using the 
Shandon Cytospin3 device (Thermo Fisher Scientific Germany, Frankfurt a. M.) and 
low speed centrifugation at 1000 rpm for 2 minutes with medium rotor acceleration onto 
Superfrost Plus glass slides. Cytospins were dried overnight, briefly washed in 1 x 
TBS, fixed in 4% paraformaldehyde for 30 minutes, permeabilized in 0.25% Triton X-
100 in 1 x TBS for 5 minutes and blocked in 3% BSA in 1 x TBS for at least 1 h at RT. 
Cells were first incubated with primary anti phospho-Histone-H2AX (Ser139, clone 
JBW301) (1:500, Merck KGaA Germany, Darmstadt) and subsequently incubated with 
secondary rabbit anti mouse IgG (H+L) Alexa Fluor 488 (1:500, Life Technologies 
Germany, Darmstadt) for at least 1h at RT in the dark, respectively. Numbers of 
γH2AX-foci per cell were determined using the EUROStar fluorescence microscope 
(EUROIMMUN, Medizinische Labordiagnostik AG Germany, Lübeck) at a 400 x 
magnification. Cells from Rnaseh2bWT/WT and Rnaseh2bKOF/KOF embryos were counted 
in a blinded fashion.  
 
2.9 Ribonuclease assays 
2.9.1 Protein extraction 
Prior to extraction, cells were harvested and washed in 1 x PBS. Cells were first 
incubated with protein extraction buffer for 10 min on ice before an equal volume of 
cytoplasmic buffer was added and incubated for additional 10 min. After incubation, 
cells were pelleted at 12000 rpm for 10 min at 4°C.  The supernatant was transferred to 
a new collection tube and protein concentration was determined using the Bradford 
assay. Protein concentrations were calculated using a standard curve.  
 
2.9.2 RNase H activity assay 
Fluorometric RNase H activity assays were performed according to Crow et al (Crow et 
al., 2006b) in collaboration with Martin Reijns and Andrew Jackson (Institute of 
Genetics and Molecular Medicine, University of Edinburgh). Substrates for the 
determination of RNase H2 activity were as follows: RNA:DNA hybrid (forward strand: 
5`-rGrArU-rCrUrG-rArGrC-rCrUrG-rGrGrA-rGrCrU-fluorescein-3`) and DNA11-RNA-
DNA3:DNA (forward strand: 5`-dGdAdT-dCdTdG-dAdGdC-dCdTdG-dGdGrA-dGdCdT-
Material & Methods 
53 
 
fluorescein-3`) (desoxyribonucleotde, ribonucleotide). Each forward strand was 
annealed to the complementary reverse DNA strand (5`-DABCYL-dAdGdC- dTdCdC-
dCdAdG-dGdCdT-dCdAcG-dAdTdC-3`). Fluorescent label in the forward strands was 
quenched by the presence of DABCYL of the reverse strand. Upon RNase H2-
mediated cleavage of the substrate, quenching of the fluorescein is released and 
fluorescence is emitted as light. Thus, RNase H2 activity is determined by light 
emission over time. For the exact determination of the converted substrate per time, a 
standard curve was generated ranging from 0.78 pmol to 50 pmol. An unlabeled DNA 
oligonucleotide was therefore annealed to the forward strands that allows for constant 
fluorescence.  
RNase H2 activity assay was performed in a total volume of 100 µl assay buffer 
containing 250 nM of the respective substrate and 100 ng / µl cell lysate at an ambient 
temperature of 37°C. Fluorescence was detected ever y 5 minutes during a time period 
of 90 minutes using a VICTOR3 1420 multi label counter (Perkin Elmer Germany, 
Rodgau) with a 480 nm excitation filter and a 535 nm emission filter. 
 
2.9.3 Nick translation assay 
DNA concentration was determined using the NanoDrop ND-1000 (Thermo Fisher 
Scientific Germany, Braunschweig). 200 ng of mouse or yeast DNA was digested in 
0.5 units E.coli RNase HII (New England Biolabs, Frankfurt a.M.) in a total volume of 
50 µl for 150 minutes at 37°C. RNase HII-digested D NA was precipitated in the 
presence of 1 µl glycogen, 0.3 M sodium acetate (pH 5.2) and two volumes of ice cold 
100% ethanol. Precipitated DNA was pelleted for 10 minutes at 13000 rpm and RT, 
quickly dried to allow the ethanol to evaporate and finally dissolved in nuclease-free 
water. Reagents of the nick translation assay were added to a final concentration of 1 x 
buffer 2 (New England Biolabs, Frankfurt a.M.), 20 µM unlabeled dATP, dGTP and 
dTTP. 3.7 x105 Bq 32P-dCTP (HARTMANN ANALYTIC GmbH Germany; 
Braunschweig) and 5 units E.coli DNA polymerase I (New England Biolabs, Frankfurt 
a.M.) in a final reaction volume of 20 µl. Nick translation reaction was performed for 
35 minutes at 16°C. Radioactively-labeled DNA was a fterwards separated from 
unincorporated nucleotides by gel electrophoresis in a 1% TAE agarose gel. The gel 
was dehydrated using a GD 2000 Vacuum Gel Dryer system (GE Healthcare Europe, 
Freiburg) and label incorporation was visualized by autoradiography using 
PhosphorImager SI (Molecular Dynamics/GE Healthcare Europe, Freiburg) 
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2.10  Statistics 
All data is shown as mean ± standard deviation (SD). Significances were calculated 
using the unpaired, two-tailed Fisher`s t-test. p ≤ 0.5 (*),p ≤ 0.1 (**).  
Due to an outlier in the knockout group, statistics were not calculable in the microarray-
based gene expression analysis of the fetal liver. Deregulated genes with a fold change 
≥ 2 were displayed. False discovery rates in the microarray-based gene expression 
analysis of total skin were corrected using the Benjamini-Hochberg correction. 
Deregulated genes with a fold change ≥ 1.5 and p ≤ 0.5 were displayed. 
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3 Results 
3.1 Generation and characterization of the Rnaseh2c knockout mouse line 
To allow the investigation of cell-intrinsic mechanisms that cause the severe 
inflammatory encephalopathy Aicardi-Goutières syndrome (AGS), this thesis aimed to 
generate a mouse model for AGS by generating knockout mice deficient for the RNase 
H2 enzyme. Loss-of-function mutations in any of the three subunits of the ribonuclease 
H2 (RNase H2) complex cause AGS in human patients (Crow et al., 2006b). We 
therefore decided to delete the Rnaseh2c gene, encoding for the smallest subunit of the 
mouse RNase H2 enzyme. In order to inactivate the Rnaseh2c gene, we replaced all 
four coding exons by a neomycin resistance cassette that concomitantly allowed for the 
selection during gene targeting (Fig. 3.1).  
 
 
Figure 3.1: Strategy for the generation of the Rnaseh2c knockout mouse line. In order to 
inactivate the mouse Rnaseh2c gene, all four exons were replaced by a neomycin resistance 
cassette. The resistance gene cassette was concomitantly used to select for ES cell clones that 
had integrated the targeting vector by homologous recombination (HR). By insertion of the neo 
cassette, an additional ApaLI (A) restriction site was introduced that allowed testing for 
homologous recombination by Southern Blot analysis.  
 
3.1.1 Generation of the Rnaseh2c knockout mouse line 
To replace the mouse Rnaseh2c gene with a neomycin resistance gene cassette, a 
targeting vector was generated that contained the neomycin gene flanked by DNA 
sequences homologous to the upstream and downstream region of the Rnaseh2c gene 
as well as an additional diphtheria toxin (DT) gene 3-prime of homology region 2 that 
allowed for negative selection of recombined ES cells. For the amplification of the 
upstream homology region (homology region 1), primers 5′ HR up and 5′ HR down were 
used to generate a 1810 bp PCR product with an 5` XbaI and a 3` BamHI restriction site. 
Accordingly, primers 3′ HR up and 3′ HR down amplified the 900 bp downstream 
homology region (homology region 2) with a 5` HindIII and 3` XhoI restriction site. Both 
homology regions were amplified on C57BL/6 mouse DNA and PCR products were 
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sequenced to eliminate mutated PCR products. For the insertion of the PCR products 
into a pBluescript vector containing a PGK-gb2-neomycin resistance cassette (previously 
generated in our group), the vector was first digested with the respective combination of 
restriction enzymes and dephosphorylated in order to prevent religation of the vector. 
Finally, PCR products of the homology regions were inserted into the pBluescript vector 
by ligation. Correct insertion was checked by a restriction enzyme digest and 
subsequent gel electrophoresis. The DT gene cassette was amplified from a pSERC 
vector (provided by Thomas Wunderlich, Cologne) with primers DT-XhoI-For-New and 
DT-XhoI-Rev-New, generating XhoI restriction sites at both ends of the PCR product. 
Again, PCR products were sequenced to avoid any mutation. The pBluescript vector 
containing the neomycin gene flanked by to homology regions was digested with XhoI, 
dephosphorylated and the DT gene cassette was inserted downstream of homology 
region 2. Correct insertion was tested by restriction enzyme digest and gel 
electrophoresis. Finally, the pBluescript vector (8592bp) containing the neomycin gene 
cassette flanked by two homology regions and the downstream DT gene cassette was 
tested for correct size by restriction enzyme digest. Additionally, upstream and 
downstream homology regions as well as the DT gene cassette were sequenced. 
 
 
Figure 3.2: Targeting vector to replace all four coding exons of the Rnaseh2c gene by a 
neomycin resistance cassette. The targeting vector of 8592bp contained a PGK promoter- and 
gb2 promoter-driven neomycin resistant cassette to facilitate selection for G418-resistance in 
prokaryotic and eukaryotic cells. The neo cassette was flanked by an 1810bp upstream homology 
region (homology region 1) and a 900bp downstream homology region (homology region 2) to 
promote homologous recombination. An additional diphtheria toxine downstream homology 
region 2 allowed for negative selection of erroneous integrates. 
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In collaboration with Dora Schreier and Ronald Naumann at the Transgenic Core Facility 
(TCF) of the Max Planck Institute for Cellular Biology and Genetics (MPI CBG) in 
Dresden, 30 µg/ml Sac I-linearized targeting vector DNA was electroporated into JM8.F6 
ES cells (C57BL/6) using the Gene Pulser Xcell™ Electroporation Systems (BioRad). 
Electroporated ES cells were subsequently cultivated in the presence of geneticin 
(G418) to select for ES cells that had integrated the targeting vector. ES cells that 
erroneously incorporated the diphtheria toxin gene cassette died upon negative 
selection. Only upon homologous recombination of the targeting vector without the DT 
cassette and the expression of neomycin resistance gene, ES cells were resistant to 
G418 selection. G418-resistant ES cell clones were picked into 96 well plates and 
cultivated until maximum density. Subsequently, DNA was isolated and screened for 
positive clones using PCR and primers annealing to homology region 2 (HR2seq1 for) 
and to wild type sequence downstream of the homology region 2 (HR2-est.). Screening 
PCR amplified a product of 1492bp only upon integration of the targeting vector into the 
wild type Rnaseh2c gene locus. We identified three clones by PCR that were 
subsequently verified by Southern Blot analysis.  
For verification of PCR-positive ES cell clones we took advantage of the additional ApaLI 
restriction site in the neomycin resistant cassette. Using DIG-labeled RNA probes, 
annealing upstream and downstream of the homology regions, allowed us to 
discriminate between the wild type (WT) and recombined (HR) allele. In the wild type 
situation, the upstream and the downstream probe labeled a DNA fragment of 9.3 kb. 
Upon homologous recombination the upstream probe labeled a DNA fragment of 5.7 kb 
while the downstream probe labeled a fragment of 3.6 kb (Fig. 3.3). Homologous 
recombination of ES cell clone C9 was finally confirmed by Southern Blot analysis 
(Fig.3.3).  
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Figure 3.3: Southern Blot strategy to detect site-specific homologous recombination of the 
targeting vector into the Rnaseh2c locus. (A) Upon homologous recombination of the targeting 
vector, an additional ApaLI (A) restriction site was introduced along with the neomycin resistance 
gene, allowing for the discrimination between the wild type Rnaseh2b allele (WT) and the 
homologous recombined allele (HR) by Southern Blot analysis. DIG-labeled RNA probes, binding 
upstream and downstream of the Rnaseh2c locus, respectively, detected a single fragment of 
9.3 kb in the wild type situation (WT). Upon homologous recombination, the upstream probe 
detected a 5.7 kb fragment and the downstream probe a 3.6 kb fragment. (B) Southern Blot 
analysis was performed on ApaLI-digested DNA from G418-resistant ES cell clone C9. Upstream 
(UP) and downstream (DO) probes detected DNA fragments of 5.7 kb and 3.6 kb, respectively, 
indicating homologous recombination of the targeting vector at the Rnaseh2c gene locus. MW, 
Molecular Weight. 
Finally, ES cell clone C9 was injected into morula of albino C57BL/6 mice (C57BL/6J-
Tyr<c-2J>) that were subsequently transplanted into CD1 foster mice Hsd:ICR(CD-1) 
We detected a single male pup with a high degree of coat color chimerism in the first 
litter. To check for germ-line transmission of the recombined ES cells, this founder 
chimera was bred to wild type albino C57BL/6 female mice. Only upon germline 
transmission of the ES cells, offspring with black coat color was born (Fig. 3.4). Pups 
with black coat color were subsequently genotyped by PCR for presence of the 
neomycin resistance gene cassette. 
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Figure 3.4: Newborn litter of the founder chimera and an albino C57BL/6 mouse. Breeding 
of the founder coat-color chimera to albino C57BL/6 mice tested germ-line transmission of the ES 
cell clone C9. Only upon germ line transmission, pups with black coat-color were born. 
 
3.1.2 Characterization of the Rnaseh2c knockout mouse line 
Heterozygous Rnaseh2c knockout mice (Rnaseh2c+/-) were intercrossed to obtain 
homozygous knockout mice. Genotyping PCR of weaned litter displayed no homozygous 
Rnaseh2c knockout mice (Rnaseh2c-/-) (Fig. 3.5), suggesting lethality of Rnaseh2c-/- 
mice during embryogenesis. To verify this and to determine the time point of lethality, 
timed breedings were set and embryos were collected at embryonic day 10.5 (E10.5) by 
caesarian section. We observed few embryos with abnormal morphology. Genotyping 
PCR of E10.5 Rnaseh2c knockout embryos identified these abnormal embryos as 
Rnaseh2c-/- embryos. Due to their abnormal morphology and their non-Mendelian 
distribution we concluded that RNase H2-deficient embryos start to degrade early in 
embryogenesis but are almost entirely reabsorbed at day E10.5. Collectively, this data 
demonstrates the importance of the RNase H2 enzyme during mouse development. 
Deficiency of the enzyme causes death and subsequent degradation in early embryonic 
development.  
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Figure 3.5: Breeding of Rnaseh2c-/WT- mice to homozygosity. To obtain Rnaseh2c-/- mice, 
heterozygous Rnaseh2c mice were crossed. (A) At weaning, no Rnaseh2c-/- mouse was 
observed. (B) Upon caesarian section at day E10.5, Rnaseh2c-/- embryos were detected which 
were characterized by non-Mendelian distribution and abnormal morphology, indicating 
degradation at earlier time points. 
 
3.2 Analysis of the Rnaseh2b KOF mouse line 
During the generation and investigation of the Rnaseh2c knockout mouse line, we 
started to analyze the Rnaseh2b KOF mouse line, not knowing that deficiency of the 
Rnaseh2c gene was embryonic lethal. The Rnaseh2b KOF mouse line was generated 
by the European Conditional Mouse Mutagenesis Program (EUCOMM, (Friedel et al., 
2007)) by inserting a promoter-less reporter cassette into intron 4/5 of the Rnaseh2b 
gene (Fig. 3.6). Main feature of the reporter cassette is a strong splice acceptor (EN2 
SA) at its 5`-terminus that is supposed to splice to exon 4 of the Rnaseh2b gene, thus 
terminating mRNA translation due to a polyadenylation sequence (pA) at the 3`-end of 
the reporter cassette. Collectively, Rnaseh2bKOF/KOF mice are supposed to express a 
non-functional and truncated RNase H2b protein that causes complete RNase H2 
deficiency (Testa et al., 2004). 
 
 
Figure 3.6: Schematic overview of the promoterless reporter cassette used to knockout the 
Rnaseh2b gene. To inactivate the Rnaseh2b gene, a promoterless reporter cassette was 
inserted into intron 4/5 of the Rnaseh2b gene locus. The strong splice acceptor EN2SA directs 
splicing to exon 4, generating gene transcripts containing sequence of the reporter cassette. 
Translation of these transcripts is subsequently terminated due to the presence of the 
polyadenylation signal (pA) at the terminus of the reporter cassette. The cassette also contains a 
β-galactosidase reporter (βgal) as well a neomycin resistance cassette (neo).  
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We obtained Rnaseh2bWT/KOF mice from EUCOMM and intercrossed heterozygous mice 
to obtain Rnaseh2bKOF/KOF mice. However, we did not observe any Rnaseh2bKOF/KOF pups 
at weaning. Upon subsequent inspection of the newborn litter, we could observe seven 
dead newborns that displayed morphological changes when compared to littermate 
controls. Genotyping identified these newborns as Rnaseh2bKOF/KOF mice. When 
compared to their littermate controls (Rnaseh2bWT/KOF and Rnaseh2bWT/WT), 
Rnaseh2bKOF/KOF newborn mice were much smaller in size, showed abnormal 
morphology and were stillborn (Fig. 3.7). To investigate the time point of lethality, we set 
timed breedings and isolated embryos at embryonic day E14.5 and E18.5. We found 
Rnaseh2bKOF/KOF embryos at Mendelian ratios at embryonic day 14.5 and 18.5. Again, 
knockout embryos were smaller in size and revealed edema and paleness when 
compared to littermate controls (Fig. 3.7). We hypothesized that paleness in RNase H2-
deficient embryos was indicative of reduced blood supply that might have caused 
embryonic lethality.  
 
 
Figure 3.7: Rnaseh2b KOF litter at weaning and at embryonic day E14.5 and E18.5. 
Rnaseh2bWT/KOF mice were crossed to obtain Rnaseh2bKOF/KOF mice. No Rnaseh2bKOF/KOF 
newborn mouse could be identified after weaning. Upon inspection of the litter, we found seven 
stillborn Rnaseh2bKOF/KOF mice. At embryonic day E14.5 and E18.5 of mouse development, 
Rnaseh2bKOF/KOF mice were present at Mendelian ratios, but appeared smaller and showed signs 
of edema and paleness.  
 
Analysis of H&E-stained paraffin-sections of stillborn Rnaseh2bKOF/KOF mice did not 
reveal major conspicuities, all organs were present but proportionally smaller in size 
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(data not shown). Additionally, no signs of inflammation, like leukocyte-infiltrations, could 
be detected. Silke Glage at the institute for laboratory animal science in Hannover 
performed detailed analysis of stillborn sections and revealed edema in many organs as 
well as extended vessels and bleedings, suggesting defects in vessel wall architecture 
(data not shown). 
However, since the pathology of Trex1-/- mice was completely dependent on an 
unbalanced type I interferon expression and could be completely rescued by breeding of 
the Trex1-/- mouse on either a RAG1-, IRF3- or IFNAR1-deficient background (Stetson et 
al., 2008), we aimed to rescue the lethal embryonic phenotype of RNase H2-deficient 
mice by breeding the Rnaseh2b KOF mouse line on a Rag1- (Mombaerts et al., 1992) 
and Ifnar1-deficient (Muller et al., 1994) background, respectively (Fig. 3.8). Neither 
RAG1- nor IFNAR1-deficiency could rescue the lethal phenotype of Rnaseh2b knockout 
mice, indicating that lethality of Rnaseh2b-deficient mice was not caused by type I 
interferon or mediated by lymphocytes. 
 
Figure 3.8: Breeding of RNase H2b-deficent mice on a RAG1- and IFNAR-deficient 
background did not rescue early embryonic lethality. To rescue the embryonic lethality of 
Rnaseh2bKOF/KOF mice, the Rnaseh2b KOF mouse line was bred to a (A) Rag1- and (B) Ifnar1-
deficient background, respectively. Neither Rag1- nor Ifnar1 deficiency rescued the lethality, 
indicating that mortality of Rnaseh2bKOF/KOF mice is not caused by a type I interferon response or 
mediated by lymphocytes. Black bars indicate observed and grey bars indicate expected 
newborns. 
 
Collectively, our data demonstrated that Rnaseh2bKOF/KOF mice were stillborn and 
lethality could not be rescued by breeding on a RAG1- or IFNAR1-deficient background, 
obviating that the pathology of RNase H2-deficient mice was mediated by a unbalanced 
type I interferon as in Trex1-/- mice. Rnaseh2bKOF/KOF embryos at day E14.5 and E18.5 
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were present at Mendelian ratios but displayed edema and paleness, indicative of 
decreased blood supply. Together with the tissue bleedings, these findings might hint to 
impaired vessel wall functions. 
 
3.2.1 Mouse embryonic fibroblasts from Rnaseh2bKOF/KOF mice display 
impaired proliferation and progress slower through the G2/M phase of the 
cell cycle 
Aiming to investigate the pathomechanism responsible for the early embryonic lethality 
in Rnaseh2bKOF/KOF mice, we bypassed lethality by generating mouse embryonic 
fibroblasts (MEFs) from mouse embryos at day E14.5. Since Rnaseh2bKOF/KOF mice 
show extended life span compared to Rnaseh2c-/- mice, we first determined the residual 
Rnaseh2b transcript levels and RNase H2 enzyme activity of MEFs from E14.5 
Rnaseh2bKOF/KOF embryos. Rnaseh2b transcript levels were determined using exon-
spanning primers annealing to exonic DNA sequences downstream of the gene trap 
cassette, allowing for the detection of full-length transcripts. Quantitative real time PCR 
(qRT PCR) of RNA extracted from Rnaseh2bKOF/KOF MEFs showed massive 
downregulation of Rnaseh2b transcripts when compared to RNA from wild type 
littermate control MEFs (49.49 ± 16.29 fold) (Fig.3.9). However, we were still able to 
detect wild type Rnaseh2b transcripts in MEFs from Rnaseh2bKOF/KOF embryos, 
suggesting that low residual Rnaseh2b transcript levels resulted from splicing of exon 4 
to exon 5. Upon correct splicing, the gene trap cassette is lost and a wild type transcript 
is generated (Fig. 3.6). In collaboration with Martin Reijns and Andrew Jackson at the 
Institute of Genetics and Molecular Medicine (University of Edinburgh) we further 
determined the residual activity of the RNase H2 enzyme in Rnaseh2b-deficient MEFs 
using an RNase H2-specific fluorometric assay (Fig. 3.9). In line with the detection of 
residual wild type Rnaseh2b transcripts, the RNase H2 activity assay displayed low 
residual activity of about 6% in Rnaseh2bKOF/KOF MEF cells (n=2) compared to wild type 
(100%, n=2) and heterozygous MEF cells (68%, n=2) (Fig. 3.9). Taken together, our 
data demonstrated that Rnaseh2bKOF/KOF MEFs were not completely devoid of wild type 
Rnaseh2b transcripts, but expressed low levels of the RNase H2 enzyme. This residual 
enzyme activity of about 6% leads to prolonged embryonic development compared to 
Rnaseh2c-/- mice. However, our data concomitantly showed that 6% residual RNase H2 
activity did not allow further development and adult life. 
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During the cultivation of MEFs from
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generated from E18.5 embryos, the number of cells in G2/M further increased in 
Rnaseh2bKOF/KOF MEFs. After four weeks, most of the cells accumulated in G2/M of the 
cell cycle. This data showed that RNase H2 is important for cell cycle progression and 
cell proliferation, while absence leads to slow progression or accumulation of cells in the 
G2/M phase of the cell cycle. Together with the data from the 3H-thymidine incorporation 
assay, we concluded that RNase H2 deficiency caused major cell-intrinsic problems, 
leading to impaired proliferation rates and slow progression or accumulation of MEF cells 
in the G2/M phase of the cell cycle. Since the number of accumulated cells in G2/M 
gradually increased, we speculated that the cell-intrinsic problem accumulated with 
every cell division, although the species of the cell-intrinsic problem is so far unknown 
and needs to be elucidated. 
 
 
Figure 3.10: RNase H2-deficient mouse embryonic fibroblasts (MEFs) from E14.5 embryos 
show impaired proliferation rates and slow progression through G2/M phase of the cell 
cycle. (A) 3H-thymidine incorporation assay to detect MEF cell proliferation. MEFs generated 
from E14.5 Rnaseh2bKOF/KOF embryos display twofold less proliferation rates with cultivation start 
that further gradually exacerbated. After four weeks of cultivation, proliferation of 
Rnaseh2bKOF/KOFMEFs (n=3) was fivefold decreased when compared to control MEFs (Cntrl, 
n=9). (B/C) DNA content analysis showed increased numbers of RNase H2-deficient cells in the 
G2/M phase of the cell cycle already after one week of cultivation. After four weeks, almost half of 
the cells were already in G2/M. (C) MEF cells generated from E18.5 Rnaseh2bKOF/KOF embryos 
accumulated almost entirely in the G2/M phase of the cell cycle after four weeks. 
 
3.2.2 p53-mediated DNA damage response in fetal liver cells from 
Rnaseh2bKOF/KOF embryos 
Since mouse embryonic fibroblasts from E14.5 Rnaseh2bKOF/KOF embryos displayed 
reduced proliferation rates and slow progression through the G2/M phase of the cell 
cycle, we hypothesized that RNase H2 deficiency might have caused DNA damage that 
E14.5 embryos E18.5 embryos
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activated a DNA damage response (DDR) and triggered checkpoint activation in G2/M. 
To prevent the propagation of mutated genomic information to the progeny, DNA is first 
repaired before it is distributed to the daughter cells. DNA damage elicits a DNA damage 
response that causes checkpoint activation and cell cycle arrest to allow for the repair of 
the damage (Jackson and Bartek, 2009). To obtain maximal information about the 
consequences of RNase H2 deficiency, we performed a microarray-based gene 
expression analysis of E14.5 fetal liver cells from Rnaseh2bKOF/KOF versus wild type 
littermate embryos. Upon pair-wise comparison of Rnaseh2bWT/WT (n=3) and 
Rnaseh2bKOF/KOF (n=3) E14.5 fetal liver cells, 882 genes were found to be at least twofold 
de-regulated (Fig. 3.11) (GEO database accession no. GSE36687). Of the 882 de-
regulated genes, 748 were found to be down-regulated and 134 to be up-regulated. The 
most down-regulated gene was the Rnaseh2b gene (18.5 fold, p = 2.78-5) demonstrating 
the reliability of the microarray analysis. Looking for prototypic DNA damage response 
genes, we did not observe deregulation of the genes encoding for the kinases ATM/ATR 
or CHEK1/CHEK2. Although we did not observe the upregulation of these DNA damage 
response (DDR) genes, we detected the upregulation of genes that are activated by the 
tumor suppressor gene TP53 (p53). p53 is an immediate target gene of the DNA 
damage repair pathways upon DNA double- and single-strand breaks, thus implicating 
the presence of a DNA damage response in RNase H2-deficient fetal liver cells of E14.5 
embryos. Four p53-activated genes (Phlda3, Isg15 and Zmat3) could be found among 
the top seven up-regulated genes, with the cyclin-dependent kinase inhibitor 1a 
(Cdkn1a/p21) being the most up-regulated gene (10.2 fold, p = 8.49-5). Microarray data 
was subsequently verified by quantitative real-time PCR (Fig. 3.11). 
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Figure 3.11: Microarray-based gene expression profile of E14.5 Rnaseh2bKOF/KOF fetal liver 
cells revealed upregulation of p53-inducible genes. (A) Pair wise comparison of RNA from 
three Rnaseh2bKOF/KOF (KO) fetal livers versus three wild type fetal livers (WT) demonstrated 
deregulation of 882 genes. Each dot in the figure represents a single gene with at least twofold 
deregulation. Genes with less deregulation are not displayed leaving the empty diagonal. Dots 
above the diagonal are found to up-regulated whereas dots below the diagonal are down-
regulated in the Rnaseh2bKOF/KOF fetal liver. Among the top seven up-regulated genes, four are 
described to be p53-inducible with Cdkn1a being the most up-regulated gene. (B) Increased 
transcript levels of the Rnaseh2b, Cdkn1a, Phlda3 and the Zmat3 gene was confirmed by qRT 
PCR of total RNA from fetal livers. 
 
Although we demonstrated that the lethal phenotype of Rnaseh2b-deficient mice was not 
mediated by type I interferon (Fig. 3.8), we found four type I interferon-stimulated genes 
(ISGs) to be up-regulated, e.g. interferon regulatory factor 7 (Irf7) and the 2`-
5`oligoadenylate synthetase 1a (Oas1a). However, to investigate if p53 activation was 
caused by a DNA damage response to DNA strand breaks, we stained E18.5 fetal liver 
and thymus cells for phosphorylated histone H2AX (γH2AX), a marker for double- and 
single strand breaks (Rogakou et al., 1998). Repair of DNA strand breaks is mediated by 
a plethora of DNA repair proteins that need to have access to the DNA strand break. 
Phosphorylation of serine 139 of the histone H2AX initiates the unwinding of the 
chromatin and subsequent binding of the repair proteins to the DNA. Since large 
complexes are subsequently formed, γH2AX bound to the chromatin of damaged cells 
can be detected as distinct foci. Staining E18.5 fetal liver and thymus cells for 
phosphorylated histone H2AX elucidated increased numbers of foci in RNase H2-
deficient cells when compared to cells from littermate controls (Fig. 3.12). Whereas the 
majority of control cells displayed 0 - 2 foci per cell, cells from RNase H2-deficient 
embryos contained more than 2 foci with the majority of cells containing more than five 
foci. Collectively, our data showed that RNase H2 deficiency likely caused DNA strand 
breaks that might have triggered a p53-mediated DNA damage response as well as 
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checkpoint activation and proliferation arrest in G2/M of the cell cycle. However, based 
on our observations we cannot specify the exact species of the DNA damage, since 
phosphorylated histone H2AX as well as the p53-mediated DNA damage can be 
detected upon DNA double-strand and single-strand breaks.  
 
 
Figure 3.12: Immunostaining for the DNA strand break-specific marker γH2AX in E18.5 
fetal liver and thymus cells revealed increased DNA damage in RNase H2-deficient cells. 
γH2AX foci were counted in (A) Rnaseh2bKOF/KOF (white columns, n=4) and control (black 
columns, n=9) fetal liver cells as well as in (B) Rnaseh2bKOF/KOF (white, n=4) and control (black, 
n=9) fetal thymus cells of E18.5 Rnaseh2b KOF embryos. Increased numbers of γH2AX foci 
could be detected in E18.5 fetal liver as well as in fetal thymus cells. 400 cells per sample were 
counted in a blinded fashion. 
 
3.2.3 Increased ribonucleotide incorporation into the genome of RNase H2-
deficient mice 
McElhinny et al. were the first to show in the yeast strain Saccharomyces cerevisiae (S. 
cerevisiae) that RNase H2 deficiency (rnh201∆) caused increased genomic 
ribonucleotide loads (Nick McElhinny et al., 2010). Using a yeast strain possessing a 
mutated leading strand DNA polymerase ε (M644G Pol ε) that frequently incorporated 
ribonucleotides when compared to wild type polymerase ε, they could show even 
increased loads of genomic ribonucleotides. Due to their reactive 2`hydroxyl group, 
ribonucleotides render the genomic DNA sensitive to hydrolysis, a property that was 
used to detect genomic ribonucleotide levels (Joyce, 1997). Alkaline treatment of DNA 
containing ribonucleotides causes hydrolysis of the DNA at positions of persistent 
ribonucleotides and subsequent gel electrophoresis separates DNA fragments. While 
DNA containing ribonucleotides fragments upon alkaline treatment, ribonucleotide-free 
DNA remains stable. 
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Since the alkaline assay to detect genomic ribonucleotides did not work in our hands, we 
developed a new method to detect ribonucleotide incorporation that was based on the 
nick translation assay (Fig. 3.13). The nick translation assay was traditionally used to 
generate radioactively-labeled DNA probes. To this end, PCR products were randomly 
nicked using the endonuclease DNase I. Subsequent incubation with polymerase I in the 
presence of radioactively-labeled desoxyribonucleotides caused incorporation of 
radioactive label. Instead of using DNase I to nick the DNA template randomly, we 
employed the bacterial RNase HII from Escherichia coli (E. coli) to specifically introduce 
nicks 5` of genomic ribonucleotides. As in the traditional nick translation assay, RNase 
HII-digested DNA was subsequently incubated with E. coli DNA polymerase I in the 
presence of radioactive label. To elucidate ribonucleotide incorporation, RNase HII- and 
polymerase I-treated DNA was first separated by gel electrophoresis and label was 
subsequently detected by autoradiography.  
 
 
Figure 3.13: Modification of the nick translation assay to detect the presence of genomic 
ribonucleotides. Genomic DNA is isolated and digested with E.coli RNase HII to specifically nick 
the DNA 5` of genomic ribonucleotides. Subsequent incubation with E.coli polymerase I in the 
presence of radioactively-labeled desoxyribonucleotides, leads to the incorporation of radioactive 
label at positions of genomic ribonucleotides. Labeled DNA is separated from excessive 
nucleotides by gel electrophoresis and radioactivity is detected by autoradiography.  
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We established the modified nick translation assay using wild type and RNase H2-
deficient (rnh201∆) yeast DNA that was already described to contain genomic 
ribonucleotides (kindly provided by Thomas Kunkel, National Institute of Environmental 
Health Sciences, North Carolina). Optimal reaction conditions were found for digestion of 
200 ng DNA with 0.5 u E.coli RNase HII for two and a half hours and subsequent 
treatment with 5 u E. coli polymerase I for 35 min at 16°C. (25012012). Figur e 3.14 
shows dose-dependent increase of radioactive label in RNase HII-digested DNA from 
the yeast strain rnh201∆. A similar increase could not be detected for RNase HII-
digested DNA from wild type yeast (Ctrl). 
To test ribonucleotide incorporation in RNase H2-deficient mice, we isolated DNA from 
E10.5 embryos completely deficient for the RNase H2 enzyme (RNaseh2c-/- and 
Rnaseh2b∆/∆) as well as from littermate controls. To this end, timed breedings were set 
and embryos were collected at E10.5 upon caesarian section. The DNA was carefully 
isolated to avoid any shearing of the DNA and either digested with or without E. coli 
RNase HII enzyme.  
As shown in Fig. 3.14, RNase HII-digested DNA from RNaseh2c-/- (n=3) and 
Rnaseh2b∆/∆ (n=2) embryos consistently showed increased ribonucleotide loads when 
compared with digested DNA from wild type littermates (Ctrl, n=2 and n=2, respectively) 
in all samples tested. This data clearly demonstrated increased genomic ribonucleotides 
in the DNA of RNase H2-deficient mouse embryos. Surprisingly, we could hardly detect 
any incorporation of radioactive label into the DNA of wild type littermate controls. 
Although, we do not know the sensitivity of our assay to detect genomic ribonucleotide 
loads, this data might indicate that endogenous RNase H2 activity efficiently removes 
incorporated ribonucleotides in the wild type mouse DNA. However, the absence of the 
RNase H2 enzyme caused massive accumulation of genomic ribonucleotides in the 
mouse DNA and either the ribonucleotides themselves or the resulting DNA damage 
(DNA single- or double-strand breaks) cause a DNA damage response that leads to the 
activation of DNA repair pathways via the tumor suppressor p53. The phosphorylation of 
histone H2AX might thus occur as a direct consequence of the DNA damage. The 
presence of radioactive label in undigested DNA samples from RNase H2-deficient 
embryos might reflect the process of denaturing and resorption of the dying embryo, but 
might also indicate that persistent genomic ribonucleotides might cause DNA strand 
breaks, potentially due to the reactive 2` OH group of the ribonucleotide. 
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Figure 3.14: Increased ribonucleotide incorporation in genomic DNA from RNase H2-
deficient mice. (A) Increased incorporation of radioactive label in a dose-dependent manner (1 –
 10 mU/µl) into DNA from RNase H2-deficient yeast (rnh201 ∆). An increased incorporation was 
not detectable in RNase HII-digested DNA from wild type yeast (control). (B/C) DNA from RNase 
H2-deficient mouse embryos (Rnaseh2c-/- and Rnaseh2b∆⁄∆) showed massive incorporation of 
label, demonstrating increased ribonucleotide levels in these embryos. In contrast to DNA from 
knockout embryos, no label could be detected in in DNA from wild type mouse embryos (WT). 
Undigested DNA from Rnaseh2c-/- and Rnaseh2b∆⁄∆ embryos displayed label incorporation, 
indicating that DNA from RNase H2-deficient embryos might either contain DNA strand-breaks as 
a consequence of RNase H2 deficiency or DNA was fragmented in the course of the degradation 
and resorption of the dying embryo. 
 
3.3 Generation of cell type-specific Rnaseh2b knockouts 
To bypass early embryonic lethality of Rnaseh2bKOF/KOF mice, we generated cell type-
specific knockouts of the Rnaseh2b gene. Thus, we first generated the Rnaseh2bFLOX 
mouse line by breeding the RNaseh2b KOF mouse with the Flpe mouse (Rodriguez et 
al., 2000)(Fig. 3.15). The Flpe mouse strain expresses an enhanced version of the flip 
recombinase that recognizes and specifically deletes DNA sequences that are flanked 
by FRT sites. Upon mating of both mouse lines, the FRT-flanked genetrap cassette was 
excised and the Rnaseh2bFLOX mouse line was generated (Fig. 3.15). Subsequent Cre-
mediated deletion of exon 5 leads to a frameshift mutation and a premature stop codon 
that either causes nonsense mediated decay of the transcript or a truncated, non-
functional protein (Fig. 3.15).  
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Figure 3.15: Generation of the Rnaseh2bFLOX and Rnaseh2b∆⁄∆ allele. Flip recombinase (Flpe) 
expression leads to site-specific deletion of the FRT-flanked gene trap cassette used to inactivate 
the Rnaseh2b allele, leaving exon 5 of the Rnaseh2b gene flanked by loxP sites (Rnaseh2bFLOX) 
that allow for cell type-specific or inducible Cre-mediated deletion of exon 5. Deletion of exon 5 
causes complete inactivation of the Rnaseh2b gene (Rnaseh2b∆⁄∆) due to a frameshift mutation 
and premature transcriptional stop. 
 
Since Cre-mediated deletion efficiency is dependent on the accessibility of the 
respective gene locus (Schmidt-Supprian and Rajewsky, 2007), we first tested the 
efficiency to delete the Rnaseh2b gene by breeding the Rnaseh2bFLOX mouse line to the 
PGK-Cre mouse line that is characterized by ubiquitous Cre recombinase expression. 
We found the litter of this breeding to recapitulate the phenotype of Rnaseh2c-/- mice. 
Rnaseh2b∆⁄∆ mice were not detectable at weaning day and embryos died around day 
E10.5. This data demonstrated the functionality of the loxP-flanked Rnaseh2b allele, 
thus allowing for cell type-specific deletion of the Rnaseh2b gene. 
Aiming to delete the Rnaseh2b gene in a cell type of the hematopoietic system we 
decided to generate a B cell-specific Rnaseh2b knockout and crossed the Rnaseh2bFLOX 
mouse line with the CD19-Cre mouse line (Rickert et al., 1997) that is reported to 
efficiently delete loxP-flanked alleles in bone marrow-derived pre-B cells (75–80%) and 
in splenic B cells (90–95%) (Rickert et al., 1997). In contrast to the Rnaseh2b KOF 
mouse line, offspring of this breeding was viable and born at Mendelian ratios. B cell-
specific knockouts of the Rnaseh2b gene did not display a macroscopic phenotype and 
numbers of B220+ CD19+ B cells in CD19-Cre+ Rnaseh2bFLOX/FLOX mice (KO, 34.37 ± 
13.17 x107, n = 6) were not altered when compared to B cell numbers from CD19-Cre- 
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Rnaseh2bFLOX/FLOX or CD19-Cre+ Rnaseh2bWT/FLOX mice (Ctrl, 37.39 ± 15.54 x107, n = 6) 
(Fig. 3.16).  
 
 
Figure 3.16: B cells of CD19Cre+ Rnaseh2bFLOX/FLOX mice showed a mild proliferation defect 
when stimulated with LPS in vitro. (A) Absolute B cell numbers in B cell-specific Rnaseh2b 
knockout mice (KO, n=6) were unaltered when compared to B cell numbers of wild type mice 
(WT, n=6). (B) FACS-sorted B cells from CD19Cre+ Rnaseh2bFLOX/FLOX mice (FLOX/FLOX Cre+, 
n=2) showed reduced residual RNase H2 activity of 5% compared with RNase H2 activity of 
control mice (WT/FLOX Cre-, n=2). B cells with a heterozygous mutation of the Rnaseh2b gene 
displayed 37% residual activity (WT/FLOX Cre+, n=2) (C/D) Upon in vitro LPS-stimulation, (C) B 
cells from CD19Cre+ Rnaseh2bFLOX/FLOX mice (KO, n=9) showed a mild, but significant 
proliferation defect in comparison to control B cells (WT, n=9). (D) DNA content analysis revealed 
that an increased portion of RNase H2-deficient B cells (KO, n=6) accumulated in the G2/M 
phase of the cell cycle when compared to wild type (WT, n=6) control B cells. 
 
To investigate the deletion efficiency upon CD19Cre-mediated deletion of exon 5, we 
tested the residual activity in FACS-sorted B cells from knockout and control cells. 
RNase H2 activity was found to be reduced to 5% of wild type activity in CD19-Cre+ 
Rnaseh2bFLOX/FLOX B cells (Fig. 3.16). Considering the sorting purity between 96.5 and 
97.7%, the residual activity of 5% was likely caused by contaminating cells, indicating 
complete RNase H2 deficiency in B cell-specific knockout mice. To investigate if the 
number of cell divisions might determine the phenotypic outcome, we stimulated B cells 
with the lipopolysaccharide (LPS) of gram-negative bacteria in vitro. LPS induces class 
switch recombination (Kracker and Radbruch, 2004) accompanied by massive B cell 
proliferation. 3H thymidine incorporation assay of LPS-stimulated B cells displayed a 
slight, but significant difference between CD19-Cre+ Rnaseh2bFLOX/FLOX B cells and 
*
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control B cells (Fig. 3.16) Knockout B cells showed impaired proliferation when 
compared to control B cells and DNA content analysis further demonstrated 
accumulation of B cells in G2/M of the cell cycle, similar to the data generated from 
E14.5 Rnaseh2bKOF/KOF MEFs (Fig. 3.16 and Fig. 3.10). Collectively, our data showed 
that RNase H2 deficiency in B cells does not cause a phenotype under steady-state 
conditions. Rnaseh2b-deficient B cells display a slight but significant proliferation defect 
upon in vitro LPS-stimulation, however, the defect was less severe compared to the 
massive proliferation defect detected in MEF cells from E14.5 and E18.5 
Rnaseh2bKOF/KOF embryos. Still, this data supported our idea that the impact of RNase 
H2 deficiency is very much determined by the numbers of cell divisions.  
Due to the moderate effect of RNase H2 deficiency in B cells we decided to delete the 
Rnaseh2b gene in a cell population outside the hematopoietic system aiming to induce a 
phenotype comparable to that of MEF cells from E14.5 and E18.5 Rnaseh2bKOF/KOF 
embryos. We thus generated an epidermis-specific knockout by crossing the 
Rnaseh2bFLOX mouse to the K14Cre mouse line (Vasioukhin et al., 2001) in which Cre-
expression is driven by the keratin 14 promoter and deleting at embryonic day E8.5. 
Keratin 14 is specifically expressed in cells of the epidermal basal membrane, thus 
resulting in deletion of the Rnaseh2b gene in the entire epidermis. Our first aim was to 
determine the deletion-efficiency of the Rnaseh2b gene and calculated Rnaseh2b 
transcript levels in the cells of epidermis from newborn K14Cre+ Rnaseh2bFLOX/FLOX mice. 
We isolated total RNA from the entire epidermis of newborn pups and performed 
quantitative real-time PCR (qRT PCR). We detected a 7.88 ± 3.01 fold reduction of the 
Rnaseh2b transcript in the knockout epidermis (n = 4) when compared to littermate 
controls (n = 4)(Fig. 3.17). We additionally determined the residual activity of the RNase 
H2 enzyme in FACS-sorted keratinocytes from the epidermis of newborn pups to verify 
the above findings. We observed significant reduction of the RNase H2 activity in 
keratinocytes from K14Cre+ Rnaseh2bFLOX/FLOX mice (n= 3) to 11% of transcript levels of 
littermate controls (n = 4, 100%)(Fig. 3.17). 
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Figure 3.17: K14Cre+ Rnaseh2bFLOX/FLOX mice display decreased RNase H2 activity in 
epidermal keratinocytes. FACS-sorted keratinocytes were analyzed for the expression of the 
Rnaseh2b transcript (A) and for the residual activity of the RNase H2 enzyme (B). (A) K14Cre+ 
Rnaseh2bFLOX/FLOX mice (n = 4) displayed an eightfold reduction in Rnaseh2b transcript levels 
when compared to control mice (n = 4). (B) Mean (without SD) RNase H2 enzyme activity of 
FACS-sorted keratinocytes from four control mice (FLOX/FLOX, Cre-, n = 4, 100%) and the mean 
RNase H2 activity of FACS-sorted keratinocytes from K14Cre+ Rnaseh2bFLOX/FLOX mice 
(FLOX/FLOX, Cre+, n = 3, 11%) were plotted. 
 
K14Cre+ Rnaseh2bFLOX/FLOX mice were born at Mendelian ratios, but within two weeks 
after birth, knockout pups were clearly distinguishable from their littermates due to 
hyperpigmented skin at the ears, paws and tail (3.18). Upon weaning, K14Cre+ 
Rnaseh2bFLOX/FLOX mice displayed less bright fur and rudimental whiskers as well as 
signs of dermatitis that manifested as reddish and tight skin (3.18). Starting with about 
ten weeks of age, K14Cre+ Rnaseh2bFLOX/FLOX mice gradually lost hair and were almost 
entirely hair less with 25 weeks of age (Fig. 3.21). 
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Figure 3.18: K14Cre+ Rnaseh2bFLOX/FLOX mice display severe skin pathology. Mice deficient 
for the RNase H2 enzyme in the entire epidermis display a massive skin phenotype soon after 
birth. With the beginning of pigmentation, knockout mice reveal hyperpigmentation that becomes 
obvious at the ears, tails and paws. Moreover, the fur is less bright as in littermate controls and 
the whiskers are only present as rudiments. 
 
To investigate the microscopic consequences of RNase H2 deficiency in the skin of 
K14Cre+ Rnaseh2bFLOX/FLOX mice, we performed hematoxylin & eosin (H&E) staining of 
paraffin sections from dorsal skin biopsies of 9 week-old mice (Fig. 3.19). In comparison 
to the epidermis from wild type littermate controls, the epidermis of knockout mice was 
moderately thickened along the entire epidermis and the epidermal cell layers were less 
well organized as in control mice. Moreover, massive focal acanthosis could be 
observed in some areas of the RNase H2-deficient epidermis. To investigate whether 
increased epidermal thickness was a consequence of increased cell proliferation, we 
stained dorsal skin sections for the proliferation marker Ki67 that labels cycling cells 
(Scholzen and Gerdes, 2000). In control skin, proliferating cells were only detectable in 
the basal membrane of the epidermis. This was expected, since the only proliferating cell 
population of the epidermis, the epidermal stem cells, are located in the basal membrane 
(Fuchs, 2008). Ki67-staining of skin sections from K14Cre+ Rnaseh2bFLOX/FLOX mice 
revealed an overall increase in cell proliferation in the entire epidermis. Moreover, Ki67-
positive cells were also detectable in suprabasal layers of the epidermis (Fig. 3.19). 
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Figure 3.19: Hematoxylin and eosin (H&E), Masson`s trichrome and Ki67 staining of dorsal 
skin from 9 week old K14Cre+ Rnaseh2bFLOX/FLOX and littermate control mice (Control). H&E 
staining of dorsal skin from 9 week-old K14Cre+ Rnaseh2bFLOX/FLOX displayed moderate 
thickening of the epidermis interrupted by spots of focal acanthosis. Staining for the proliferation 
marker Ki67 demonstrated massive suprabasal cell proliferation in the epidermis that was absent 
in the dermis. The dermis completely lost basket work-like structure and showed increased 
infiltration of nucleated cells. Masson`s trichrome staining for collagen showed revealed 
increased collagen deposition in the knockout dermis. 
 
The dermis of control skin sections showed basket work-like structure and only few 
nucleated cells were detectable. In contrast to control skin, skin sections from K14Cre+ 
Rnaseh2bFLOX/FLOX mice did not display basket work-like organization. The dermis in 
knockout mice appeared massively thickened and tightly packed with a concomitant 
infiltration of nucleated cells (Fig. 3.19), reminiscent of the pathology of fibrotic diseases. 
Since dermal fibrosis is associated with increased collagen deposition, we performed 
Massson`s trichrome staining (MTC). We could detect increased collagen deposition in 
the dermis of K14Cre+ Rnaseh2bFLOX/FLOX mice (Fig. 3.19) when compared to the dermis 
of control mice, indicating that the absence of the RNase H2 enzyme in the epidermis 
likely caused fibrosis in the underlying dermal tissue. We subsequently quantified total 
skin thickness by measuring the dorsal skin fold at various time points in order to 
determine the increase in skin thickness upon collagen deposition and observed 
increased skin thickness in K14Cre+ Rnaseh2bFLOX/FLOX mice that significantly peaked 
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between week 10 and 20 (Fig. 3.20). Surprisingly, skin thickness decreased thereafter 
and K14Cre+ Rnaseh2bFLOX/FLOX mice older than 30 weeks displayed skin thickness 
similar to that of control mice. 
 
 
Figure 3.20: Maximum thickness of dorsal skin from K14Cre+ Rnaseh2bFLOX/FLOX mice 
between 10 and 20 weeks of age. Dorsal thickness of K14Cre+ Rnaseh2bFLOX/FLOX (knockout) 
and littermate controls (control) were determined at various time points, beginning at six weeks of 
age. Skin thickness gradually increased, peaked around week 12 and declined thereafter to 
control levels again. 
 
K14Cre+ Rnaseh2bFLOX/FLOX mice gradually lost the entire fur and developed spontaneous 
ulcerations in the neck area of the dorsum beginning with the age of 20 weeks (Fig. 
3.21). Ulcerations developed as a consequence of massive scratching and were thus 
limited to the neck area of the mouse. So far, we were not able to identify the reason for 
extensive scratching, but we hypothesize that RNase H2 deficiency might likely cause a 
barrier defect due to impaired function of RNase H2-deficient keratinocytes. This idea is 
supported by the fibrotic changes and the infiltration of nucleated cells into dermis that 
might also be a direct consequence of a barrier defect. We subsequently performed H&E 
staining of dorsal skin sections from 35 week-old mice that were taken from dorsal skin 
that did not display ulcerations. Surprisingly, we observed the amelioration of the 
microscopic skin alterations. The epidermal thickness was reduced in 35 week-old mice 
compared to epidermal thickness of younger mice, although skin thickness was still not 
comparable to control skin (Fig. 3.21). The dermis displayed basket work-like structure 
and the number of nucleated cells were comparable to that of wild type dermis. 
However, all adnexal structures of the skin were absent in the skin of K14Cre+ 
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Rnaseh2bFLOX/FLOX mice, indicating that hair loss was caused by the loss of the adnexal 
structures and not by impaired hair growth. 
 
Figure 3.21: Amelioration of the dermal and epidermal pathology did not prevent 
spontaneous skin ulcerations. (A) Dorsal skin from 35 week-old K14Cre+ Rnaseh2bFLOX/FLOX 
was undistinguishable from skin of age-matched littermate controls (Control). Epidermis and 
dermis were reduced in thickness and dermis showed basket work-like structure and normal 
numbers of nucleated cells. Adnexal structures were completely absent in the skin of knockout 
mice. (B) Although amelioration of the skin pathology was observed, K14Cre+ Rnaseh2bFLOX/FLOX 
mice developed spontaneous ulcerations mostly in the neck area of the dorsum starting with the 
age of 20 weeks. 
 
Since the loss of the adnexal structures of the skin represents the end point of a gradual 
process, we checked for the presence of epidermal stem cells in 12 week-old K14Cre+ 
Rnaseh2bFLOX/FLOX mice. We stained epidermal stem cells according to Jensen et al. 
(Jensen et al., 2010) and detected a significant decrease of hair follicle stem cells, while 
no changes could be detected for interfollicular epidermal cells (Fig. 3.22). Detailed 
FACS analysis revealed a specific decrease of hair follicle stem cells and suprabasal 
hair follicle stem cells, while stem cells of the isthmus and the junctional zone were 
unaltered (data not shown). This data might indicate that the gradual loss of hair follicle 
stem cells might lead to the loss of the entire hair follicle. 
 
H
&
E
 (
4
0
x
)
Control K14Cre+ Rnaseh2bFLOX/FLOX
A B
K14Cre+ Rnaseh2bFLOX/FLOX
Results 
80 
 
 
Figure 3.22: Massive reduction of hair follicle stem cells in the epidermis of K14Cre+ 
Rnaseh2bFLOX/FLOX mice. (A) A mild increase of absolute epidermal cells numbers could be 
observed in K14Cre+ Rnaseh2bFLOX/FLOX mice, likely attributing to epidermal hyperproliferation. (B) 
FACS analysis of epidermis cells revealed constant cell numbers of non-hematopoietic as wells 
as keratinocytes in wild type and knockout mice. In contrast, a drastic decrease in hair follicle 
stem cells could be observed in the epidermis from K14Cre+ Rnaseh2bFLOX/FLOX mice. 
 
In order to characterize the dermal infiltrate of nucleated cells from K14Cre+ 
Rnaseh2bFLOX/FLOX mice, we collaborated with Prof. Jörg Wenzel from the university 
hospital in Bonn who stained dorsal skin sections for the leukocyte cell surface marker 
CD45. Staining for CD45 could confirm that the infiltrating nucleated cells were indeed 
CD45-positive leukocytes (Fig. 3.23). Moreover, detailed microscopic analysis of dorsal 
skin sections from 7 week-old K14Cre+ Rnaseh2bFLOX/FLOX mice revealed skin pathology 
associated with a group of diseases, termed interface dermatitis that comprises the 
diseases lichen planus, dermatomyositis and the cutaneous lupus erythematosus (CLE) 
(Sontheimer, 2009a)(Fig. 3.23). 
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Figure 3.23: CD45-staining in K14Cre+ Rnaseh2bFLOX/FLOX mice revealed poor leukocyte 
infiltration and interface dermatitis. Dorsal skin sections of 7 week and 34 week-old K14Cre+ 
Rnaseh2bFLOX/FLOX mice and littermate controls (Control) were stained for the hematopoietic cell 
marker CD45. Skin from mice with an epidermis-specific knockout of the Rnaseh2b gene showed 
mild leukocyte infiltration at 7 weeks and 34 weeks. CD45-staining also revealed interface 
dermatitis at the bulge region of hair follicles. (black arrows label interaction of CD45+ cells with 
epidermal cells of the hair follicle) 
 
Interface dermatitis manifests at the dermo-epidermal junction of the skin while 
inflammatory cells mediate pathology. Inflammatory cell-mediated vacuolization of basal 
cells and the induction of apoptosis in keratinocytes cause the obscuring of the dermo-
epidermal junction, the characteristic feature of interface dermatitis. Figure 3.23 shows 
the infiltration of inflammatory cells into the dermo-epidermal junction and the resulting 
vacuolization that can be identified as white spots adjacent to the leukocyte infiltrate. As 
in human CLE patients, leukocyte infiltration in K14Cre+ Rnaseh2bFLOX/FLOX mice is 
localized to the bulge region of the hair follicle. The observed interface dermatitis at the 
bulge region of the hair follicle and the associated destruction of the dermo-epidermal 
junction might likely explain the decrease in the numbers of hair follicle stem cells while 
numbers of other epidermal cells, like interfollicular epidermis cells, remained unaltered.  
The pathology of interface dermatitis is characteristic but not specific for CLE. However, 
since CLE is caused by an unbalanced type I interferon response (Farkas et al., 2001), 
we subsequently analyzed skin from K14Cre+ Rnaseh2bFLOX/FLOX mice for the presence 
of a type I interferon response. We performed FACS analysis of epidermal cells of eight 
to ten week old K14Cre Rnaseh2bFLOX mice and stained for the cell surface marker Sca1 
that is supposed to be up-regulated upon type I interferon encounter (Hartner et al., 
2009). We could detect considerable upregulation of Sca1 expression on CD45-positive 
cells of the epidermis from K14Cre+ Rnaseh2bFLOX/FLOX mice, implicating that pathology in 
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K14Cre+ Rnaseh2bFLOX/FLOX mice could be mediated by the expression of type I 
interferon. To test this hypothesis we next performed gene expression analysis of total 
skin from eight week-old K14Cre Rnaseh2bFLOX mice using quantitative real time PCR 
(qRT PCR). Pairwise comparison of RNA from three to four knockouts versus littermate 
controls showed a five-fold downregulation of the Rnaseh2b gene, showing the reliability 
of the method. Further expression analysis of type I interferon-inducible genes (ISGs) 
Isg15, Oas1a, Rsad2 and Ifi44 revealed upregulation of all four ISGs. However, while 
Isg15 and Oas1a revealed a mean upregulation by 4 fold, Rsad2 and Ifi44 showed a 
mean upregulation by 1.5 fold (Fig. 3.24). Considering that most fold changes were 
substantially decreased by a single outlier (blue symbol) and that epidermal transcript 
levels were diluted by the transcripts of dermal cells, we hypothesized that skin 
pathology K14Cre+ Rnaseh2bFLOX/FLOX mice was at least partly mediated by type I 
interferon.  
 
Figure 3.24: Type I Interferon signature in epidermal CD45+ cells and in skin of K14Cre+ 
Rnaseh2bFLOX/FLOX mice. (A) FACS analysis of CD45+ epidermal cells revealed increased 
expression of the type I interferon-induced Sca1 marker in eight week old K14Cre+ 
Rnaseh2bFLOX/FLOX mice (n=3) when compared to littermate controls (control, n=2). (B) 
Quantitative real time PCR (qRT PCR) of RNA from total skin of K14Cre+ Rnaseh2bFLOX/FLOX mice 
revealed the upregulation of the type I interferon-inducible genes Isg15, Oas1a, Rsad2 and Ifi44 
by at least 1.5 fold. At the same time, transcripts of the Rnaseh2b gene were fivefold down-
regulated, confirming the reliability of the qRT PCR data. Fold change was determined by 
pairwise comparison of qRT PCR data from K14Cre+ Rnaseh2bFLOX/FLOX mice and control mice 
(n=3-4). Each color represents data of a single individual. 
 
To confirm our hypothesis that pathology in K14Cre+ Rnaseh2bFLOX/FLOX mice was at 
least partially mediated by increased type I interferon expression, we performed a 
microarray-based gene expression analysis of RNA from total skin of 7 week-old K14Cre 
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Rnaseh2bFLOX/FLOX mice. Pair-wise comparison of four knockouts versus four wild type 
littermate controls revealed significant deregulation of 331 genes (fold change ≥ 1.5, p = 
0.05). 31 genes were found to be down-regulated, whereas 286 genes were up-
regulated (Table 6.1). 
In contrast to our previous data, microarray-based gene expression analysis of RNA 
from total skin of 8 week-old K14Cre+ Rnaseh2bFLOX/FLOX mice did not display increased 
expression of type I interferon-inducible genes (ISGs). The interferon-inducible genes 
Isg15 (1.7), Oas1a (1.43), Rsad2 (1.0), Ifi44 (1.0) were not as deregulated as in the 
previous qRT PCR analysis (Fig. 3.24). However, since the Rnaseh2b gene displayed a 
2.7 fold down-regulation (compared to the more than fivefold downregulation measured 
by qRT PCR), we think that the differences between both methods may be a result of the 
quenching effects that are described for microarray analysis (Ramdas et al., 2001).  
However, since gene expression analysis of total skin did not reveal a type I interferon 
response in K14Cre+ Rnaseh2bFLOX/FLOX mice, we subsequently performed a cluster 
analysis using the Ingenuity Pathway Analyzer (Krämer et al., 2014) and identified the 
cluster “Cell cycle: G2/M DNA damage checkpoint regulation” to contain the greatest set 
of de-regulated genes in our array (Table 6.2). The cluster comprised genes like Chek1, 
Chek2 and Brca1. These genes encode for well-known members of the DNA damage 
repair pathway that is activated upon DNA double-strand or single strand breaks. 
Additionally, the p53-signalling cluster was also shown to contain de-regulated genes of 
our array. Hence, the gene expression profile of total skin from K14Cre Rnaseh2bFLOX 
mice was very similar to the gene expression profile of E14.5 fetal liver cells from 
Rnash2bKOF/KOF embryos, since both arrays predominantly display a DNA damage-
mediated p53 response. In line with the phenotypic observations made in the K14Cre+ 
Rnaseh2bFLOX/FLOX mice, the “Eumelanin Biosynthesis” cluster could also be detected 
among the top gene clusters. The upregulation of this cluster very well correlated with 
the hyperpigmentation on the skin of ears, paws and tail of K14Cre+ Rnaseh2bFLOX/FLOX 
mice. 
Due to the finding that RNase H2 deficiency leads to the activation of a p53-mediated 
DNA damage response and based on data from several studies that describe the tumor 
suppressor p53 as an important mediator for pathologies associated with hair loss and 
hyperpigmentation (Sotiropoulou et al., 2013; Cui et al., 2007), we crossed the K14Cre+ 
Rnaseh2bFLOX/FLOX mouse on a p53-deficient background aiming to rescue the skin 
pathology. Preliminary data confirmed our hypothesis and K14Cre+ Rnaseh2bFLOX/FLOX 
mice with a heterozygous deletion of the p53 gene already showed amelioration of the 
skin phenotype. These mice showed intermediate pigmentation and did not lose hair at 
least until the age of 30 weeks. Moreover, these mice did not develop spontaneous 
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ulcerations compared with age-matched K14Cre+ Rnaseh2bFLOX/FLOX mice. K14Cre+ 
Rnaseh2bFLOX/FLOX p53ko/ko mice showed complete reversion of the skin phenotype and 
were very similar to RNase H2-proficient littermate controls. In slight contrast to the 
littermate controls, double knockout mice displayed scrubby fur. However, with about 10 
to 12 weeks of age mice started to lose hair in the dorsal neck region due to extensive 
scratching, while hair loss could not be observed at any other region of the mouse body. 
Subsequent histological analysis of the K14Cre+ Rnaseh2bFLOX/FLOX p53-/- mouse line will 
provide detailed information about the underlying mechanism that cause the 
macroscopic phenotype. Anyway, preliminary data from K14Cre+ Rnaseh2bFLOX/FLOX 
p53wt/ko and K14Cre+ Rnaseh2bFLOX/FLOX p53ko/ko might also indicate that RNase H2 
deficiency might cause the formation of cancer. Both mouse lines demonstrated 
hyperplastic tissue that could be found in mice that were RNase H2-proficient, but p53-
deficient. Further studies of K14Cre+ Rnaseh2bFLOX/FLOX p53-/- mice will show whether we 
can provide evidence that RNase H2 deficiency increases the susceptibility for cancer 
formation, as it was already predicted in earlier studies (Crow et al., 2006b). 
 
3.4 Generation and analysis of bone marrow chimera  
In parallel to the generation of cell type-specific knockout mice, we also generated bone 
marrow chimera. For the generation of chimera, mice are irradiated with a lethal dosage 
of gamma irradiation that causes the destruction of the radio-sensitive hematopoietic 
system, including the hematopoietic stem cells. Lethality of irradiated mice is 
subsequently rescued by reconstitution with either bone marrow cells of adult mice or 
with embryonic liver cells, since embryonic hematopoiesis takes place in the fetal liver 
(Golub and Cumano, 2013). To allow the discrimination between residual cells of the 
irradiated recipient and transplanted cells of the donor, cells of syngenic mouse strains 
are transferred that express variants of the hematopoietic cell surface protein CD45. 
Whereas hematopoietic cells from C57BL/6 mice express the CD45.2 variant, 
hematopoietic cells from SJL mice express CD45.1. The F1 generation of C57BL/6 and 
SJL mice expresses both variants at an equal ratio (CD45.1/2) (Figure 3.25). In order to 
determine the donor cell contribution, the chimerism is regularly (every four weeks) 
determined in peripheral blood polymorphonuclear cells (PMNs), B cells and T cells 
using flow cytometry. PMNs are characterized by a short life time of only about 14 days 
and need to be replenished by hematopoietic stem and progenitor cells to maintain the 
PMN pool. Thus peripheral blood chimerism is used as a marker for bone marrow 
chimerism. While various progenitor cells, multipotent progenitors and short-term 
hematopoietic stem cells can deliver short-term reconstitution, long term reconstitution 
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for longer than 16 weeks can only be achieved by the activity of long-term hematopoietic 
stem cells (Morrison and Weissman, 1994; Purton and Scadden, 2007). 
 
 
Figure 3.25: Discrimination between donor and recipient hematopoietic cells by the cell 
surface marker CD45. The surface marker CD45 is expressed on all hematopoietic cells and 
allows for the discrimination between cells from syngenic mouse lines. Cells of common C57BL/6 
mice express CD45.2, whereas syngenic SJL mice express CD45.1. The F1 litter of C57BL/6 and 
SJL mice expresses CD45.2 and CD45.1. 
 
3.4.1 Non-competitive transfer of E14.5 fetal liver cells 
To investigate the role of RNase H2-deficient hematopoietic cells in the pathology of 
Rnaseh2bKOF/KOF mice, we generated bone marrow chimera by transplanting E14.5 fetal 
liver cells of Rnaseh2bWT/WT and Rnaseh2bKOF/KOF embryos into irradiated recipient SJL 
mice. In a first experiment, 2.5 x 105 (1,25 x radio protection dosage, (Morrison et al., 
1995)) viable fetal liver cells of E14.5 Rnaseh2bWT/WT and Rnaseh2bKOF/KOF embryos 
were transferred into five and six irradiated (7Gy) recipient SJL mice, respectively. Within 
the first two weeks after transfer, both irradiation controls (irradiated, but not 
reconstituted with fetal liver cells) and mice that were either reconstituted with wild type 
(1) or knockout (4) fetal liver cells died. Analysis of the remaining recipient mice four 
weeks after the transfer showed high-level chimerism of about 98% in mice that were 
reconstituted with Rnaseh2bWT/WT fetal liver cells. However, recipient mice that were 
reconstituted with Rnaseh2bKOF/KOF fetal liver cells showed low-level chimerism of 24% 
and 0.37%, respectively (data not shown). We suggested that low-level chimerism was 
either a consequence of technical problems during the retro-orbital cell transfer of fetal 
liver cells, reduced overall stem cell numbers in the fetal liver of Rnaseh2bKOF/KOF 
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embryos or impaired stem cell function. To investigate if the low-level chimerism was 
caused by reduced stem cell numbers or impaired stem cell function in RNase H2-
deficient embryos, we performed a second experiment with a 20 fold radioprotection 
dosage and transferred 4 x 106 fetal liver cells of E14.5 Rnaseh2bWT/WT and 
Rnaseh2bKOF/KOF embryos into lethally irradiated (7Gy) F1 recipients (Fig. 3.26).  
 
Figure 3.26: 4x106 E14.5 fetal liver cells of Rnaseh2bKOF/KOF embryos could successfully 
reconstitute primary recipients for at least 42 weeks. 4x106 fetal liver cells of E14.5 
Rnaseh2bWT/WT (n=3, black circles) and Rnaseh2bKOF/KOF (n=3, black triangles) embryos were 
transplanted into lethally irradiated (7Gy) recipients. Stable high-level donor cell chimerism 
(%CD45.2 cells) in polymorphonucleated (PMNs) cells showed that fetal liver cells of wild type 
and RNase H2-deficient embryos were capable of reconstituting recipients for at least 42 weeks. 
 
Four weeks after transplantation, all recipient mice were viable and displayed high-level 
chimerism. Mice reconstituted with knockout fetal liver cells showed a chimerism of 97.9 
± 1.1% in the PMN cell population, while mice that were reconstituted with wild type fetal 
liver cells displayed a chimerism of 97.5 ± 1.0%. High-level chimerism remained stable in 
mice reconstituted with RNase H2-deficient fetal liver cells, even after 25 (97.9 ± 1.2%) 
and 44 weeks (97.7 ± 1.3%). Since long-term reconstitution (≥ 16 weeks, (Morrison and 
Weissman, 1994; Purton and Scadden, 2007)) is completely dependent on the activity 
and proper function of LT-HSCs, this data likely indicated that the failure of RNase H2-
deficient fetal liver cells to reconstitute irradiated mice in the first experiment was likely 
caused by the technical problems or reduced stem cell numbers and not by non-
functional stem cells. However, transplantation of high cell numbers of knockout fetal 
liver cells might have compensated for reduced cell numbers. To address this question, 
we subsequently determined hematopoietic stem cell numbers in E14.5 fetal livers from 
Rnaseh2bWT/WT, Rnaseh2bWT/KOF and Rnaseh2bKOF/KOF embryos.  
4 x106 E14.5 
fetal liver cells
CD45.2
primary recipient 
CD45.1/2
donor cells survival
Rnaseh2bWT/WT 3/3
Rnaseh2bKOF/KOF 3/3
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Hematopoietic stem cells are defined by the absence of lineage-determining markers 
(lineage-, lin-) and the concomitant expression of the stem cell growth factor receptor (c-
Kit, CD117) and the stem cell antigen 1 (Sca1). The Kit+, Sca1+ and lineage- (KSL) cell 
population comprises diverse stem cell populations that differ in respect to their self-
renewal capacity and the spectrum of progenitor cells they can give rise to. Using the 
signaling lymphocyte activation markers (SLAM) CD48 and CD150, KSL cells can be 
subdivided into multipotent progenitors (MPPs, CD48+ CD150-), short-term 
hematopoietic stem cells (ST-HSCs, CD48+ CD150+) and long-term hematopoietic stem 
cells (LT-HSCs, CD48- CD150+). LT-HSCs possess the highest self-renewal capacity 
and the potential to give rise to any cell type of the hematopoietic system, whereas 
MPPs have no self-renewal capacity with only limited potential. ST-HSCs display an 
intermediate phenotype with limited self-renewal capacity (Morrison and Weissman, 
1994; Wilson et al., 2007) (Fig. 3.27). 
 
 
Figure 3.27: Gating strategy for the definition of hematopoietic stem cells by flow 
cytometry. KSL cells were defined as propidium iodide (PI)-negative and lineage-negative cells 
that concomitantly expressed the cell surface markers CD117 and Sca1. KSL cells could be 
further subdivided into MPPs, ST-HSCs and LT-HSCs using the SLAM markers CD48 and 
CD150, with LT-HSCs having the highest self-renewal capacity and the potency to give rise to 
any cell of the hematopoietic system. 
 
According to the small size of the fetal liver from E14.5 Rnaseh2bKOF/KOF embryos, 
absolute cell numbers of RNase H2-deficient fetal liver cells were also dramatically 
reduced (4.88 ± 0.72 x106, n = 8) when compared to fetal liver cells of wild type (14.62 ± 
3.57 x106, n = 12) and heterozygous embryos (16.84 ± 3.92 x106, n = 7) (Fig.3.28). KSL 
SLAM staining of E14.5 fetal liver cells displayed only moderate changes in relative 
terms (data not shown). However, due to the massive reduction in total cell numbers, all 
hematopoietic cell populations in Rnaseh2bKOF/KOF embryos were massively reduced in 
absolute numbers. While the lineage-negative (lin-) population displayed the mildest 
reduction of about 20 fold, LT-HSCs showed the strongest reduction of more than 75 
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fold. LT-HSC numbers in fetal livers of Rnaseh2bKOF/KOF embryos were reduced to 0.032 
± 0.019 x 104 cells (n=8), compared to 2.134 ± 0,996 x 104 wild type cells (n=12) and 
2.822 ± 1.127 x 104 fetal liver LT-HSCs from Rnaseh2bWT/KOF embryos (n=7). However, 
as a consequence of reduced stem cell numbers in the fetal liver of RNase H2-deficient 
embryos, LT-HSC frequencies were also twofold reduced (1 LT-HSC / 1525 cells, 
0.065%), compared to frequencies from wild type (1 LT-HSC / 686 cells, ~0.15%) and 
heterozygous embryos (1 LT-HSC / 597 cells, ~0.17%). Considering the calculated 
mean LT-HSC frequency of 0.065% in the fetal liver of E14.5 Rnaseh2bKOF/KOF embryos, 
we transferred approximately 150 LT-HSCs into lethally irradiated recipients during the 
first transfer experiment, a number that is reported to be sufficient to generate stable 
chimerism (Morrison et al., 1995). Together with the observation that RNase H2-defcient 
fetal liver cells can reconstitute irradiated recipients as long as enough donor cells are 
transplanted, we conclude that the low-level chimerism in the first experiment was 
caused by technical problems during the retro-orbital injection. Therefore, we transferred 
cell numbers smaller 4 x 106 in the following experiments. 
 
 
Figure 3.28: Reduced absolute cell numbers in E14.5 Rnaseh2bKOF/KOF mice. (A) Absolute 
cell numbers were found to be fourfold reduced in E14.5 fetal liver cells of Rnaseh2bKOF/KOF (black 
bars, n=8) embryos when compared to Rnaseh2bWT/WT (light grey bars, n=12) and 
Rnaseh2bWT/KOF (dark grey bars, n=7) embryos. (B) Although relative numbers of most cell 
compartments in Rnaseh2bKOF/KOF embryos were only mildly altered, decreased absolute cell 
numbers in Rnaseh2bKOF/KOF fetal liver caused reduced overall cell numbers in various bone 
marrow cell compartments. Calculating the ratio of one LT-HSC per total cells also revealed a 
twofold reduction in the frequency of LT-HSC cells. 
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3.5.1 Secondary transfer of Rnaseh2b KOF bone marrow cells 
Since bone marrow chimera did not display a macroscopic phenotype after reconstitution 
with RNase H2-deficient fetal liver cells, we wondered if these cells were also competent 
to reconstitute secondary recipients in a serial transfer experiment. To this end, bone 
marrow cells of primary recipients were transplanted into lethally irradiated secondary 
recipients. The secondary transfer represents massive stress for the cells of the 
hematopoietic system, in particular, hematopoietic stem cells, since the reconstitution of 
a secondary recipient requires massive proliferation of these cells. In case RNase H2 
deficiency causes a defect that is determined by the number of cell divisions, we 
hypothesized that RNase H2-deficient fetal liver cells fail to repeatedly reconstitute 
recipient mice. To test this hypothesis, we first generated primary recipients by 
reconstituting irradiated (7Gy) F1 hybrid mice with 1 x 106 E14.5 Rnaseh2bKOF/KOF fetal 
liver cells and 0.5 x 106 E14.5 Rnaseh2bWT/WT and Rnaseh2bWT/KOF fetal liver cells, 
respectively. We used twice as much fetal liver cells from RNase H2-deficient mice in 
order to compensate for the decreased stem cell frequency in fetal livers from 
Rnaseh2bKOF/KOF embryos. Although we transplanted fourfold less cell numbers when 
compared with the previous transfer experiment, almost all recipient mice survived (Fig. 
3.29). Moreover, all recipients demonstrated stable high-level chimerism in the PMN-, B 
cell- and T cell compartment during 36 weeks (Fig. 3.29), independent of the genotype of 
the donor fetal liver cells. This data showed that the five-fold radioprotection dosage or 
transfer of 1 x 106 RNase H2-deficent fetal liver cells were sufficient to long-term 
reconstitute irradiated recipients. 
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Figure 3.29: 1x106 E14.5 fetal liver cells of Rnaseh2bKOF/KOF embryos stably reconstituted 
lethally irradiated recipient mice. Irradiated (7Gy) F1 recipients were either reconstituted with 
0.5 x 106 fetal liver cells from Rnaseh2bWT/WT (black circles) and Rnaseh2bWT/KOF (black boxes) 
embryos or with 1 x 106 fetal liver cells from Rnaseh2bKOF/KOF (black triangles) embryos to 
compensate for twofold less LT-HSC frequency in RNase H2-deficient fetal liver cells. Stable 
chimerism was detected in the PMN-, B cell- and T cell compartment for 36 weeks.  
 
In preparation of the secondary transfer of bone marrow cells, we determined absolute 
bone marrow cell numbers of primary recipients and determined the chimerism of 
various bone marrow cell populations by FACS analysis (Fig. 3.30). We could not detect 
any difference in absolute bone marrow cell numbers between mice that were either 
reconstituted with wild type, heterozygous or knockout fetal liver cells. Differences could 
also not be observed in absolute numbers of MPPs, ST-HSCs and LT-HSCs and also 
the chimerism in all these cell populations was close to 100% (98.7 – 99.7%). The even 
absolute cell numbers and the high-level chimerism in the bone marrow of primary 
recipients allowed us to use these cells in a subsequent secondary transfer experiment.  
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Figure 3.30: Similar absolute numbers of bone marrow cells in primary recipients. (A) 
Absolute bone marrow cell numbers of primary recipients were determined and no differences 
could be observed between recipients that were either reconstituted with wild type (light grey 
bars, n=6), heterozygous (dark grey bars, n=3) or knockout (dark bars, n=3) E14.5 fetal liver cells. 
(B) Staining for various bone marrow stem cells did not show different absolute cell numbers for 
KSL cells, MPPs, ST-HSCs and LT-HSCs.  
 
In order to eliminate contaminating cells of the primary recipient (CD45.1/2), we 
subsequently FACS-sorted CD45.2+ CD117+ bone marrow cells of primary recipients 
and finally transplanted 5 x 104 CD45.2+ CD117+ cells into lethally irradiated (8Gy) 
recipient SJL mice. Progenitor cell populations within the CD117+ cell compartment 
delivered short-term radioprotection. Two recipient mice died within the first two weeks, 
while most recipient mice survived until the end of the experiment (Fig. 3.31). Four 
weeks after the transfer, chimerism was determined by FACS analysis. High-level 
chimerism could be observed in peripheral blood PMNs and B cells. The slightly reduced 
chimerism of peripheral blood PMNs of mice reconstituted with RNase H2-deficient bone 
marrow (84.7 ± 30.4%) was likely caused by low-level chimerism of a single recipient 
(30%). However, eight weeks after the transfer, the chimerism of peripheral blood PMNs 
and B cells of recipients that received Rnaseh2bKOF/KOF bone marrow displayed a gradual 
decline of the chimerism to 17.55 ± 19.44% and 31.64 ± 22.17%, respectively, after 32 
weeks. In contrast to the chimerism of recipients that were reconstituted with knockout 
bone marrow, the chimerism of recipients that were reconstituted with wild type or 
heterozygous bone marrow showed stable, high-level chimerism for 32 weeks. The T 
cell chimerism of all recipients was found to be initially very low and slowly increased 
four weeks after the transfer. While the T cell chimerism increased to about 50 – 60% in 
recipients that were reconstituted with Rnaseh2bWT/WT and Rnaseh2bWT/KOF bone marrow 
from primary recipients, the T cell chimerism of recipients that were reconstituted with 
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Rnaseh2bKOF/KOF bone marrow also gradually decreased to a level of 15.67 ± 7.66% after 
32 weeks (Fig. 3.31). 
Final analysis of secondary recipients displayed the greatest cellularity in recipients that 
were reconstituted with Rnaseh2bKOF/KOF bone marrow when compared with mice 
reconstituted with wild type and heterozygous bone marrow. However, these mice 
showed low level chimerism in the peripheral blood. Staining for bone marrow stem cells 
demonstrated reduced absolute KSL, MPP, ST-HSC and LT-HSC cell numbers. Thus, 
low level chimerism of peripheral blood cells was a likely consequence of reduced stem 
cell numbers in the bone marrow of secondary recipients. Surprisingly, reduced stem cell 
numbers could also be observed in the bone marrow of secondary recipients that were 
reconstituted with Rnaseh2bKOF/KOF bone marrow from primary recipients. Although 
these mice displayed intermediate absolute cell numbers, the peripheral blood 
chimerism remained stable and comparable to that of the wild type. 
 
 
Figure 3.31: RNase H2-deficient bone marrow from primary recipients cannot reconstitute 
secondary recipients. Lethally irradiated (8Gy) secondary recipients were reconstituted with 
5x104 sorted CD45.2+ CD117+ bone marrow cells from primary recipients. Whereas bone marrow 
from primary recipients that were either reconstituted with Rnaseh2bWT/KOF (n=4, black boxes) or 
Rnaseh2bWT/WT (n=4, black circles) fetal liver cells could stably reconstitute secondary recipients 
for 32weeks, bone marrow cells from primary recipients that were reconstituted with 
Rnaseh2bKOF/KOF (n=4, black triangles) fetal liver cells failed to reconstitute secondary recipients. 
Chimerism (% CD45.2 cells) in secondary recipients declined in the PMN-, B cell- and T cell-
compartment at different time points, with the most dramatic decline in the population of PMNs 
that finally dropped to about 15%.  
As hypothesized, our data showed that bone marrow cells of primary recipients that were 
initially reconstituted with RNase H2-deficient E14.5 fetal liver cells did not have the 
capacity to reconstitute recipients in a secondary transfer experiment. This data clearly 
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supported our hypothesis that the impact of RNase H2 deficiency is directly linked to the 
number of cell divisions. So far we cannot conclude what caused the failure to 
reconstitute recipients in a secondary transfer experiment. Based on our previous data 
generated from Rnaseh2bKOF/KOF embryos, RNase H2 deficiency might have caused 
increased DNA damage and subsequent cell death in the stem cell compartment. 
However, increased DNA damage and cell death might have occurred in stem cell 
progenitor cells leading to increased stem cell activity and subsequent stem cell 
exhaustion in a chronic setting.  
 
Figure 3.32: Secondary recipients that were reconstituted with knockout bone marrow 
from primary recipients displayed increased bone marrow cellularity but reduced stem cell 
numbers. (A) Absolute bone marrow cell numbers per femur were determined of secondary 
recipients that were either reconstituted with wild type (light grey bars, n = 3), heterozygous (dark 
grey bars, n = 3) or knockout (black bars, n = 3) bone marrow of primary recipients. (B) FACS 
staining for bone marrow stem cells demonstrated reduced absolute stem cell numbers in mice 
reconstituted with Rnaseh2bKOF/KOF bone marrow of primary recipients.
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4 Discussion 
4.1 RNase H2-deficient mice do not develop an autoimmune pathology. 
The aim of this project was to generate a mouse model for the human encephalopathy 
Aicardi-Goutières syndrome (AGS) that is caused by mutations in at least seven genes. 
Three of them encode for the subunits of the heterotrimeric RNase H2 enzyme, while the 
others encode for TREX1, SAMHD1, ADAR and IFIH1 (MDA5) (Crow et al., 2006a; 
Crow et al., 2006b; Rice et al., 2009; Rice et al., 2012; Oda et al., 2014; Diamond, 2014). 
While null mutations can be found in AGS patients with mutations in TREX1 and 
SAMHD1, mutations in the other genes were rather found to cause a partial loss-of-
function or a gain-of-function instead of causing complete deficiency. RNase H2, TREX1 
and SAMHD1 were described to possess nuclease activity with different nucleic acid-
specificity, while ADAR is a RNA-editing enzyme with deaminase activity. In contrast, the 
Ifih1 gene encodes for a RIG I-like helicase MDA5 that senses long double-stranded 
RNA. However, all share the common feature that mutations in these genes cause the 
de-novo synthesis of type I interferon, a hallmark of the Aicardi-Goutières syndrome. 
Chronic type I interferon production in AGS patients causes massive inflammation in the 
brain, dramatic physical and mental retardation and often lethality in early childhood. The 
current hypothesis is that nucleic acids accumulate in patients with partial loss-of-
function mutations in RNase H2, TREX1, SAMHD1 and ADAR that leads to an 
uncontrolled type I interferon response and subsequent AGS pathology. The gain-of-
function mutations in the IFIH1 gene cause constitutive activity and enhanced ligand-
sensitivity, respectively, that leads also to uncontrolled type I interferon expression. 
A mouse model for TREX1 deficiency was shown to recapitulate most of the clinical and 
molecular features of human AGS patients and greatly contributed to the elucidation of 
AGS pathomechanisms. Trex1-deficient mice show multi-organ inflammation (except for 
the brain) and die of circulatory failure caused by a myocarditis (Morita et al., 2004; 
Stetson et al., 2008; Gall et al., 2012). However, lethality of Trex1-deficient mice could 
be completely rescued by concomitant Ifnar1-, Irf3- and Rag1-deficiency, showing the 
important impact of the type I interferon response and lymphocytes on the onset of the 
disease. Moreover, it could be shown that Trex1 deficiency caused the accumulation of a 
nucleic acid species that is detected by the nucleic acid sensor cyclic GMP/AMP 
synthase (cGAS) that activates STING (Stimulator of interferon genes) via the second 
messenger cGMP/AMP. STING in turn induces the expression of type I interferon via the 
mediator TBK1 (Tank binding kinase 1) and the transcription factor IRF3 (Ablasser et al., 
2014). Yet, the origin of the nucleic acid species is still discussed, either deriving from 
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DNA replication and repair (Lan et al., 2014) or from retrotransposition of endogenous 
retroelements (Stetson et al., 2008; Beck-Engeser et al., 2011). Samhd1- and Adar-
deficient mice also display a spontaneous type I interferon response, although Samhd1 
knockout mice do not develop any pathology (Behrendt et al., 2013; Rehwinkel et al., 
2013) and lethality of Adar knockout mice could only be postponed by few days upon 
concomitant Ifnar1-deficiency (Hartner et al., 2009; Mannion et al., 2014). Concomitant 
deficiency for the adaptor protein Mavs postponed lethality of Adar-deficient mice to birth 
To elucidate the pathomechanism in human AGS patients with mutations in the genes 
encoding for the RNase H2 enzyme, we generated RNase H2-deficient mice by 
inactivating one of the three murine genes encoding for the RNase H2 enzyme. We 
generated mice with ubiquitous deletion of the Rnaseh2b and Rnaseh2c gene, 
respectively. However, mice with complete RNase H2 deficiency (Rnaseh2c-/- and 
Rnaseh2b∆/∆) died during early embryonic development around day 10.5. Knockout mice 
with hypomorphic RNase H2 expression (Rnaseh2bKOF/KOF), showing 5% residual 
enzyme activity, died perinatally or were stillborn (Hiller et al., 2012; Reijns et al., 2012). 
In line with early embryonic lethality in mice with ubiquitous RNase H2 deficiency, 
homozygous null mutations have never been observed in AGS patients with mutations in 
the genes encoding for the RNase H2 enzyme (Rice et al., 2007). All mutations in the 
genes encoding for the RNase H2 enzyme are missense mutations, implicating that 
complete RNase H2 deficiency might cause lethality in early mammalian development 
(Rice et al., 2007). In contrast to the data from mammals, a yeast strain deficient for the 
RNase H2 enzyme (rnh201∆) did not display lethality or impaired viability, indicating that 
RNase H2 is not essential during homeostasis in lower eukaryotes (Arudchandran et al., 
2000). Even the concomitant deletion of the RNase H1 enzyme in yeast did not cause 
lethality. Impaired growth of RNase H2-deficient yeast could only be detected upon 
treatment with DNA-damaging agents, like hydroxyurea (HU) (Arudchandran et al., 
2000) Since hydroxyurea prevents the de novo synthesis of desoxyribonucleotides by 
blocking the ribonucleotide reductase, impaired growth was likely caused by increased 
incorporation and accumulation of ribonucleotides into the genomic DNA.  
As a consequence of ubiquitous deletion of RNase H2-encoding genes, knockout mice 
did not show any (Rnaseh2c-/- and Rnaseh2b∆/∆) or maximal 5% residual activity 
(Rnaseh2bKOF/KOF). In contrast to the complete deficiency for the RNase H2 enzyme in 
mice, overexpression studies have shown that the most frequent human AGS mutations 
in the B subunit (A177T, V185G) and the C subunit (R69W) are partial loss-of-function 
mutations with no consequences for the RNase H2 enzyme activity. The G37S mutation 
in the A subunit was the only mutation shown to reduce RNase H2 activity by directly 
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affecting the active center of the enzyme (Perrino et al., 2009; Reijns et al., 2011). Since 
most mutations in the genes encoding for the RNase H2 enzyme do not alter residual 
enzyme activity, mutations in AGS patients must have other consequences on RNase 
H2 function. By determining the crystal structure of the human RNase H2 enzyme, 
Reijns et al. could show that seven mutations (A subunit: R291H; B subunit: A177T; C 
subunit: R69W, P76L, P138L, K143I and P151S) that are found in AGS patients, affect 
amino acids located at the interface between the three subunits (Reijns et al., 2011). 
They could also demonstrate that all seven AGS mutations caused reduced thermal 
stability of the RNase H2 enzyme and concomitant reduced RNase H2 enzyme activity 
for almost all mutations. However, the A177T as well as the P138L mutation did not 
affect enzyme activity again. The authors thus speculated that the A177T and P138L 
mutation may lead to reduced total RNase H2 protein levels and therefore cause 
impaired cellular activity (Reijns et al., 2011). A recent publication investigated if AGS 
mutations might render the localization or the recruitment of the RNase H2 enzyme to 
sites of DNA damage and repair but could not find any differences for the common 
A177T and R69W mutation when compared to the wild type RNase H2. Again, only the 
G37S mutation showed delayed recruitment to DNA damage repair foci (Kind et al., 
2014).  
Histology of E18.5 or stillborn RNaseh2bKOF/KOF mice did not show leukocyte infiltration, 
neither in the brain nor in any other tissue, clearly demonstrating the absence of an 
immune response that might have caused lethality. Accordingly, early lethality could not 
be rescued by additional deficiency for IFNAR1 or RAG1, eliminating the possibility that 
lethality in RNaseh2bKOF/KOF mice was driven by type I interferon or lymphocytes (Hiller et 
al., 2012). Yeast experiments showed that RNase H2 deficiency caused increased 
genomic loads of ribonucleotides (Nick McElhinny et al., 2010). Using our own assay to 
detect the incorporation of ribonucleotides into genomic DNA, we were able to detect 
increased ribonucleotide loads in knockout cells, however, based on our data we were 
unable to determine whether single ribonucleotides or stretches of ribonucleotides were 
incorporated in the absence of the RNase H2 enzyme. Since ribonuclease H1 (RNase 
H1) is competent to degrade the RNA moiety in RNA:DNA hybrids and can also cleave 
at positions of at least four subsequent ribonucleotides, RNase H2 deficiency likely 
caused the accumulation of single ribonucleotides or short stretches of maximal three 
ribonucleotides in the genomic DNA (Cerritelli and Crouch, 2009). How the presence of 
single or short stretches of ribonucleotides in genomic DNA cause DNA damage is only 
incompletely understood. Desoxyribonucleotide triphosphates (dNTPs) and 
ribonucleotide triphospahtes (rNTPs) differ only at the 2-prime carbon atom (C2) of the 
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sugar ring, with the carbon bound to hydrogen in dNTPs while it is bound to a hydroxyl-
group in rNTPs. It was described that the nucleophilicity of this particular hydroxyl group 
renders the DNA more susceptible to strand breaks (Joyce, 1997; Williams and Kunkel, 
2014). Although incorporation of ribonucleotides likely cause single-strand breaks, DNA 
double-strand breaks can result in case two ribonucleotides are in close proximity 
located on opposing DNA strands or in case the replication fork runs into an unrepaired 
single-strand break. Kim et al. could also show in yeast that topoisomerase IB is also 
competent to remove ribonucleotides from genomic DNA in the absence of the RNase 
H2 enzyme (Kim et al., 2011). However, topoisomerase IB-mediated removal of 
ribonucleotides is only partial and imperfect, leading to the generation of unligatable 2`, 
3`- cyclic phosphate ends. Repair of these ends was shown to cause 2-5 bp deletions, 
increased dNTP-levels and accumulation of cells in S and G2/M of the cell cycle (Kim et 
al., 2011; Williams et al., 2013). Collectively, complete RNase H2 deficiency in the 
mouse rather leads to the accumulation of ribonucleotides in genomic DNA that likely 
cause DNA single- and double-strand breaks and the activation of a DNA damage 
response, than causing a type I interferon- and lymphocyte-mediated immune response. 
Although we could not specify the DNA damage that arose from the persistent 
ribonucleotide load in the genomic DNA, we were able to detect the activation of 
downstream molecules of a DNA damage response upon DNA strand breaks. Thus, a 
p53 signature could be detected in the gene expression analysis of fetal liver cells from 
E14.5 RNaseh2bKOF/KOF embryos and of total skin from eight week-old K14Cre+ 
Rnaseh2bFLOX/FLOX mice. The most prominent p53 signature was observed in fetal liver 
cells from RNaseh2bKOF/KOF embryos with the cell cycle inhibitor Cdkn1a (p21) being the 
most up-regulated gene of the array and likely explaining the growth arrest in MEF 
cultures from Rnaseh2b-defcient embryos. Fetal liver and fetal thymus cells from E18.5 
RNaseh2bKOF/KOF embryos also displayed increased numbers of γH2AX foci, a well-
known marker for DNA strand breaks (Hiller et al., 2012). Eventually, we also observed 
transcriptional up-regulation of Chek1 and Chek2 in the gene expression analysis of skin 
from K14Cre+ Rnaseh2bFLOX/FLOX mice. Both markers are important mediators in the DNA 
damage response pathway, located downstream of the kinases ATM and ATR that are 
activated upon DNA damage. In theory, double-strand breaks are sensed by ATM while 
ATR detects single-strand breaks. But since single-strand breaks naturally occur as 
byproducts during the repair of double-strand breaks, ATR activation cannot exclusively 
assigned to the repair pathway of single-strand breaks. However, since the described 
DNA damage response pathway is regulated post-transcriptionally by phosphorylation, 
we cannot conclude if the transcriptional upregulation of the Chek1 and Chek2 gene 
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represents the activation of the DNA damage response pathway. But it might well be that 
the transcriptional upregulation might be a consequence of the increased need for the 
two proteins in the DNA damage response pathway.  
Collectively, our data shows that the absence of the RNase H2 enzyme leads to the 
accumulation of single or short stretches of ribonucleotides in the genomic DNA. These 
persistent ribonucleotides might in turn cause DNA single- and/or double-strand breaks 
that trigger a p53-mediated DNA damage response. According to our data, Reijns et al. 
published similar findings. They could also demonstrate increased genomic 
ribonucleotides and using the alkaline assay to detect ribonucleotide incorporation they 
were able to estimate that a single ribonucleotide is incorporated into the DNA every 
7600 nucleotides. Moreover, they could also show increased phosphorylation of histone 
H2AX (γ-H2AX) and the presence of micronuclei and chromosomal rearrangements in 
Rnaseh2b-/- p53-/- double knockout cells. This additional data might indicate that RNase 
H2 deficiency may lead to DNA double-strand breaks that facilitate gross chromosomal 
rearrangements (Reijns et al., 2012).  
 
4.2 RNase H2-deficient mice likely die of the accumulation of an unknown 
DNA damage-species. 
We showed that mice completely deficient for the RNase H2 enzyme die in early 
embryogenesis, independent of an immune response involving type I interferon and 
lymphocytes. Instead, we and others could show that complete RNase H2 deficiency 
caused the accumulation of ribonucleotides in the genomic DNA that initiated a p53-
mediated DNA damage response (Hiller et al., 2012; Reijns et al., 2012). 
To bypass this early embryonic lethality, we generated cell type-specific knockout mice. 
We first deleted the Rnaseh2b gene in various cell types of the hematopoietic system. 
Surprisingly, a B cell-specific knockout of the Rnaseh2b gene (CD19Cre+ 
Rnaseh2bFLOX/FLOX) did not show any impact on B cell-homeostasis. Mice were born at 
Mendelian ratios and B cell numbers from these mice were comparable to B cell 
numbers from littermate control mice. The same observations were made in mice with a 
knockout of the Rnaseh2b gene in dendritic cells (CD11cCre) as well as in monocytes, 
macrophages and granulocytes (LysMCre) (data not shown). LPS-stimulation of 
Rnaseh2b-deficient B cells in vitro caused reduced proliferation and impaired 
progression of B cells through G2/M of the cell cycle. However, in comparison to mouse 
embryonic fibroblasts (MEFs) from E14.5 or E18.5 Rnaseh2bKOF/KOF embryos, impaired 
proliferation and accumulation in G2/M was much milder. In very contrast to the 
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CD19Cre-specific knockout, a VavCre-specific knockout (Stadtfeld and Graf, 2005) of 
the Rnaseh2b gene had a tremendous impact on cell viability. As a consequence of the 
VavCre-specific deletion, all stem cell-derived cells, i.e. all cells of the hematopoietic 
system, are deficient for the Rnaseh2b gene from the very first developmental stage. 
 
Figure 4.1: Deletion of the Rnaseh2b gene in the early hematopoietic stem cell caused 
massive impact on viability of various cell lineages. Upon VavCre-mediated deletion of the 
Rnaseh2b gene in early hematopoietic stem cells, (A) total leukocyte numbers in the peripheral 
blood decreased more than tenfold in knockout mice (open circles, n=3) compared to control 
littermates (black circles, n=4). (B) Flow cytometric analysis of peripheral blood leukocytes 
showed reduced cell numbers for all investigated cell lineages in knockout mice (white bars, n=3) 
in comparison to control mice (black bars, n=4). Lymphoid cells appeared more affected than 
myeloid cells, with B cells displaying the strongest decrease in absolute cell numbers.  
 
VavCre+ Rnaseh2bFLOX/FLOX mice showed a more than tenfold reduction in peripheral 
blood leukocyte numbers (Figure 4.1). Analysis of the different leukocyte populations 
demonstrated a general reduction of cell numbers for all cell types, with lymphoid cells 
being slightly more affected than myeloid cells. B cells showed the strongest reduction of 
a hundred fold. We don`t know yet why lymphoid cells seem to be more affected than 
myeloid cells and why deletion of the Rnaseh2b gene in B cells had the strongest impact 
on cell viability. Based on our previous findings, we think that the number of cell divisions 
might directly determine the impact of RNase H2 deficiency. Compared to myeloid cells, 
lymphoid B and T cells are characterized by increased numbers of cell divisions 
attributed to their unique feature of expressing a surface B and T cell receptor, 
respectively. This hypothesis might also explain the dramatic differences observed 
between CD19Cre+ Rnaseh2bFLOX/FLOX and VavCre+ Rnaseh2bFLOX/FLOX mice. While 
VavCre deletes in the very early hematopoietic stem cell, CD19Cre deletes rather late in 
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the pro-B cell stage of B cell development (Figure 4.2)
B cells in CD19Cre+ Rnaseh2b
divisions in the absence of the RNase H2 enzyme compared to B cells from 
Rnaseh2bFLOX/FLOX mice. Taken together, the observations made in cell type
Rnaseh2b knockouts might implicate that the numbe
the RNase H2 enzyme determines the strength of the phenotypic outcome, i.e. the 
impact on cell viability.  
This idea was further supported by 
RNaseh2bKOF/KOF embryos that sho
G2/M when compared to control cells. Moreover, impaired proliferation exacerbated with 
cultivation time, and MEF cells generated from E18.5 
an even stronger phenotype with mo
cycle (Hiller et al., 2012). 
 
Figure 4.2: B cell development starting from the hematopoietic stem cell
Nagasawa T., Nature Reviews Immunology
The hematopoietic stem cells (HSC), residing in particular niches of the bone marrow maintain 
the hematopoietic system by their self
differentiate to any cell type of the hematopoietic system, while the remaining daughter cell keeps 
the potency. During differentiation and maturation, cells lose their capability to differentiate to all 
cells of the hematopoietic system. Whil
the lymphoid and myeloid compartment, common lymphoid progenitors (CLPs) can only give rise 
to lymphoid cells. B cells are derived from the CLPs but undergo several additional maturation 
steps characterized by the expression of different cell surface markers. CD19 is expressed in the 
pro-B cell that is situated later in B cell development compared to the expression of the 
that takes place in the early hematopoietic stem cell (HSC). 
 
In line with the above findings are also the observations made in the transfer 
experiments to obtain bone marrow chimera. Our data show
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lethally irradiated mice, either in a non-competitive or competitive setting (data not 
shown). Primary recipients in the non-competitive setting that were reconstituted with 
RNase H2-deficient fetal liver cells or control fetal liver cells showed a chimerism of 
about 100% that remained stable during the entire experiment. However, bone marrow 
cells from these primary recipients were not competent to reconstitute irradiated mice in 
a secondary bone marrow transfer experiment. Failure to reconstitute secondary 
recipients could be observed as dramatic decrease in peripheral blood chimerism in B 
cells, T cells and polymorphonucleated cells (PMNs). B cell- and PMN- chimerism 
rapidly decreased, while T cell-chimerism dropped after a short period of latency. The 
different kinetics of the peripheral blood chimerism can well be explained by the different 
turnover of the cells. PMNs, showing the most rapid decrease, are characterized by the 
shortest turnover of about 14 days (Bainton et al., 1971). In contrast, T cells are long-
lived, radio-resistant cells that have a monthly turnover (Jameson, 2002). Finally, our 
data demonstrate that Rnaseh2b-deficient stem and progenitor cells have only a limited 
capacity to reconstitute irradiated mice when compared to stem and progenitor cells from 
wild type and Rnaseh2bWT/KOF mice. This limited capacity does not allow for repetitive 
transfer of bone marrow cells. Again, this failure to stably reconstitute secondary 
recipient mice might be directly linked to the number of cell divisions. To reconstitute the 
empty niche space in primary recipients, donor hematopoietic stem cells and commited 
progenitor cells (common lymphoid (CLPs) and common myeloid progenitors (CMPs)) 
have to proliferate massively. When these cells are used to reconstitute secondary 
recipients, donor hematopoietic stem and committed progenitor cells have to proliferate 
massively again.  
Based on our previous observations made in cell type-specific knockout mice and in 
MEF cells from E14.5 and E18.5 Rnaseh2bKOF/KOF embryos, we suggest that the reduced 
capacity to reconstitute secondary recipient mice was a consequence of a particular 
DNA damage species that accumulated during massive cell proliferation. We think that 
the deficiency for the RNase H2 enzyme and the concomitant increased loads of 
ribonucleotides might lead to the accumulation of DNA damage with every cell division. 
In the absence of the RNase H2 enzyme, ribonucleotides that are incorporated during 
replication cannot be removed and persist in the genomic DNA (Rydberg and Game, 
2002; Reijns et al., 2012; Hiller et al., 2012). However, the most important question that 
came up from these observations was what kind of DNA damage might have been 
generated in the absence of the RNase H2 enzyme? Why can`t the damage be 
efficiently repaired? And why does its nature allow for a certain number of cell divisions 
before cells die?  
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Because of the semiconservative replication of the genomic DNA it seems unlikely that it 
is the number of ribonucleotides that increased with rounds of proliferation, accounting 
for the observed phenotype. During each round of replication one DNA strand serves as 
a template for the complementary DNA strand to be newly synthesized. Therefore, 
ribonucleotides are only incorporated into one DNA strand while the other remains 
unaltered. Thus, the number of ribonucleotides can only increase during the first two 
replication rounds, whereas the number of ribonucleotides remains largely stable during 
every subsequent replication, considering that ribonucleotides are incorporated with the 
same probability during each replication. Therefore, ribonucleotide accumulation cannot 
explain the immediate proliferation defect after several rounds of normal proliferation. 
There is the possibility that ribonucleotide incorporation may lead to a different 
distribution pattern of ribonucleotides in the genomic DNA. Random incorporation might 
cause the localization of two ribonucleotides in close proximity on complementary DNA 
strands, facilitating the generation of DNA double-strand breaks. Again, this hypothesis 
would not explain the observations above that the proliferation defect suddenly occurred 
after a period of normal growth and proliferation. The accumulation of RNase H2-
deficient cells in G2/M of the cell cycle might indicate checkpoint activation upon the 
detection of single- and/or double-strand breaks in the newly synthesized DNA. 
However, this kind of damage would be immediately repaired since it poses a big threat 
to the genomic information and all cells are well equipped with multiple DNA repair 
pathways to be able to fix various types of common DNA damage (Harper and Elledge, 
2007). If the damage could not be repaired, these cells would likely be immediately 
erased by apoptosis. 
Since this is true for all human and mouse somatic cells, stem cells behave different and 
are equipped with additional features that help to maintain and to propagate the correct 
genomic information. In contrast to somatic cells, hematopoietic stem cells are quiescent 
cells that rarely cycle and are mainly in G0 of the cell cycle. As described above, while 
one daughter maintains full stem cell potency, the other daughter cell can differentiate to 
all cells of the hematopoietic system. The maintenance of the hematopoietic system 
mainly relies on the totipotency of the stem cells and the high proliferation rate of stem 
cell-derived cells. Together with a unique DNA damage repair pathway these properties 
prevent the generation of mutations, their propagation and the development of cancer. If 
persistent genomic ribonucleotides would cause the generation of a new species of 
strand breaks that cannot be immediately repaired, damaged cells would likely undergo 
apoptosis to prevent mutations and their propagation or would re-enter quiescence. 
Since the accumulation of DNA damage in hematopoietic stem cells is rather unlikely 
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due to their unique properties, failure of RNase H2-deficient bone marrow cells to 
reconstitute secondary recipients might be caused as a secondary effect in response to 
increased damage in stem cell-derived hematopoietic cells. If increased DNA damage in 
these cells would cause increased apoptosis, hematopoietic stem cells are enforced to 
enter the cell cycle and replenish the lost cells to maintain the function of the 
hematopoietic system. However, the capacity to cycle is limited in hematopoietic stem 
cells and chronic activation might cause their exhaustion. This hypothesis is well 
supported by the findings in K14Cre+ Rnaseh2bFLOX/FLOX mice that lose hair as a 
consequence of exhaustion and loss of hair follicle stem cells.  
As was shown for yeast and human, topoisomerase I could cleave at sites where 
ribonucleotides were inserted (Sekiguchi and Shuman, 1997; Kim et al., 2011). But 
topoisomerase I-mediated cleavage was shown to cause 2-5 bp deletions, increased 
dNTP levels and accumulation in the S and G2/M phase of the cell cycle. The 
consequences of topoisomerase I-mediated cleavage of ribonucleotides could not yet be 
shown for higher eukaryotes. It might likely be that topoisomerase I-mediated cleavage 
might generate a so far unknown DNA damage that allows for a limited number of cell 
divisions until a certain threshold of damage is reached that does not allow for further 
proliferation.  
 
4.3 The K14Cre+ Rnaseh2bFLOX/FLOX mouse could be a valuable mouse 
model for the investigation of SLE pathomechanisms 
Besides deletion of the Rnaseh2b gene in cells of the hematopoietic system, we also 
bred the Rnaseh2bFLOX mouse to a K14Cre-expressing mouse line. Keratin 14 (K14) is 
expressed in cells of the epidermal basal membrane, causing Cre-mediated deletion of 
the Rnaseh2b gene in the entire epidermis starting at day E12 of embryonic 
development (Vasioukhin et al., 2001). Unlike Rnaseh2bKOF/KOF mice, K14Cre+ 
Rnaseh2bFLOX/FLOX mice were viable and born at Mendelian ratios. K14Cre+ 
Rnaseh2bFLOX/FLOX mice soon developed a severe skin phenotype, manifesting as 
hyperpigmented skin limited to the tail, paws and ears, loss of hair and spontaneous skin 
ulcerations. Microscopically, increased thickness of the epidermis and dermis could be 
detected. While the epidermis was only modestly affected, K14Cre+ Rnaseh2bFLOX/FLOX 
mice displayed massive dermal alterations with interface dermatitis and fibrotic changes. 
In order to elucidate the molecular cause that accounted for the dramatic pathological 
changes in the skin of K14Cre+ Rnaseh2bFLOX/FLOX mice, like hyperpigmentation, hair loss 
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and fibrosis, we studied the literature and found data describing similar pathology for 
mouse models that were associated with DNA damage.  
Cui et al. investigated the regulative role of the tumor suppressor gene p53 in the 
process of hyperpigmentation upon UV light exposure (Cui et al., 2007), a phenomenon 
known as suntan response. They could demonstrate that UV light exposure caused DNA 
damage in the skin of mice, leading to DNA damage-induced activation of p53. DNA 
damage-induced activation of p53 led to its translocation into the nucleus where it 
activated the Pomc gene encoding for the melanin precursor pro-opiomelanocortin. As a 
consequence of increased pro-opiomelanocortin expression and the subsequent de 
novo synthesis of melanin, the skin of mice that were exposed to UV light became 
hyperpigmented. Sotiropoulou et al. generated a K14Cre-specific knockout of the Brca1 
gene (Sotiropoulou et al., 2013) . Breast cancer 1 (Brca1) encodes for an important 
transducer in the DNA damage repair pathway that is activated upon DNA double-strand 
breaks (Roy et al., 2011). BRCA1 mediates homologous recombination in the S and 
G2/M phase of the cell cycle (Moynahan et al., 1999). Mice deficient for the Brca1 gene 
in the epidermis were born hairless. Sotiropoulou et al. could demonstrate that BRCA1 
deficiency caused elevated p53 levels and increased DNA damage and apoptosis in the 
hair follicle of K14Cre+ Brca1FLOX/FLOX mice. Surprisingly, pathology could only be 
observed in the matrix cells of the lower hair follicle, while the pathology was absent in 
the upper hair follicle, the isthmus and the interfollicular epidermis (IFE). The authors 
concluded that increased apoptosis in Brca1-deficient matrix cells has led to the chronic 
activation of hair follicle stem cells that caused their exhaustion and subsequent hair loss 
(Sotiropoulou et al., 2013). Most importantly, p53-mediated hyperpigmentation as well as 
hair loss could both be prevented by concomitant deficiency for the p53 gene in both 
experimental settings, indicating the important role of the tumor suppressor gene p53 in 
the pathology associated to DNA damage. While p53-deficient mice did not display 
hyperpigmentation upon UV light exposure, K14Cre+ Brca1FLOX/FLOX p53-/- mice did not 
show any hair loss (Cui et al., 2007; Sotiropoulou et al., 2013). Based on the data from 
the literature and our own previous data we think that the pathology of K14Cre+ 
Rnaseh2bFLOX/FLOX mice might also be mediated by the tumor suppressor p53. Gene 
expression analysis of total skin from eight week-old K14Cre+ Rnaseh2bFLOX/FLOX mice 
revealed a profound p53 signature, as well as the upregulation of mediators of the DNA 
damage repair pathway (Chek1, Chek2 and Brca1). Concomitantly, genes clustering to 
the eumelanin synthesis pathway were significantly up-regulated. This data might 
indicate that hyperpigmentation in K14Cre+ Rnaseh2bFLOX/FLOX mice was also caused by 
a p53-mediated DNA damage response and hyperpigmentation in these mice can 
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therefore be regarded as a mimic of the suntan response observed in mice exposed to 
UV light. However, we cannot conclude if hyperpigmentation in the skin of K14Cre+ 
Rnaseh2bFLOX/FLOX mice was caused by increased melanin biosynthesis of residual 
melanocytes or whether it was caused by elevated numbers of melanocytes. 
Subsequent staining for melanocytes in skin sections from K14Cre+ Rnaseh2bFLOX/FLOX 
mice is needed to answer this question. Although we believe that RNase H2 deficiency 
caused systemic p53 activation, hyperpigmentation could only be observed in the skin of 
the tail, ears and paws. This observation can likely be explained by the restricted 
presence of melanocytes in the IFE of skin that is not covered with fur (Quevedo and 
Fleischmann, 1980). Due to their function to protect the deep skin layers from harmful 
radiation, melanocytes are completely absent in the IFE of skin that is protected from 
light by the fur. Therefore, systemic p53 activation in the skin of K14Cre+ 
Rnaseh2bFLOX/FLOX mice did not cause increased melanin biosynthesis outside the skin of 
the tail, ears and paws.  
Increased DNA damage and the p53 signature in K14Cre+ Rnaseh2bFLOX/FLOX mice might 
also explain the loss of hair in these mice. So far we were unable to detect increased 
DNA damage or elevated apoptosis rates in the skin of K14Cre+ Rnaseh2bFLOX/FLOX mice. 
However, FACS analysis of epidermal cells from 11-13 week-old K14Cre+ 
Rnaseh2bFLOX/FLOX mice revealed massive reduction of hair follicle stem cells and 
suprabasal hair follicle stem cells. So far we do not know whether reduction was caused 
by stem cell exhaustion in response to increased apoptosis of a certain hair follicle cell 
population.  
In line with the important role of p53, hyperpigmentation and hair loss was completely 
prevented by concomitant deletion of the p53 gene, indicating that the pathology in 
K14Cre+ Rnaseh2bFLOX/FLOX mice was mediated by p53 activity. K14Cre+ 
Rnaseh2bFLOX/FLOX mice with a heterozygous knockout of the p53 gene (K14Cre+ 
Rnaseh2bFLOX/FLOX p53+/-) showed intermediate pigmentation when compared to K14Cre+ 
Rnaseh2bFLOX/FLOX mice and wild type mice, showing that half levels of p53 caused 
already an amelioration of the skin phenotype in respect to the hyperpigmentation. 
K14Cre+ Rnaseh2bFLOX/FLOX p53-/- mice (n=4) that were so far born were almost 
indistinguishable from their wild type littermate controls within the first few weeks of age. 
With about 12 weeks, K14Cre+ Rnaseh2bFLOX/FLOX p53-/- mice appeared sick and showed 
macroscopical skin alterations (n=3) and the development of cancer (n=1). K14Cre+ 
Rnaseh2bFLOX/FLOX p53-/- mice did not display massive hair loss until the age of 12 weeks, 
at a time point where K14Cre+ Rnaseh2bFLOX/FLOX mice have already lost most of the 
dorsal fur. However, selective loss of hair could be observed in the neck, most likely as a 
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consequence of increased scratching. We could also observe tumor formation in 
K14Cre+ Rnaseh2bFLOX/FLOX p53+/- mice, appearing in older mice and significant 
incidence. Therefore, our data might show for the first time that RNase H2 deficiency 
may promote tumor formation as it was already suggested due to the mutator phenotype 
observed in RNase H2-deficient yeast (Crow et al., 2006b). Further studies, will provide 
information about kinetics and incidences of tumor formation as well as a detailed 
description of the tumor species. 
According to our data, reduced hair follicle stem cells and suprabasal hair follicle stem 
cells might also be a consequence of the interface dermatitis observed in the skin of 7 
week-old K14Cre+ Rnaseh2bFLOX/FLOX mice. The pathology of interface dermatitis 
manifests at the dermo-epidermal junction and is caused by a leukocyte infiltration 
(mainly cytotoxic T lymphocytes) that leads to apoptosis of keratinocytes and 
vacuolization of basal cells (Joshi, 2013). Therefore, leukocyte infiltration located in 
proximity of the bulge region of the hair follicle might cause the destruction of the hair 
follicle stem cells in the bulge region. This discrete leukocyte infiltration restricted to the 
hair follicle and consisting of only few numbers of infiltrating leukocytes (cell-poor 
infiltrate) is typically observed but not specific for human patients suffering from 
cutaneous lupus erythematosus (CLE) (Sontheimer, 2009b). Together with the data 
showing a possible type I interferon response (see Figure 3.20) in the skin of K14Cre+ 
Rnaseh2bFLOX/FLOX mice, our data might show for the first time a lupus-like phenotype in a 
mouse model for RNase H2 deficiency. However, since gene expression analysis of total 
skin from eight week-old mice did not reveal the upregulation of type I interferon-
stimulated genes further investigations are needed to prove this hypothesis. Since we 
detected increased Sca1 surface expression on epidermal leukocytes, epidermal 
leukocytes might be a promising target of detailed analysis to test for the expression of a 
type I interferon response. Due to their low frequency in the epidermis, a type I interferon 
signature deriving from these cells might be likely diluted by the large number epidermal 
keratinocytes. Moreover, type I interferon expression might be limited to only a certain 
cell type of epidermal hematopoietic cells, like Langerhans cells, that have a very low 
frequency of total epidermal cells and type I interferon of these cells might likely be even 
more diluted and therefore even more difficult to detect. 
Along with hyperpigmentation and loss of hair, K14Cre+ Rnaseh2bFLOX/FLOX mice 
displayed fibrosis characterized by increased dermal thickness and concomitant tight 
package of dermal structures. Immunohistochemistry demonstrated increased collagen 
deposition and leukocyte infiltration in the dermis. We wondered why the deficiency for 
the RNase H2 enzyme in the epidermis caused fibrosis in the dermis. Data from human 
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patients suffering from idiopathic pulmonary fibrosis provided important insights in 
understanding the molecular mechanisms that could have caused fibrosis in K14Cre+ 
Rnaseh2bFLOX/FLOX mice. Idiopathic pulmonary fibrosis belongs to a family of diseases 
that is collectively termed ‘telomere syndromes’ and that further encompasses 
diskeratosis congenita and aplastic anemia (Armanios and Blackburn, 2012). Pathology 
in ‘telomere syndromes’ is caused by mutations in the genes encoding for the 
telomerase reverse transcriptase (TERT), the RNA component (TR) as well as dyskerin 
(DKC1). Collectively, the products of these three genes represent important components 
of the telomerase complex, an important enzyme that maintains the DNA-protein 
complex at the chromosomal ends, termed the telomere (Nandakumar and Cech, 2013). 
Due to the inability of the replication machinery to duplicate the DNA at the chromosomal 
ends, replication would inevitably cause the shortening of those. Thus, telomerase 
activity prevents the shortening of the telomeres by adding tandem repeats of six 
nucleotides (TTAGGG) during S and G2 phase of the cell cycle. Deficiency for the 
telomerase enzyme was shown trigger replicative senescence, a state in which cells 
maintain metabolic functions but remain in G0 of the cell cycle. Moreover, telomere-
initiated senescent cells display a DNA damage response similar to the DNA damage 
response observed in cells treated with ionizing radiation (d'Adda di Fagagna et al., 
2003). It is characterized by phosphorylation of the DNA damage sensors ATM and 
ATR, the downstream signal transducers CHK1 and CHK2 as well as the mediator 
histone 2AX (H2AX). It is believed that the chronic DNA damage response in telomere-
initiated senescent cells might cause increased stem cell activation and subsequent 
exhaustion of those, due their limited proliferation capacity. Senescence and apoptosis 
of epidermal cells in IPF patients stimulate remodeling of the lung tissue that manifests 
as fibrosis. However, mice with short telomeres did not initially display lung disease or 
fibrosis and a second hit (i.e. exposure to cigarette smoke) was necessary to induce lung 
fibrosis (Armanios, 2012). The need for the second hit might indicate that increased cell 
proliferation, i.e. a high cell turnover, is needed in addition to the shortened telomeres for 
the development of fibrosis (Pardo and Selman, 2002) 
According to the pathology in IPF patients, fibrosis in K14Cre+ Rnaseh2bFLOX/FLOX mice 
might be a consequence of increased DNA damage and subsequent apoptosis of RNase 
H2-deficient epidermal cells. As discussed earlier, so far we could not detect increased 
DNA damage or elevated apoptosis in these cells, but reduction of hair follicle stem cell 
numbers might be a consequence of increased DNA damage in these cells. As in IPF 
patients, DNA damage and apoptosis might likely cause stem cell exhaustion. Therefore, 
RNase H2 deficiency might also cause exhaustion of interfollicular epidermis stem cells 
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and subsequent remodeling of the underlying dermis. We cannot conclude whether a 
second trigger for the generation of fibrosis was needed in K14Cre+ Rnaseh2bFLOX/FLOX 
mice. It might be that the DNA damage response itself, being stronger than the DNA 
damage response in telomere-initiated senescent cells, might have caused fibrosis and a 
second hit was not necessary. Finally, it might be that there was already an unknown 
second trigger for the generation of fibrosis, like a barrier defect. Pathologic changes in 
the dermis could also be a consequence of an impaired barrier function of the epidermis 
in K14Cre+ Rnaseh2bFLOX/FLOX mice. Reduced barrier function of the epidermis might 
result from impaired keratinocyte function that is caused by the chronic DNA damage 
and apoptosis. To develop and maintain the barrier function of the skin, it is important 
that epidermal keratinocytes have the capability to differentiate from the epidermal stem 
cell that is located in the basal membrane to cells of the stratum granulosum and cells of 
the stratum corneum that represent the outer most body layers and thus have an 
important protective function. In order to maintain barrier function, cells of the stratum 
granulosum need to form tight junctions to adjacent cells, creating a strong physical and 
mechanical barrier for invading pathogens and other substances but also to avoid 
transepidermal water loss. Reduced barrier function in K14Cre+ Rnaseh2bFLOX/FLOX mice 
could therefore be a result of the inability of DNA damage-containing keratinocytes to 
differentiate to cells of the stratum granulosum and stratum corneum, but also by 
impaired formation of tight junctions between keratinocytes in the stratum granulosum.  
 
Based on the above findings, we propose the K14Cre x Rnaseh2bFLOX mouse line as a 
new model for fibrotic diseases (Fig. 4.3). Central to this model is the epidermis-specific 
deletion of the Rnaseh2b gene that leads to increased ribonucleotide loads in the 
genomic DNA causing a chronic p53-mediated DNA damage response. However, we do 
not know yet, why the deficiency for the RNase H2 enzyme in the epidermis leads to 
massive alterations in the dermis.  
We hypothesize that the DNA damage response in RNase H2-deficient epidermal 
keratinocytes leads to increased apoptosis of these cells. As one potential consequence, 
quiescent, non-cycling epidermal stem cells might be activated in order to compensate 
for dying cells and to maintain skin function. Due to the chronicity of the DNA damage 
and the subsequent persistent apoptosis of RNase H2-deficient cells, epidermal stem 
cells might exhaust, causing the remodeling of the underlying tissue as in IPF patients. 
Concomitant leukocyte infiltration might be independent of the remodeling in this setting. 
As another consequence of the chronic DNA damage and persistent apoptosis in RNase 
H2-deficient epidermal cells, epidermis might lose its important barrier function. Loss of 
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the barrier function would allow for the penetration of pathogens or other stimulatory 
substances that could elicit an 
could subsequently result in the remodeling of the dermis induced by increased collagen 
production by dermal fibroblasts. As another possibility, fibrosis of the dermis could be a 
consequence of the interface dermatitis. Althou
interface dermatitis is not yet completely understood, interface dermatitis goes along with 
inflammation. Leukocyte infiltration in the bulge region of the hair follicle might cause T 
cell-mediated destruction of 
leukocyte infiltration and stem cell destruction might cause remodeling of the dermis.
However, subsequent studies will help to elucidate the pathomechanisms that causes 
dermal fibrosis in response to the deficiency for the RNase H2 enzyme in the epidermis.
 
Figure 4.3: The K14Cre+ Rnaseh2b
Deficiency for the RNase H2 in the epidermis causes the accumulation of genomic 
ribonucleotides that induces a p53
massive alterations occur in the dermis that manifest as dermal fibrosis, characterized by 
increased collagen deposition and concomitant mild inflammation. However, the origins of the 
phenotypic changes detected in the skin of 
understood so far. Several pathomechanisms could in theory lead to the fibrotic changes of the 
dermis and further studies are needed for their elucidation.
 
4.4 Future perspectives
Our data has shown that deficiency for the RNase H2 enzyme leads to the accumulation 
and persistence of ribonucleotides in the genomic DNA. By rendering the DNA sensitive 
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inflammatory immune response. Chronic inflammation 
gh the exact origin for the development of 
hair follicle stem cells and the loss of hair. Collectively, 
 
FLOX/FLOX mouse, a new mouse model for fibrosis.
-mediated DNA damage response. As a consequence, 
K14Cre+ Rnaseh2bFLOX/FLOX mice
 
 
 
 
 
 are not completely 
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to DNA strand breaks, by the imperfect removal mediated by the topoisomerase I or by a 
so far unknown mechanism, ribonucleotides cause a p53-mediated DNA damage 
response. Our data implicates that the impact of RNase H2 deficiency is linked to the 
number of cell divisions, suggesting that a so far unknown DNA damage species 
accumulates during each round of proliferation. One important future aim will be to 
characterize this DNA damage species. So far we were just able to detect the 
consequences of the DNA damage that are caused by the persistence of genomic 
ribonucleotides. Our future experiments will therefore focus on the elucidation of the 
initial damage and the DNA damage repair pathway that is activated upon the damage. 
To this end, we would like to perform Western Blot analysis of total proteins obtained 
from cells that display impaired proliferation, loss of function and lethality after a period 
of normal growth and function. As mentioned above, since members of the different DNA 
damage repair pathways are regulated by posttranscriptional modifications, we would 
like to stain for phosphorylated members of distinct DNA repair pathways. Western Blot 
analysis should help us to elucidate whether persistent ribonucleotides cause the 
generation of single-strand breaks, double-strand breaks or any other species of DNA 
damage. We hope that the species of DNA damage might help us to understand how 
this damage can accumulate and why it is not efficiently repaired or why it is not repaired 
at all. Knowing the exact DNA damage would allow the investigation of the respective 
DNA damage checkpoint, whether it is active or inactive. To address the same question 
we would also like to perform gene expression analysis of the same cells. Although, 
gene expression analysis can only provide information about the deregulation of genes 
and is not suitable to detect posttranscriptional modifications, it provides information 
about the transcriptional regulation of the entire genome. This large overview might allow 
for the detection of deregulated genes that are not member of a DNA damage repair 
pathway, but might play a role in the pathology.  
Another future aim will be to elucidate the pathology in K14Cre+ Rnaseh2bFLOX/FLOX mice. 
So far we do not know why the absence of the RNase H2 enzyme in keratinocytes 
causes the complex pathology in the skin of these mice. Beside massive alterations in 
the epidermis, we also detected massive transformation of the dermis. Although we 
performed gene expression analysis of RNA from total skin of eight week-old K14Cre+ 
Rnaseh2bFLOX/FLOX mice and of RNA from the epidermis of K14Cre+ Rnaseh2bFLOX/FLOX 
newborn mice, we do not know yet the mechanism that is responsible for the pathology. 
Gene expression analysis of the epidermis from newborn mice demonstrated that RNase 
H2 deficiency has yet only a mild effect on the homeostasis of the epidermis, indicated 
by a low number of deregulated genes and the absence of a DNA damage response that 
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could be observed so far in all other assays. Genes with functions in cell metabolism and 
the de novo synthesis of melanin were found to be up-regulated, most likely reflecting 
increased proliferation and hyperpigmentation of the skin. Gene expression analysis of 
total skin from K14Cre+ Rnaseh2bFLOX/FLOX mice provided more information, displaying a 
p53-mediated DNA damage response similar that found in the gene expression profile of 
fetal liver cells from Rnaseh2bKOF/KOF mice. As discussed above, we could also found 
genes to be up-regulated that are important mediators of a DNA damage response upon 
DNA single- and double-strand breaks. Due to their overlap and their posttranscriptional 
regulation, we cannot conclude if their transcriptional upregulation is reflecting their 
activation, but hope to answer this question by Western Blot analysis. The fibrotic 
phenotype in the dermis of K14Cre+ Rnaseh2bFLOX/FLOX mice might also be a 
consequence of a barrier defect caused by the p53-mediated DNA damage response. 
Future experiments will focus on the detection of trans-epidermal water loss as indication 
of a barrier defect. So far, we could not detect increased trans-epidermal water loss in 
newborn K14Cre+ Rnaseh2bFLOX/FLOX mice, but we suggest detecting increased trans-
epidermal water loss in older mice that already display massive epidermal changes like 
hair loss and spontaneous ulcerations. In this case we will have to demonstrate what 
causes the barrier defect. To this end, we will check for the layer-specific expression of 
various keratins and loricrin by staining of histological skin sections. This staining 
furthermore allows for the evaluation of the proper expression and function of the 
different epidermal cell layers. Additionally, we will also determine the cell death rate in 
the epidermis. Since we have observed a massive increase in cell proliferation by Ki67 
staining, we are also expecting higher levels of cell death to compensate for increased 
cell proliferation. In case cell death exceeds cell proliferation, increased rates of cell 
death would likely explain a barrier defect and the spontaneous ulcerations. Of particular 
value will also be K14Cre+ Rnaseh2bFLOX/FLOX p53-/- mice, since they will demonstrate the 
consequences of RNase H2 deficiency independent of a p53-mediated DNA damage 
response. As one double knockout already showed, hyperpigmentation and hair loss are 
completely absent in these mice and microscopical alterations are less pronounced as in 
K14Cre+ Rnaseh2bFLOX/FLOX mice. Moreover, concomitant deletion of the Rnash2b gene 
and the p53 gene in the epidermis caused cancer formation, indicating that RNase H2 
deficiency could render mice prone to develop cancer, as it was already suggested from 
studies in yeast. However, to evaluate the consequences of concomitant p53 deficiency 
needs further investigation of more double knockout mice. 
Finally, we aim to investigate the consequences of heterozygous deletion of the 
Rnaseh2b and Rnaseh2c gene, respectively. As described earlier for human AGS 
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patients, mutations in any of the three genes encoding for the RNase H2 enzyme cause 
a partial loss of function instead of the complete inactivation. Therefore we hope that a 
reduction of the transcript levels of the Rnaseh2b and Rnaseh2c gene by 50% might be 
a better mouse model for AGS. Although we have not observed any spontaneous 
phenotype in these mice, we still think that these mice could be a valuable tool to study 
AGS pathology. Based on our recent findings we think that cells of Rnaseh2bWT/KOF or 
Rnaseh2c+/- mice need to be challenged by increased proliferation rates to display AGS 
pathology. Therefore we aim to perform repetitive transfers of bone marrow from 
Rnaseh2bWT/KOF or Rnaseh2c+/- mice versus control mice. A pilot experiment already 
showed a growth disadvantage of Rnaseh2c+/- bone marrow cells after the third repetitive 
transfer, when compared to wild type controls. These cells would also be a valuable tool 
to investigate by Western Blot analysis or gene expression analysis.  
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6 Appendix 
Table 6.1: List of deregulated genes from a gene expression analysis of total skin 
from K14Cre RNaseh2bFLOX mice.  
Deregulated genes with a fold change ≥1.5 and p ≤ 0.05 are displayed.  
Probe Set ID p (corr) p FC (abs) 
 
Regulation Gene Symbol 
        
1450468_at 0.011078357 1.71E-05 7.58   down Myoc 
1436279_at 0.022228211 9.73E-05 7.06 down Slc26a7 
1458268_s_at 0.010874013 1.64E-05 6.38 down Igfbp3 
1423062_at 0.005604662 3.41E-06 5.97 down Igfbp3 
1444451_at 0.022921821 1.05E-04 5.39 down Pappa2 
1419473_a_at 0.02003716 6.84E-05 3.62 down Cck 
1438641_x_at 0.011341926 1.94E-05 3.10 down Fam57b 
1434667_at 0.045409087 4.64E-04 2.71 down Col8a2 
1452807_s_at 0.03454647 2.40E-04 2.53 down Fam57b 
1416693_at 0.022214346 9.63E-05 2.37 down Foxc2 
1417633_at 0.02437203 1.21E-04 2.13 down Sod3 
1417343_at 0.04192272 3.99E-04 2.04 down Fxyd6 
1437937_at 0.039222952 3.25E-04 1.98 down Ccbp2 
1417070_at 0.040957343 3.72E-04 1.95 down Cyp4v3 
1416968_a_at 0.04904834 5.46E-04 1.84 down Hsd3b7 
1460346_at 0.02909892 1.59E-04 1.71 down Arsa 
1448167_at 0.016263928 4.52E-05 1.70 down Ifngr1 
1424029_at 0.047810193 5.20E-04 1.69 down Tspyl4 
1417634_at 0.047810193 5.16E-04 1.68 down Sod3 
1435212_at 0.037562784 2.78E-04 1.67 down P2rx2 
1454104_a_at 0.042330243 4.09E-04 1.66 down Slc16a9 
1454015_a_at 0.011341926 2.12E-05 1.66 down Cdh13 
1429206_at 0.005308266 2.58E-06 1.60 down Rhobtb1 
1448613_at 0.03926199 3.45E-04 1.58 down Ecm1 
1427773_a_at 0.04627189 4.82E-04 1.55 down Rabac1 
1425093_at 0.024503976 1.23E-04 1.55 down P2rx3 
1439038_at 0.043363128 4.28E-04 1.54 down Khnyn 
1421867_at 0.043392874 4.30E-04 1.52 down Nr3c1 
1460319_at 0.033932794 2.23E-04 1.52 down Fut8 
1422803_at 0.039040215 3.17E-04 1.51 down Fstl3 
1457097_at 0.033932794 2.31E-04 1.50   down Skap2 
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Probe Set ID p (Corr)  p  FC (abs)   Regulation Gene Symbol 
    
 
  
  
  
1418173_at 1.99E-04 1.09E-08 248..75   up Krt25 
1449378_at 0.003385193 7.46E-07 101.10 up Krt27 
1436557_at 0.012015101 2.35E-05 57.28 up Krt73 
1434425_at 0.002337471 3.86E-07 41.67 up Tchh 
1448457_at 0.003963769 9.82E-07 34.72 up Krt71 
1419507_at 0.045409087 4.63E-04 30.91 up Krtap15 
1427211_at 0.039222952 3.33E-04 30.13 up Krtap8-1 
1419767_at 0.009040871 8.26E-06 21.03 up Padi3 
1439100_s_at 0.048752893 5.37E-04 21.00 up Krtap11-1 
1417717_a_at 0.009040871 9.72E-06 19.30 up Tyr 
1430132_at 0.017622245 5.49E-05 18.92 up Krt28 
1453214_at 0.020978615 7.78E-05 15.98 up Lrrc15 
1429835_at 0.03164906 1.92E-04 15.78 up 2310033E01Rik 
1448470_at 0.02873153 1.57E-04 15.61 up Fbp1 
1415861_at 0.005604662 3.55E-06 15.60 up Tyrp1 
1436869_at 0.03336487 2.15E-04 14.92 up Shh 
1456901_at 0.005604662 3.24E-06 14.83 up Adamts20 
1415862_at 0.02759537 1.48E-04 14.71 up Tyrp1 
1415844_at 0.002337471 3.32E-07 12.58 up Syt4 
1422523_at 0.017685393 5.78E-05 12.46 up Pmel 
1423271_at 0.012675797 2.64E-05 11.84 up Gjb2 
1420409_at 0.032779336 2.04E-04 11.58 up Krt35 
1439409_x_at 0.009040871 1.17E-05 11.51 up Tyrp1 
1430635_at 0.037410703 2.72E-04 11.30 up Mlana 
1419709_at 0.020978615 7.79E-05 11.27 up Stfa3 
1436055_at 0.03153318 1.90E-04 10.94 up Lrrc15 
1421856_at 0.045342103 4.58E-04 10.79 up S100a3 
1415845_at 0.009040871 1.01E-05 10.66 up Syt4 
1435761_at 0.039222952 3.29E-04 10.34 up BC100530///Stfa1 
1460185_at 0.017685393 5.67E-05 8.67 up Krt85 
1418028_at 0.009040871 8.75E-06 8.59 up Dct 
1435639_at 0.02386954 1.16E-04 8.04 up 2610528A11Rik 
1417422_at 0.017330242 5.22E-05 6.78 up Gnmt 
1448397_at 0.004339723 1.56E-06 6.45 up Gjb6 
1418935_at 0.037357025 2.71E-04 6.40 up Trpm1 
1448485_at 0.020881187 7.48E-05 6.08 up Ggt1 
1448752_at 0.039040215 3.15E-04 5.82 up Car2 
1437445_at 0.016128201 4.34E-05 5.43 up Trpm1 
1419152_at 0.016128201 4.40E-05 5.25 up 2810417H13Rik 
1438752_at 0.03390757 2.20E-04 5.23 up A230058F20Rik 
1423952_a_at 0.023398947 1.12E-04 4.95 up Krt7 
1455540_at 0.03560491 2.49E-04 4.87 up Cps1 
1450618_a_at 0.048919447 5.43E-04 4.55 up Sprr2a1///Sprr2a2 
1427372_at 0.039040215 3.16E-04 4.44 up Cyp27b1 
1428304_at 0.017622245 5.58E-05 4.32 up Esco2 
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1424629_at 0.03114012 1.87E-04 4.32 up Brca1 
1419153_at 0.022214346 9.67E-05 4.23 up 2810417H13Rik 
1418211_at 0.036173876 2.58E-04 4.20 up Oca2 
1424046_at 0.004339723 1.83E-06 4.13 up Bub1 
1429171_a_at 0.008196097 6.32E-06 4.12 up Ncapg 
1437540_at 0.013930823 3.30E-05 4.06 up Mcoln3 
1424292_at 0.009040871 1.15E-05 3.88 up Depdc1a 
1416686_at 0.041561574 3.83E-04 3.80 up Plod2 
1415810_at 0.04192272 3.99E-04 3.78 up Uhrf1 
1424118_a_at 0.015429875 3.95E-05 3.65 up Spc25 
1434240_at 0.02146454 8.58E-05 3.59 up 4632434I11Rik 
1448754_at 0.042233054 4.05E-04 3.59 up Rbp1 
1452954_at 0.017622245 5.58E-05 3.58 up Ube2c 
1416802_a_at 0.029505746 1.66E-04 3.57 up Cdca5 
1416687_at 0.04400499 4.41E-04 3.53 up Plod2 
1426817_at 0.011992623 2.28E-05 3.43 up Mki67 
1448205_at 3.74E-04 3.09E-08 3.38 up Ccnb1///Gm5593 
1435306_a_at 0.003385193 7.06E-07 3.33 up Kif11 
1435281_at 0.01274057 2.72E-05 3.31 up Cpt1c 
1417323_at 0.014069148 3.45E-05 3.31 up Psrc1 
1425916_at 0.014069148 3.43E-05 3.31 up Capn8 
1424278_a_at 0.02146454 8.25E-05 3.27 up Birc5 
1417938_at 0.009040871 1.08E-05 3.22 up Rad51ap1 
1452458_s_at 0.009275186 1.28E-05 3.21 up Lrr1 
1454694_a_at 0.023398947 1.12E-04 3.21 up Top2a 
1439040_at 0.014494368 3.63E-05 3.21 up Cenpe 
1418203_at 0.02146454 8.47E-05 3.18 up Pmaip1 
1448314_at 0.018790066 6.25E-05 3.18 up Cdk1 
1433893_s_at 0.02146454 8.52E-05 3.10 up Spag5 
1452242_at 1.41E-04 3.87E-09 3.07 up Cep55 
1424128_x_at 0.012992521 2.93E-05 3.04 up Aurkb 
1418026_at 0.022541879 1.01E-04 3.04 up Exo1 
1419127_at 0.022199633 9.32E-05 3.04 up Npy 
1416558_at 0.016974647 4.85E-05 3.02 up Melk 
1427161_at 0.009040871 1.11E-05 2.99 up Cenpf 
1439377_x_at 0.007017641 5.22E-06 2.99 up Cdc20 
1438009_at 0.023104781 1.06E-04 2.98 up Hist1h2ab 
1417910_at 0.011341926 2.10E-05 2.97 up Ccna2 
1450842_a_at 0.015196107 3.85E-05 2.95 up Cenpa 
1418281_at 0.006813805 4.88E-06 2.95 up Rad51 
1435005_at 0.020916197 7.55E-05 2.91 up Cenpe 
1451246_s_at 0.022907764 1.04E-04 2.91 up Aurkb 
1416299_at 3.81E-04 4.19E-08 2.89 up Shcbp1 
1439019_at 0.037562784 2.77E-04 2.88 up Fras1 
1416309_at 0.006567447 4.52E-06 2.85 up Nusap1 
1436808_x_at 0.033932794 2.32E-04 2.85 up Mcm5 
1416757_at 0.012675797 2.65E-05 2.85 up Zwilch 
1450920_at 0.036173876 2.59E-04 2.84 up Ccnb2 
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1452314_at 0.012992521 2.93E-05 2.83 up Kif11 
1448627_s_at 0.02146454 8.47E-05 2.83 up Pbk 
1434748_at 0.012912958 2.81E-05 2.81 up Ckap2 
1449133_at 0.029163785 1.61E-04 2.79 up Sprr1a 
1437611_x_at 0.016974647 4.86E-05 2.75 up Kif2c 
1428105_at 0.03767577 2.90E-04 2.75 up Tpx2 
1432453_a_at 0.026208734 1.38E-04 2.74 up Ms4a10 
1419323_at 0.026782457 1.42E-04 2.73 up Padi1 
1448635_at 0.009040871 1.17E-05 2.70 up Smc2 
1417541_at 0.034454297 2.38E-04 2.70 up Hells 
1434767_at 0.014069148 3.44E-05 2.70 up Mis18bp1 
1421594_a_at 0.030217253 1.78E-04 2.70 up Sytl2 
1449207_a_at 0.046111293 4.78E-04 2.67 up Kif20a 
1447363_s_at 0.02576449 1.35E-04 2.67 up Bub1b 
1421546_a_at 0.020818172 7.40E-05 2.65 up Racgap1 
1422430_at 0.041895613 3.91E-04 2.65 up Fignl1 
1434278_at 0.017622245 5.39E-05 2.64 up Mtm1 
1437716_x_at 0.009275186 1.29E-05 2.62 up Kif22 
1447040_at 0.039222952 3.24E-04 2.61 up   
1458374_at 0.017685393 5.80E-05 2.61 up Mis18bp1 
1416118_at 0.03767577 2.90E-04 2.60 up Trim59 
1419943_s_at 0.023398947 1.13E-04 2.60 up Ccnb1///Gm5593 
1423847_at 0.04067832 3.66E-04 2.60 up Ncapd2 
1437580_s_at 0.04688727 4.89E-04 2.59 up Nek2 
1418334_at 0.016002957 4.19E-05 2.59 up Dbf4 
1429734_at 0.023377985 1.09E-04 2.58 up 4632434I11Rik 
1436707_x_at 0.015452961 4.00E-05 2.56 up Ncaph 
1441693_at 0.011078357 1.77E-05 2.55 up Adamts3 
1427707_a_at 0.008415986 6.95E-06 2.55 up Stil 
1456280_at 0.02534305 1.29E-04 2.54 up Clspn 
1428104_at 0.047810193 5.23E-04 2.53 up Tpx2 
1455609_at 0.009275186 1.30E-05 2.53 up Cit 
1416076_at 0.04192272 3.97E-04 2.49 up Ccnb1///Gm5593 
1416342_at 0.02576449 1.35E-04 2.49 up Tnc 
1449877_s_at 0.013691212 3.20E-05 2.48 up Kifc1 
1435575_at 0.016263928 4.52E-05 2.48 up Kntc1 
1416664_at 0.025420498 1.31E-04 2.48 up Cdc20 
1431087_at 0.04949901 5.58E-04 2.46 up Spc24 
1437187_at 0.010408515 1.49E-05 2.46 up E2f7 
1419513_a_at 0.033932794 2.33E-04 2.46 up Ect2 
1437370_at 0.005472912 2.86E-06 2.44 up Sgol2 
1422460_at 0.02146454 8.28E-05 2.43 up LOC100045924///Mad2l1 
1417019_a_at 0.03560491 2.50E-04 2.38 up Cdc6 
1439510_at 0.011341926 2.00E-05 2.37 up Sgol1 
1434280_at 0.046918575 4.91E-04 2.36 up   
1456593_at 0.013691212 3.20E-05 2.36 up   
1449708_s_at 0.029257255 1.64E-04 2.35 up Chek1 
1422814_at 0.009040871 9.54E-06 2.35 up Aspm 
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1428481_s_at 0.02873153 1.56E-04 2.34 up Cdca8 
1418264_at 0.016974647 4.79E-05 2.34 up Cenpk 
1436847_s_at 0.011341926 2.08E-05 2.33 up Cdca8 
1425815_a_at 0.004339723 1.77E-06 2.33 up Hmmr 
1416666_at 0.008734481 7.46E-06 2.32 up Serpine2 
1445298_at 0.009040871 1.16E-05 2.31 up   
1434437_x_at 0.03767577 2.90E-04 2.31 up Rrm2 
1454904_at 0.030217253 1.77E-04 2.30 up Mtm1 
1444416_at 0.037562784 2.78E-04 2.30 up Cenpa 
1453226_at 0.011341926 1.95E-05 2.30 up Kif18b 
1448113_at 0.045409087 4.63E-04 2.28 up Stmn1 
1436186_at 0.020978615 7.80E-05 2.27 up E2f8 
1449064_at 0.039040215 3.16E-04 2.27 up Tdh 
1433408_a_at 0.041561574 3.83E-04 2.26 up Mcm10 
1433583_at 0.039222952 3.42E-04 2.26 up Zfp365 
1419539_at 0.033932794 2.24E-04 2.25 up Irx4 
1423524_at 0.012675797 2.63E-05 2.25 up Mastl 
1439436_x_at 0.004339723 1.31E-06 2.23 up Incenp 
1422462_at 0.012574891 2.53E-05 2.23 up Ube2t 
1417450_a_at 0.022214346 9.65E-05 2.23 up Tacc3 
1443230_at 0.03771621 2.97E-04 2.22 up   
1417587_at 0.03167863 1.94E-04 2.22 up Timeless 
1449699_s_at 0.024215348 1.19E-04 2.22 up C330027C09Rik 
1430811_a_at 0.040133316 3.56E-04 2.21 up Nuf2 
1452287_at 0.032973 2.10E-04 2.20 up Msi1 
1439695_a_at 0.012992521 2.86E-05 2.20 up Kif20b 
1437033_a_at 0.004339723 1.71E-06 2.20 up Skp2 
1416961_at 0.03767577 2.83E-04 2.19 up Bub1b 
1437251_at 0.029840494 1.72E-04 2.18 up Cdca2 
1424511_at 0.02146454 8.59E-05 2.17 up Aurka 
1415860_at 0.011341926 2.03E-05 2.16 up Kpna2 
1456482_at 0.017155636 5.05E-05 2.15 up Pik3r3 
1429172_a_at 0.029731033 1.69E-04 2.13 up Ncapg 
1429660_s_at 0.009040871 9.06E-06 2.13 up Smc2 
1415978_at 0.0453028 4.55E-04 2.13 up Tubb3 
1449324_at 0.022285804 9.82E-05 2.12 up Ero1l 
1424268_at 0.033932794 2.30E-04 2.11 up Smox 
1450862_at 0.039222952 3.29E-04 2.11 up Rad54l 
1429295_s_at 0.033932794 2.31E-04 2.10 up Trip13 
1441757_at 0.010874013 1.63E-05 2.10 up 1190002F15Rik 
1443086_at 0.039040215 3.12E-04 2.09 up Alcam 
1441991_at 0.039222952 3.42E-04 2.07 up Prss53 
1418969_at 0.032779336 2.05E-04 2.07 up Skp2 
1420081_s_at 0.021874292 8.92E-05 2.06 up D2Ertd750e 
1423092_at 0.037506506 2.75E-04 2.04 up Incenp 
1417926_at 0.011992623 2.31E-05 2.03 up Ncapg2 
1455990_at 0.029624688 1.67E-04 2.03 up Kif23 
1424766_at 0.009040871 1.11E-05 2.03 up Ercc6l 
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1419030_at 0.048919447 5.42E-04 2.02 up Ero1l 
1422513_at 0.04067832 3.66E-04 2.01 up Ccnf 
1418919_at 0.005308266 2.63E-06 2.01 up Sgol1 
1428518_at 0.033932794 2.32E-04 2.01 up Mlf1ip 
1433543_at 0.023398947 1.12E-04 1.99 up Anln 
1451377_a_at 0.030590737 1.81E-04 1.99 up Aaas 
1426300_at 0.024503976 1.22E-04 1.98 up Alcam 
1460247_a_at 0.017155636 5.01E-05 1.98 up Skp2 
1415878_at 0.017622245 5.50E-05 1.98 up Rrm1 
1424221_at 0.027517257 1.46E-04 1.97 up Susd4 
1415849_s_at 0.03767577 2.87E-04 1.96 up Stmn1 
1426301_at 0.023192793 1.07E-04 1.95 up Alcam 
1425416_s_at 0.022199633 9.35E-05 1.95 up Psrc1 
1419156_at 0.045885 4.73E-04 1.95 up Sox4 
1437466_at 0.039040215 3.13E-04 1.94 up Alcam 
1433988_s_at 0.013006523 2.97E-05 1.94 up C230098O21Rik 
1436174_at 0.016128201 4.39E-05 1.94 up Atad2 
1431893_a_at 0.032779336 2.06E-04 1.94 up Pdss1 
1438434_at 0.017685393 5.75E-05 1.94 up Arhgap11a 
1455188_at 0.036307853 2.61E-04 1.94 up Ephb1 
1418108_at 0.039222952 3.35E-04 1.93 up Rtkn2 
1416854_at 0.029163785 1.62E-04 192 up Slc34a2 
1439269_x_at 0.028265612 1.53E-04 1.91 up Mcm7 
1430193_at 0.022541879 1.01E-04 1.91 up Casc5 
1417125_at 0.03771621 2.95E-04 1.90 up Ahcy 
1455049_at 0.043249365 4.21E-04 1.89 up Igsf3 
1434564_at 0.04192272 3.99E-04 1.89 up E2f3 
1443354_at 0.01274057 2.74E-05 1.89 up   
1426002_a_at 0.041561574 3.81E-04 1.87 up Cdc7 
1460593_at 0.020818172 7.39E-05 1.87 up Susd4 
1423463_a_at 0.022214346 9.54E-05 1.85 up D2Ertd750e 
1449345_at 0.011078357 1.77E-05 1.85 up Ccdc34 
1419838_s_at 0.025420498 1.31E-04 1.85 up Plk4 
1433807_at 0.03924884 3.44E-04 1.84 up 6720463M24Rik 
1416563_at 0.005836203 3.86E-06 1.83 up Ctps 
1416969_at 0.03767577 2.86E-04 1.82 up Gtse1 
1422768_at 0.01429238 3.54E-05 1.82 up Syncrip 
1444646_at 0.033334363 2.14E-04 1.81 up Bnc2 
1432591_at 0.012281142 2.44E-05 1.80 up Pappa 
1448821_at 0.017330242 5.25E-05 1.80 up Tyr 
1452098_at 0.039622713 3.49E-04 1.80 up Chtf18 
1449170_at 0.009040871 8.26E-06 1.80 up Piwil2 
1438063_at 0.03767577 2.86E-04 1.80 up Mphosph9 
1455790_at 0.009090032 1.20E-05 1.78 up E2f2 
1436532_at 0.040570073 3.63E-04 1.78 up Dclk3 
1459741_x_at 0.022519425 9.98E-05 1.76 up Ucp2 
1439394_x_at 0.03873198 3.07E-04 1.76 up Cdc20 
1435773_at 0.011341926 2.10E-05 1.75 up 4930547N16Rik 
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1426323_x_at 0.02146454 8.61E-05 1.74 up Siva1 
1441081_a_at 0.023227999 1.08E-04 1.73 up 1110038B12Rik 
1434399_at 0.02534305 1.29E-04 1.73 up Galnt6 
1423714_at 0.035847817 2.53E-04 1.73 up Asf1b 
1435136_at 0.03771621 2.96E-04 1.73 up Whsc1 
1424971_at 0.04192272 3.96E-04 1.71 up Ccdc99 
1423760_at 0.04192272 3.98E-04 1.71 up Cd44 
1435497_at 0.032973 2.10E-04 1.70 up 5730590G19Rik 
1423957_at 0.010874013 1.65E-05 1.68 up Aen 
1447364_x_at 0.043363128 4.27E-04 1.68 up Myo1b 
1419909_at 0.016128201 4.30E-05 1.67 up Mphosph9 
1419556_at 0.03093096 1.84E-04 1.67 up Elf5 
1418184_at 0.040570073 3.63E-04 1.67 up Cenpm 
1422685_at 0.020007981 6.78E-05 1.66 up Exoc4 
1440262_at 0.041561574 3.82E-04 1.64 up AI414108 
1459679_s_at 0.046937827 4.94E-04 1.63 up Myo1b 
1452197_at 0.018790066 6.26E-05 1.62 up Smc4 
1417837_at 0.030217253 1.78E-04 1.62 up Phlda2 
1458076_at 0.03767577 2.93E-04 1.61 up   
1436434_at 0.036173876 2.58E-04 1.61 up E2f2 
1449291_a_at 0.039222952 3.29E-04 1.60 up Dcbld1 
1415829_at 0.037506506 2.74E-04 1.59 up Lbr 
1416575_at 0.030217253 1.75E-04 1.59 up Cdc45 
1431358_at 0.039222952 3.39E-04 1.58 up 4930547N16Rik 
1424110_a_at 0.03767577 2.86E-04 1.58 up Nme1 
1459890_s_at 0.04187566 3.88E-04 1.58 up 1110008P14Rik 
1423525_at 0.02759537 1.48E-04 1.58 up Mastl 
1421309_at 0.045885 4.72E-04 1.57 up Mgmt 
1422686_s_at 0.005604662 3.49E-06 1.57 up Exoc4 
1448426_at 0.03873198 3.08E-04 1.56 up Sardh 
1450506_a_at 0.043363128 4.26E-04 1.56 up Aen 
1422747_at 0.043363128 4.25E-04 1.56 up Chek2 
1438645_x_at 0.02096506 7.62E-05 1.55 up Bace2 
1419267_at 0.033932794 2.33E-04 1.54 up Nfyb 
1433485_x_at 0.042330243 4.09E-04 1.54 up Gpr56 
1424156_at 0.047810193 5.17E-04 1.53 up Rbl1 
1454659_at 0.02146454 8.17E-05 1.52 up Dctd 
1455035_s_at 0.025596472 1.33E-04 1.52 up Nop56 
1442134_at 0.011341926 1.94E-05 1.52 up Prr11 
1435452_at 0.036452714 2.63E-04 1.51 up Tmem20 
1446507_at 0.008415986 6.79E-06 1.51 up   
1443999_at 0.03167863 1.93E-04 1.51 up   
1434382_at 0.049268622 5.50E-04 1.51 up Serinc2 
1422723_at 0.047810193 5.20E-04 1.51 up Stra6 
1452414_s_at 0.022740904 1.03E-04 1.51 up Ccdc86 
1454642_a_at 0.04697512 4.98E-04 1.51 up Commd3 
1422684_a_at 0.039222952 3.25E-04 1.50 up Exoc4 
1436472_at 0.004339723 1.44E-06 1.50   up Slfn9 
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Table 6.2: Top 12 gene cluster from the microarray-based gene expression profile 
of total skin from K14Cre Rnaseh2bFLOX/FLOX mice 
# cluster 
1 Cell cycle: G2/M DNA damage checkpoint regulation 
2 Cell cycle control of chromosomal replication 
3 Mitotic roles of polo-like kinase 
4 Estrogen-mediated S-phase entry 
5 ATM signaling 
6 Role of CHK proteins in cell cycle checkpoint control 
7 Role of BRCA1 in DANN damage response 
8 Cyclins and cell cycle regulation 
9 DANN damage-induced 14-3-3 signaling 
10 Hereditary breast cancer signaling 
11 Eumelanin biosynthesis 
12 p53 signaling 
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